Yaya tsawon lokacin da waɗannan alamun zasu kasance?
Kuma duk wani ciwon kirji ya kamata a bi da shi haka, musamman ma a shekarun da ya dace.
Kuma akwai kuma zafi.
Kuma ku duba hawan jini da kuma cholesterol.
Kuma yanzu kuna da zazzabi?
Kuma yanzu kuna da ciwon kirji?
Kuma banda haka, kuna numfashi?
Kuma za ku iya gaya mani, waɗanne alamun cutar kuke da su?
Kuma yaya zafin jikinka ya tashi?
Kuma ina da ciwon tari.
Kuma ina da mura da kuma wani ɗan tari.
Kuma a yau, na ji ciwon kirji sosai.
Kuma wannan shine lokacin da ya dace don fushinka?
Kuma yana sa ni ciwon kirji.
Kuma ina ganin na yi kadan kadan.
Kuma ina so ku yi bayani dalla-dalla game da wannan ciwon kirji.
Kuma suna da ƙananan ƙwayoyin cuta.
Kuma da tarihin ciwon sukari.
Ka sani, yana kama da kirji na yana shirin fashewa.
Kuma kun san cewa ana yi mini ba'a a koyaushe.
Kuma kana da ciwon kirji.
Kuma kun ce wannan shine matsin lamba a cikin kirjin ku.
Wani a cikin iyalin yana da ciwon zuciya, ciwon zuciya, hawan jini, da kuma yawan sinadarin cholesterol.
Shin akwai wasu alamun ko matsaloli da kuka lura da su, kamar ciwon tsoka?
Shin akwai wani a gidan da ke da irin wannan ciwo da kuma irin wannan bayyanar cututtuka?
Shin kuna da wasu alamun cutar?
Shin kuna da numfashi?
Shin har yanzu kuna da ciwon kirji?
Domin lokacin girbi ne.
Amma kuma bai kamata mu dauki alhakin ciwon kirji da ke fitowa daga cikin zuciya ba.
Amma yanzu, matsalar da ta fi tsanani ita ce ciwon kirji.
Amma ina da matsala a numfashi.
Amma na san cewa mutane da yawa suna yi mini ba'a.
Amma muna bukatar mu bi da duk wani ciwon kirji da ya fi dacewa.
Amma yanzu kana numfashi yadda ya kamata?
"Na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka, na yi ta kuka".
Kuna jin kamar wani yana taɓawa kirjinku.
Ina jin kamar na daina numfashi.
Shin suna gunaguni ne game da ciwo da alamun cutar iri ɗaya?
Shin kuna da cutar sankara kamar cutar hawan jini ko wani irin cuta?
Shin kuna da wasu matsalolin kiwon lafiya kamar ciwon sukari?
Shin kuna da ciwon numfashi tare da ciwon kirji?
Shin kana da hawan jini?
Shin zazzabi yana sa ka numfashi?
Shin kun san abin da ya nuna?
Ka ga hoton?
Ka sha ruwa mai yawa yau
Duk da haka, na yi gwajin jini don ciwon sukari.
Duk da haka, yana da irin wannan cututtuka kamar ni.
Yaya zafinka yake?
Yaya hawan jini?
Idan har yanzu kuna da zazzabi mai tsanani,
Idan kana da gado mai zafi, digiri dari biyu, sai ka hau.
Idan ka ga alamarka ko matsalarka ta fi kyau,
A jiya ina da zazzabi
Ina da ɗan zafin jiki.
Ina da zazzabi jiya.
Na ji ciwon zuciya sosai.
Ina da ciwon numfashi.
Zan aiko muku da hoto.
Ina da ciwon kirji a yau.
Ina da ciwon kai da kuma ɗan zazzabi a yau.
A ganina, cutar mura ce.
A ganina, wannan shi ne cutar da ta fi kowa.
Shin yana kama da wani mutum mai nauyi yana zaune a kirjinka?
Yana farawa da ciwon kai da zazzabi a lokaci guda.
Yana ciwo a tsakar kirji na.
Yana da matsi kamar ciwon kirji.
A cikin ƙirjina
Yana tsakiyar kirjina.
Yana tsakiyar kwari
Ina da ciwo a kirji na.
Na yi baƙin ciki sosai don ciwon kirji.
Ina so ku gaya mini dalla-dalla game da ciwon kirji.
Kamar hawan jini ko ciwon sukari.
Kamar yadda yake a tsakiyar kirji a hannun dama.
Yanzu don zazzabi, za ku iya shan tachipirin.
Mary ta yi kwanaki tana da alamun cutar
Yanzu kun ce kuna da ciwon kirji.
Na yi addu'a ga Jehobah kuma na yi masa addu'a.
A'a, ba ka da wasu alamun cutarwa ban da ciwon kirji?
Ko kuwa wani yana zaune a kirjinka?
Yana kama da zazzabi, kuma yana da tari, ciwon kai, da kuma ciwon tsoka.
A tsakar kirji na, a hannun dama
Ka nuna mini inda kake jin zafi a cikin wannan hoton.
A lokacin da kake da zazzabi
To, kuna tsammanin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da irin wannan alamar?
Ka gaya mini game da ciwon kirjinka
A lokacin da ake yin wannan aikin, ana yin zafi sosai.
A cikin kwanakin da suka gabata, ina da zazzabi.
A cikin dare, zafin ya fara ƙaruwa.
Wannan mataimakin likita ne a sashen gaggawa a cibiyar kula da cututtuka.
Za ka iya gaya mani kadan game da ciwon kirjinka?
Ina jin ciwo a gaba na, a nan a kirjina.
Haka ne, ina da ciwo mai tsanani a kirji.
Lokacin da nake da irin wannan ciwo a kirjina
Shin kuna da ciwon kirji?
Yaushe ne wannan ciwon kirji ya fara?
Shin kuna da ciwon kirji?
A wane bangare na kirjinka kake jin zafi?
"Na ji kamar an matsa mini a kan kirji.
Na kamu da ciwon sukari da sauran cututtuka.
Ka ce kana da ciwon kirji.
Hawan gaggawa na cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Hawan cutar coronavirus (COVID-19) yana nuna kamanceceniya a cikin ƙasashen EU / EEA, kuma Burtaniya ta tabbatar da cewa yayin da yake cikin matakai daban-daban dangane da ƙasa, cutar ta COVID-19 tana haɓaka cikin sauri a cikin dukkan ƙasashe.
Dangane da kwarewar Italiya, asibitoci da cibiyoyin kulawa ya kamata su haɓaka shirye-shirye don karuwar masu cutar COVID-19 waɗanda zasu buƙaci kulawa ta lafiya da musamman kulawa mai ƙarfi.
A ranar 31 ga Disamba, 2019, an ba da rahoton wani sabon kamuwa da cutar sankarar bargo, wanda ba a san asalin cutar ba, a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta ba da rahoton wani sabon nau'in kwayar cutar coronavirus, wanda ke nufin kwayar cutar coronavirus 2 na cutar ta hanyar numfashi mai saurin kamuwa da cuta (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da kwayar SARS-CoV-2 an sanya mata sunan cutar Coronavirus (COVID-19).
Shaida a yanzu ita ce kashi 80% na waɗanda ke da COVID-19 suna da ƙananan cututtuka, wato, kamuwa da cutar numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan marasa lafiya sun warke.
A cikin kashi 14 na cutar, COVID-19 ta ci gaba zuwa mummunan yanayin da ke buƙatar izinin asibiti, yayin da kashi 6% ke da mummunan yanayin da ke buƙatar kulawa mafi mahimmanci.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4%.
A cikin wannan binciken, mun kimanta yanayin karuwar cutar COVID-19 a kowace ƙasa ta Tarayyar Turai / EEA da Burtaniya, kuma mun kwatanta su da lardin Hubei na China.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a cikin ƙasashen Tarayyar Turai/EEA da Burtaniya tare da adadin waɗanda suka kamu da cutar a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
An samu karin mutane da suka kamu da cutar COVID-19 a kasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya.
Bayan mamaye kasar Sin, cutar ta COVID-19 ta ci gaba da yaduwa, kuma annobar COVID-19 mai saurin yaduwa a duniya a halin yanzu tana bin hanyar China.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba ta duniya.
A cikin Eurosurveillance 2020 na 5th Edition, Spiteri da sauransu sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai, bisa ga bayanan WHO na cutar.
A cikin Turai / Yankin Tattalin Arziki na Turai, an fara ba da rahoton tabbatar da shari'o'i uku da Faransa ta bayar a ranar 24 ga Janairu, 2020 ga mutanen da suka dawo daga Wuhan, lardin Hubei, China.
Ya zuwa ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a cikin ƙasashe 30 na EU / EEA da Burtaniya, waɗanda a tsakanin 31 ga Disamba, 2019, kuma a wannan ranar, sun kai adadin shari'o'in cutar 39,768, kuma an ba da rahoton mutuwar 1,727 daga cikinsu, 17,750 na kamuwa da cuta da 1,441 na mutuwa sun fito ne daga Italiya kadai.
Samun jimlar abubuwa da abubuwan da suka faru a matsayin ci gaba na adadin masu kamuwa da cutar COVID-19.
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin adadin COVID-19 da aka ruwaito a kowace ƙasa a duniya, wanda aka samo daga tushen hukuma kamar ma'aikatar lafiya, hukumomin kiwon lafiya na ƙasa da na yanki, da kuma Hukumar Lafiya ta Duniya, kowace rana da karfe 8:00 na safe.
An yi amfani da duk waɗannan bayanan don kimanta cutar COVID-19 a cikin ƙasashen EU / EEA, da kuma Burtaniya, kuma an kwatanta duk waɗannan bayanan da na Italiya.
A matsayin wakilcin masu cutar COVID-19 masu aiki, mun ƙididdige jerin abubuwan da suka faru na COVID-19 waɗanda suka daidaita zuwa kwanaki 14, la'akari da yanayin yanayin cutar COVID-19 a kowace ƙasa ta Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU/EEA) da Burtaniya, a lokacin Janairu 1 zuwa Maris 15, 2020.
Mun kuma nuna karuwar adadin masu kamuwa da cutar a kowace kasa da aka ruwaito a ranar 15 ga Maris, 2020, da karfe 8:00 na safe, idan aka kwatanta da Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen Turai / Yankin Tattalin Arzikin Turai da Burtaniya
A cikin yanayin yanayin COVID-19 wanda ya faru a cikin kwanaki 14 a cikin EU / EEA da Burtaniya, ya bi hanyar yanayin a lardin Hubei (China) (Hoto 1).
Ga Tarayyar Turai/EEA da kuma Burtaniya baki ɗaya, abubuwan da suka faru a matsayin barkewar cutar COVID-19 sun fara ƙaruwa a kusan 21 ga Fabrairu sannan suka ƙaru sosai a ranar 28 ga Fabrairu, 2020.
Wannan ya samo asali ne daga saurin karuwar adadin masu kamuwa da cutar da aka ruwaito daga Italiya, amma kasashen Turai/EEA da Burtaniya sun nuna irin wannan karuwar a cikin yanayin COVID-19.
Hoto na 2 ya nuna jimillar adadin kamuwa da cutar COVID-19 a ƙasashen Turai/EEA da Burtaniya idan aka kwatanta da Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Rahoton ya nuna cewa a ranar 15 ga Maris da karfe 8:00 na safe, sauran kasashe 15 na Tarayyar Turai / EEA da Burtaniya sun ba da rahoton ƙananan adadin masu kamuwa da cutar, idan aka kwatanta da adadin waɗanda ke Italiya, wanda ya kasance makonni uku da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin cututtukan COVID-19 da aka ruwaito sun yi saurin ƙaruwa a cikin ƙasashen EU/EEA da kuma Burtaniya.
Abubuwan da aka lura a cikin yanayin COVID-19 sun nuna cewa cutar ta ci gaba da haɓaka cikin ƙimar kusan a cikin dukkan ƙasashe.
Wannan ya bambanta da ƙasashe da ke cikin matakai daban-daban, canje-canje a cikin martani na lafiyar jama'a na ƙasa da ma'anar shari'a daban-daban a cikin ƙasashe, da kuma al'ada daban-daban don zaɓar marasa lafiya don gwaji don tabbatar da cutar COVID-19, gami da gwaji.
A farkon watan Maris na 2020, likitoci a yankunan da aka fi fama da cutar a Italiya sun ba da rahoton halin da ake ciki a yankin cewa kashi 10% na masu fama da COVID-19 suna buƙatar kulawa mai mahimmanci, kuma kafofin watsa labarai da yawa sun ba da rahoton cewa asibitoci da sassan kulawa mai mahimmanci a yankunan suna aiki da iyakar ƙarfin su.
Bayanai kan karbar COVID-19 a asibitoci da/ko cibiyoyin kulawa mai tsanani a halin yanzu ana samun su a matakin EU/EEA don kashi 6% da 1% na shari'o'i, bi da bi (bayanai ba a nuna su ba).
Koyaya, yakamata a tattara su azaman tsari don haɓaka bayanan sa ido na yanzu wanda ke mai da hankali kan adadin lamuran da aka ruwaito da adadin mutuwar.
Nazarin da aka gudanar a cikin 2010-11 ya nuna babban canji a cikin damar bayar da kulawa mai mahimmanci da matsakaitan gado a Turai, wanda ya fara daga 29.2 a Jamus zuwa 4.2 gadaje a cikin mutane 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu da yawa ko ƙasa da Italiya (a matsakaici 12.5 wuraren kulawa da gadajen kulawa a kowace mutane 100,000 a cikin 2010-11).
An ba da yanayin samfurin da ya shafi rashin iyawar kiwon lafiya a cikin sabon sabon ƙididdigar haɗarin COVID-19 na ECDC na shida, tare da kimantawa ga ƙasashen EU / EEA da Burtaniya cewa yawan masu karɓar COVID-19 suna da haɗarin wuce gona da iri na asibiti &gt; 90%.
Saboda yawancin shari'o'in sun kasance a wasu yankuna a cikin ƙasashen Turai, Yankin Tattalin Arzikin Turai da Burtaniya, kuma asibitoci da cibiyoyin kulawa galibi suna ba da sabis ne kawai ga yawan jama'ar yankin da aka ƙayyade, saboda haka ya kamata a ba da bayanin shari'o'in da kuma kulawar kulawa a kan yankin na yanki na 2 (NUTS-2).
Kwarewa daga Italiya da kuma halin yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 ta duniya tana ci gaba cikin sauri a cikin ƙasashen Tarayyar Turai/EEA da Burtaniya.
Kasashe, asibitoci da cibiyoyin kulawa ya kamata su kasance a shirye don sabon yanayin watsawa na SARS-CoV-2 mai yuwuwar cutar coronavirus da kuma karuwar adadin marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa ta musamman da kulawa mai mahimmanci, kamar yadda lamarin yake faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda sabon Binciken Hadarin Cikin Gida na ECDC ya nuna, hanzarin amsawa, daidaitacce, da kuma cikakke hanya na da mahimmanci wajen jinkirta yaduwar cutar SARS-COV-2-ta hanyar sauyawa daga hanawa zuwa ragewa, yayin da saurin karuwar adadin shari'o'i na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da amsawa yadda ya kamata idan ba a aiwatar da su ba da wuri.
A cikin wannan rahoton, an bayyana cewa, "An yi amfani da wannan hanya ta hanyar yin amfani da hanyoyin sadarwa na yanar gizo don magance matsalolin da ke tattare da cutar".
Akwai ɗan gajeren lokaci a cikin wannan lokacin da ƙasashe za su iya ƙara haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba a kan hukumomin kiwon lafiya.
Idan aka kasa yin hakan, tsarin kiwon lafiya na sauran kasashen Turai na EU / Yankin Tattalin Arzikin Turai na iya fuskantar karuwar marasa lafiya da ke bukatar kulawa mai zurfi a cikin kwanaki da makonni masu zuwa.
Barkewar cutar coronavirus ta 2019 (COVID-19), wanda cutar ta coronavirus ta 2 (SARS-CoV-2) ta haifar, ya kashe mutane sama da 3,000 ya kuma kamu da mutane sama da 80,000 a China da sauran wurare a duniya, sakamakon hakan ya haifar da bala'i ga mutane.
Kwayar cutar ta yi kama da kwayar cutar ta SARS-CoV, wacce ta haifar da cutar SARS a kan dubban mutane a 2003. SARS-CoV-2 na iya yaduwa daga ƙudaje kuma yana haifar da alamun cutar ta hanyar tsarin kama da kwayar cutar SARS-CoV.
Koyaya, COVID-19 yana da ƙarancin tsanani da ƙarancin mutuwa fiye da SARS, amma yana da yaduwar cuta kuma yana shafar tsofaffi fiye da matasa, kuma maza sun kamu da cutar fiye da mata.
Don amsa yawan wallafe-wallafen da ke kan cutar mai yaduwa, wannan labarin yana so ya ba da cikakken bayani game da batun bincike mai saurin canzawa.
Za mu tattauna game da asali game da cutar, dalilin cutar, ganewar asali, magani, tsinkaya da rigakafin cutar.
Duk da cewa akwai tambayoyi da yawa da ba a amsa ba, muna fatan cewa wannan bita zai taimaka mana mu fahimci kuma mu magance wannan barazanar cutar.
Bikin Kirsimeti na 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa gani ba ga duk Sinawa, waɗanda aka ƙarfafa su su zauna a gida don hutu da makonni bayan barkewar sabon cutar.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar sankara mai saurin kamuwa da cuta (SARS) a 2003. Saboda haka, an sanya mata suna SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, kuma an sanya wa sauran cututtukan da ke da alaƙa da cutar CoV Disease-19 (COVID-19).
Barkewar cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta yadu cikin sauri a fadin kasar da kuma kasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, kwayar cutar ta haifar da kamuwa da cutar COVID-19 guda 80,000, tare da sama da marasa lafiya 40,000 da aka sallama daga asibiti, kuma sama da marasa lafiya 3000 sun mutu.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 shine babban makiyin jama'a kuma yana da damar da ta fi ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), cikin ƙasa da watanni biyu, sama da karatu 200 aka buga game da COVID-19, gami da nazarin kwayar cutar, sanadin, ganewar asali da magani tun bayan rahoton farko a ranar 7 ga Janairu, 2020, wanda ya tsara kwayar cutar ta ware daga masu cutar da yawa.
Wannan bita yana ƙoƙari ya rage ci gaban bincike a cikin sabon fannin da ke saurin canzawa.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS, wani cuta da ke haifar da kwayar cutar coronavirus (CoV), ciwon numfashi na tsakiya (MERS, wanda ya ɓarke a shekarar 2012).
Za mu kuma tattauna abin da muka koya game da rigakafi da kuma hasashen cutar, da kuma tambayoyin da muke buƙatar amsawa cikin gaggawa.
Yawancin lokaci, ana ɗaukar CoVs a matsayin ƙwayoyin cuta marasa haɗari ga mutane, waɗanda galibi ke haifar da cutar mura ta yau da kullun, kusan kashi 15% na cutar mura ta 4.
A wannan karni, duk da haka, mun fuskanci kwayar cutar coronavirus (CoVs) masu saurin ninka yawan mutane, SARS-CoV da cutar zazzabin cizon sauro (MERS-CoV), wanda ya haifar da barkewar cutar farko a China a 2003 da Saudi Arabiya a 2012, sannan ya bazu zuwa wasu ƙasashe da yawa tare da ƙaruwa da ƙaruwa da ƙimar mutuwa.
Saboda haka, COVID-19 a halin yanzu shine annoba ta uku ta kwayar cutar coronavirus (CoV) a cikin tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, an fara bayar da rahoton wani kwari na cutar huhu daga birnin Wuhan a ranar 31 ga watan Disamba, 2019 zuwa hukumar lafiya ta kasa ta kasar Sin.
Kwana bakwai bayan haka, an fitar da jerin kwayar cutar coronavirus (CoV).
A ranar 15 ga Janairu, 2020, an ba da rahoton mutuwar farko daga Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwan da ke makwabtaka da larduna da ƙasashe.
A ranar 20 ga watan Janairu, an bayar da rahoton kamuwa da cutar ta masu ba da kiwon lafiya, wanda ya tabbatar da cewa kamuwa da mutum daga mutum zuwa mutum na iya faruwa.
A ranar 23 ga Janairu, an rufe Wuhan ba tare da sufuri ba.
A ranar 24 ga watan Janairu, binciken farko na gwaji kan cutar ya nuna cewa daga cikin dukkan marasa lafiya 41 da suka kamu da cutar, 21 ne kawai suka kasance cikin hulɗa kai tsaye da kasuwar kayan kiwon teku ta Wuhan, wacce ake ganin ita ce tushen kamuwa da cutar daga dabbobi da ba a san asalin su ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta ayyana annobar a matsayin gaggawa ta duniya.
A lokacin da aka fitar da wannan rahoton, cutar ta bazu ko'ina cikin kasar Sin da kuma kusan wasu kasashe 50 a duniya (Hoto na 2).
Yayin da yanayin ke ci gaba da bunkasa, yanayin kwanan nan da kuma tsananin barkewar cutar na ci gaba da sanya ido sosai.
A ranar 11 ga watan Fabrairun 2020, wani binciken da aka gudanar a cibiyoyi da dama kan marasa lafiya 8866 daga cikinsu akwai marasa lafiya 4021 da aka tabbatar da cutar COVID-19, ya nuna yadda cutar ta yadu kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Cutar SARS-CoV-2 tana faruwa a kowane zamani, amma mafi yawan lokuta tana faruwa ne a tsakanin shekaru 30-65.
Kusan rabin (47.7%) na masu kamuwa da cutar sun haura shekaru 50, kaɗan ne ke da shekaru 20 da haihuwa, kuma 14 daga cikin masu kamuwa da cutar ne kawai ke da shekaru 10 da haihuwa.
SARS-CoV-2 ya kamu da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya faɗaɗa a cikin ƙugiya ko ƙugiya a cikin da kewayen lardin Hubei.
COVID-19 yana ɗaukar matsakaicin kwanaki 5 (2-9) daga farkon cutar zuwa ganewar asali.
Matsakaicin lokacin da za a iya haifar da cutar ya kasance tsakanin kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga farawar cutar zuwa mutuwa shine kwanaki 9.5 (4.8-13).
Matsakaicin asalin asalin (R0) shine 3.77 (95% CI: 3.51-4.05) kuma gyaran R0 shine 2.23-4.82.
Adadin masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, lokacin da ake samun gagarumin tashin hankali kafin bikin Kirsimeti na bazara a kasar Sin.
Yawan mutuwar marasa lafiya da aka tabbatar da su ya kasance 1.44% (95% CI: 1.10-1.86%) kuma yawan mutuwar da aka daidaita na dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Babban abubuwan haɗari guda uku don COVID-19 sune jinsi, shekaru 60 da haihuwa, da kuma waɗanda ke da cututtukan huhu.
Kwayoyin cuta na corona, ko CoVs, ƙwayoyin cuta ne masu girman gaske, masu kewaye da kewaye, waɗanda ke ɗauke da RNA guda ɗaya.
Ana iya rarraba su zuwa nau'i hudu, wato alpha-beta-gamma da beta-beta-CoVs, kuma an san cewa suna iya kamuwa da mutane.
Kwayar cuta ta spike (S) tana da alaƙa da ƙwayoyin cuta masu karɓar ƙwayoyin cuta na 2 waɗanda ke canza angiotensin (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV daban-daban, kuma daga baya an sami haɗin gwiwa.
Bayan an gama kwayar cutar, RNA mai kewaye da glycoproteins da nucleocapsid sun hada da kananan ruwa, wanda ya narke tare da sinadarin plasma don fitar da kwayar cutar.
An fara ba da rahoton kwayar cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in kwayar cutar beta-CoV wanda ke da kimar kwayoyin halitta sama da kashi 99.98% a cikin samfura 10 da aka tattara daga asalin cutar, kasuwar kayan masarufi ta Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscopic electron microscope, an gano kwayar cutar SARS-CoV-2 a cikin mafi girman ɓangaren epithelium na numfashin mutum.
An gano ACE2 na ɗan adam a matsayin mai haɓaka ƙwayar cutar SARS-CoV-2 da kuma cutar SARS-CoV.
Koyaya, kwayar S na kwayar cutar SARS-CoV-2 tana da rauni sosai a cikin haɗuwa da ACE2 na ɗan adam fiye da haɗuwa da kwayar cutar SARS-CoV, wanda ya saba da gaskiyar cewa SARS-CoV-2 yana haifar da ƙarancin kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya haifar da sabon ɗan ƙaramin furotin wanda aka tsara ta hanyar orf3b da kuma ɓoyayyen furotin da aka tsara ta hanyar orf8.
SARS-CoV-2 orf3b na iya taka rawa wajen cutar da kwayar cutar da kuma hana fitar da IFNβ. Koyaya, orf8 bashi da sanannen tsari ko tsarin aiki.
A ranar 18 ga Fabrairu, 2020, Joe da sauransu sun ba da rahoton tsarin cryoEM na ACE2 mai cikakken girman mutum a cikin 2.9 A tare da hadaddun B0AT1 na masu karɓar amino acid.
Sun gano cewa yana da daidaituwa, wanda aka ba da cikakkun tsari na buɗewa da rufewa a matsayin dimer, kuma yana iya haɗa sunadarai biyu na S, dukansu sun ba da tabbaci game da ganewar asali da kuma kamuwa da cutar coronavirus.
B0AT1 na iya zama wata manufa ta magani don kula da magunguna don kawar da cutar SARS-CoV-2.
A cikin wannan labarin, za mu tattauna wasu abubuwa da suka faru a lokacin da aka kashe Yesu.
An san cewa SARS-CoV biyu sun samo asali ne daga tsuntsaye kuma an watsa su ga mutane ta hanyar civet, kuma MERS-CoV ya samo asali ne daga dabbobi masu kama da dabbobi.
Ta hanyar kwatanta tsarin halittar SARS-CoV-2 da sauran kwayar cutar korona (CoVs), an dauki bat a matsayin asalin kwayar cutar SARS-CoV-2 saboda sabon kwayar cutar ta kasance daidai da kashi 96% na kwayar cutar korona (CoVs) wanda ya yi kama da SARS guda biyu da suka fito daga bat, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san ainihin abin da ya sa cutar ta shiga daga dabbobi zuwa mutane ba, kuma ba a san hanyar da za a iya watsa ta ba.
Ji da sauransu sun nuna cewa giwaye ne ke daukar kwayar cutar daga fararen tsuntsaye zuwa ga mutane, wanda ya shafi sake haɗuwa da ke da kama a cikin S-protein.
A cewar wani bincike, ƙungiyar masu bincike a Guangzhou, China sun nuna cewa tsuntsaye, masu amfani da dogon baki, masu amfani da maganin gargajiya na kasar Sin, sune matsakaitan nau'ikan kwayar cutar SARS-CoV-2 wanda ke da tasiri, bisa ga tsarin halittar jini wanda ya yi daidai da kashi 99% na coronavirus da aka gano a cikin tsuntsaye da SARS-CoV-2.
Duk da haka, bambancin 1% da ya bazu zuwa kwayoyin halittar biyu har yanzu babban bambanci ne. Saboda haka, ana jiran sakamakon da aka yanke akan hujjojin da aka tabbatar (Figure 33).
Ba a san yawancin abubuwan da ke tattare da kwayar cutar SARS-CoV-2 ba.
Kwayar cutar SARS-CoV da kwayar cutar MERS-CoV na iya rayuwa na tsawon sa'o'i 48 a cikin bushewar yanayi, kuma tana rayuwa na tsawon kwanaki 5 a ƙarƙashin zafin jiki 20 da ƙanshi 40%-50%.
Kwayar cutar SARS-CoV-2 na iya zama mai kama da juna.
An ba da rahoton cewa SARS-CoV-2 ba shi da tsayayya ga kyamarar ultraviolet da zafi a zazzabi na 56 ° C na tsawon minti 30. 75% ethylene ethanol kashe kwayoyin cuta, yana dauke da perocetic acid, chloroform da sauran mai mai maye gurbin mai wanda ba chlorhexidine ba, wanda zai iya kashe kwayar cutar.
Yawan mutanen duniya ba su da kariya ga cutar SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, ba a yi cikakken bincike game da yadda tsarin garkuwar jiki ke amsa SARS-CoV-2.
Don haka mun kalli binciken da aka yi a baya kan wasu CoVs, musamman SARS-CoV da MERS-CoV (Figure 4) 4.
A cikin al'ada, bayan da kwayar cutar ta shiga cikin kwayar halitta, tsarin rigakafin kwayar halitta ne ya fara gane ta ta hanyar masu karɓar karɓar karɓar karɓa (PRRs), gami da masu karɓar lectin-kamar C-type, masu karɓar karɓar karɓa kamar Toll (TLR), masu karɓar karɓa kamar NOD (NLR), da masu karɓar karɓar RIG-I-like (RLR).
A wasu hanyoyi, kwayar cutar ta haifar da sakin wakilai masu haifar da kumburi, tsufa na kwayar cuta, da kuma kwayar cutar fashewar fashewar fashewar fashewar fashewar kwayar cutar (IFNs), wanda ke rage yaduwar kwayar cutar da kuma hanzarta fashewar fashewar fashewar kwayar cutar.
Koyaya, kwayar cutar N ta SARS-CoV na iya taimakawa kwayar cutar ta tsere daga tsarin garkuwar jiki.
Ba da daɗewa ba, tsarin garkuwar jiki mai daidaitawa zai shiga cikin yaƙi da kwayar cutar.
Kwayoyin jini T lymphocytes sun hada da CD4 + da CD8 + T sun taka muhimmiyar rawa a cikin rigakafin jiki.
CD4+T tana motsa B don samar da takamaiman kwayar cutar da ta dace da ita, kuma CDC8+T tana kashe kwayar cutar kanta.
T-cell mai taimako tana samar da cytokines masu hana kumburi don taimakawa kwayoyin garkuwar.
Koyaya, coronavirus na iya hana aikin T-cell ta hanyar haifar da yanayin mutuwar T-cell.
Tsarin rigakafin mutum, gami da C3a da C5a da kuma kwayoyin halitta, suna da mahimmanci wajen yaki da kamuwa da kwayar cutar.
Misali, kwayar halitta da aka cire daga marasa lafiya da suka warke ta mayar da kwayar cutar MERS-CoV cikin yanayi na al'ada.
A gefe guda, yawan amsawar jikin mutum yana haifar da yawan yaduwar 'yan ciwon daji wanda zai iya haifar da mummunar lalacewa ga hanta da sauran gabobin jiki, kuma a mafi munin yanayin, gazawar kwayar halitta da mutuwa.
Cutar SARS-CoV-2 da aka nuna ta hanyar farawar alamun cutar na iya shafar tsofaffi marasa lafiya da mata masu juna biyu.
Yana da kyau ga mutanen da ke fama da manyan ƙwayoyin cuta ko kuma waɗanda ke da rauni a tsarin garkuwar jiki, su sami damar kamuwa da cutar fiye da sauran.
Matsakaicin lokacin fitar da kwayar cutar SARS-CoV-2 daga kwanaki 1-14 ne, wanda ya fi tsawon kwanaki 3-7, bisa ga nazarin shari'o'i 425 na farko a Wuhan.
Koyaya, nazarin shari'o'in 1099 ya nuna cewa tsawon lokacin cutar shine kwanaki 3 a matsakaici kuma ya fara daga kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka bayyana a sama, ya nuna cewa lokacin farkawa na cutar shine kwanaki 4.8 (3.0-7.2) bisa ga yawan jama'a na 8,866 lokuta.
Yana da matukar mahimmanci ga hukumomin kiwon lafiya su daidaita lokacin gwajin cutar ta hanyar ingantaccen lokacin farkawa, don haka ya kare wadanda ke dauke da cutar amma basu da alamun cutar daga yada cutar ga wasu.
A cikin al'ada, ana buƙatar mutum wanda ya kamu da cutar ko ya kamu da cutar ta hanyar yin gwajin gwaji na kwanaki 14.
Shin zan killace kaina har tsawon kwanaki 24?
Zazzabi shine farkon kuma babban bayyanar cutar ta COVID-19, wanda ba shi da alamun bayyanar cututtuka ko kuma wasu alamun bayyanar cututtuka kamar su bushewa, rashin numfashi, ciwon tsoka, ciwon kai, ciwon fuska, kumburi, ciwon kirji, kumburi, tashin zuciya, da tari.
Wasu marasa lafiya sun sami matsala da kumburi da/ko rashin isashshen iskar oxygen a cikin jini a cikin mako guda bayan farawar cutar.
A cikin mawuyacin hali, mai haƙuri ya fara haɓaka zuwa alamun rashin numfashi, rashin ƙarfi, rashin ƙarfi, ƙarancin acid, ƙarancin abinci, da kuma zubar da jini.
Ya kamata a fara bincika marasa lafiya da ke da zazzabi da / ko alamun cututtukan numfashi da zazzabi, duk da cewa babu wani rashin daidaituwa na ƙwayar cuta.
Nazarin alƙaluma a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar shine 98% don zazzabi, 76% don tari, 55% don ciwon hanta da 3% don cutar kansa, kuma kashi 8% na marasa lafiya suna buƙatar isar da iska.
Wannan binciken ya nuna cewa, wasu nazarin biyu na baya-bayan nan na kwayar cutar, da kuma na mutane, sun samo asali ne daga kamuwa da cutar daga mutanen da ba su da alamun cutar.
Idan aka kwatanta da binciken alƙaluma na shekarar 2012, an nuna cewa masu fama da cutar MERS-CoV suna da kashi 98% na zazzabi, kashi 47% na tari, kashi 55% na kumburi, wanda shine babban alamun su.
Koyaya, kashi 80% na waɗannan marasa lafiya suna buƙatar ƙarin taimakon iska fiye da marasa lafiya na COVID-19, kuma ya yi kama da MERS, wanda ya fi cutar COVID-19 muni.
An kuma lura da cutar kansa (26%) da ciwon ciki (21%) a cikin marasa lafiya (MERS).
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99%-100%), tari (29%-75%), tari (40%-42%), kumburi (20-25%) da ciwon kumburi (13-25%) sune alamun bayyanar, kuma ana buƙatar tallafin iska mai shigowa don kusan 14%-20% na marasa lafiya.
A ranar 14 ga watan Fabrairu, mutuwar COVID-19 ta kai kashi 2 cikin dari, yayin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
Idan aka kwatanta da mutuwar SARS, a watan Nuwamba na 2002, kashi 10% na cutar, wanda ya kai 8,096 da aka tabbatar.
Game da cutar MERS bisa ga binciken alƙaluma a watan Yunin 2012, yawan mutuwar ya kai kashi 37 cikin ɗari na 2,494 da aka tabbatar.
Nazarin da ya gabata ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da ingantaccen 95% (CI) na 5.71 zuwa 7.23, yayin da R0 na SARS-CoV kawai ya kai tsakanin 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da kuma SARA-CoV dangane da alamomin cutar da R0 na shi an nuna su a cikin tebur  tebur 1.1 .
Wannan adadi ya nuna cewa SARS-CoV-2 ya fi MERS-CoV da SARS-CoV iya yaduwa, amma ya fi na baya biyu muni.
Saboda haka, yana da wahala a sarrafa yaduwar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Ana iya samun cutar ta hanyar iyali daya ko ta hanyar taro ko kuma ta hanyar tafiya a cikin jirgin ruwa guda daya, kamar su turkey.
Marasa lafiya galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da ke fama da cutar, ko kuma sun kasance tare da wani mutum mai cutar ko mai cutar a cikin makonni biyu da suka gabata kafin fara cutar.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba fiye da makonni biyu, kuma marasa lafiya waɗanda suka warke kuma suka bar asibiti na iya ɗaukar kwayar cutar kuma, wanda ke nuna sanarwar gaggawa don ƙara lokaci don aikin likita.
Mai yiwuwa ne ya kasance yana da ƙarancin ƙwayoyin jini a farkon lokacin.
Misali, an gano lymphopenia mai yawan kwayar jini 4×109/L, gami da yawan lymphocytes 1×109/L, da kuma kasancewar kwayar cutar a cikin jini, da kuma yawan amino acid mai suna aspartame a cikin marasa lafiya 1,099 na COVID-19.
An samu karuwar sinadarin hanta, tsoka da kuma myoglobin a cikin jinin wasu marasa lafiya, kuma an samu karuwar sinadarin C da kuma karuwar electrocyte a cikin jinin wasu marasa lafiya masu yawa.
A cikin marasa lafiya masu tsanani, an ƙara yawan D-dimer, wanda shine ƙarancin fibrin a cikin jini, kuma an rage yawan ƙwayoyin lymphocyte.
An gano rashin daidaito a cikin hotunan kirji na radiation a cikin yawancin marasa lafiya na COVID-19 kuma an nuna shi ta hanyar mirroring na biyu ko mirroring na hanta.
Marasa lafiya sukan ci gaba da rashin kumburi na huhu, lalacewar huhu da kuma bayyanar cututtukan numfashi na numfashi (ARDS).
Lokacin da cututtukan numfashi suka yi tsanani, kumburi mai yawa, tarin ruwa da kuma juyin halitta na huhu na iya haifar da rashin yiwuwar motsawar gas ko iska a cikin jiki.
Rashin aiki na nau'ikan nau'ikan I da na II na ƙwayar cutar huhu yana haifar da raguwar matakan surfactant da haɓaka matsin lamba na waje, don haka yana haifar da raguwar ƙarfin huhu wanda ba zai iya girma ba kuma yana ƙara haɗarin lalacewar huhu.
Saboda haka, sakamakon gano mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar mummunar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na COVID-19 ya nuna rushewar pneumocytes, bayyanar da kwayar cuta, da shigar da ƙwayoyin cuta na interstitial da ƙwayoyin cuta na numfashi, ƙwayoyin cuta masu yawa a cikin huhu na marasa lafiya da suka mutu da cutar, daidai da cutar da ARDS, kuma yayi kama da cutar da SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar aikin trans-transcriptase polymerase (RT-PCR) an yi amfani da shi azaman babban abin tantancewa don ganewar asali na cutar COVID-19.
Koyaya, saboda yawan rashin inganci wanda zai iya hanzarta yaduwar cutar, an fara amfani da nunin asibiti don yin bincike (wanda baya dogaro da RT-PCR) a China a ranar 13 ga Fabrairu, 2020.
Irin wannan yanayin ya faru ne a lokacin da aka gano cutar SARS.
Wannan shine dalilin da ya sa hada bayanan cututtukan, sakamakon gwajin gwaji, sakamakon gwajin gwaji, da kuma hotunan X-ray yana da mahimmanci kuma yana da amfani don ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar ta bayyana wani taron amfani da fasahar CRISPR mai suna SHERLOCK don gano kwayar cutar SARS-CoV-2 wanda ke gano ɓangarorin SARS-CoV-2 RNA a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 rule per micron of input) ta amfani da jerin ƙwayoyin cuta a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu ƙarfi ba.
Ana fatan cewa wannan sabuwar fasaha za ta iya inganta fahimtar mahimman bayanai da kuma samar da sauƙi idan aka sanya ta cikin samfurin gwaji na ainihi.
Saboda rashin ƙwarewa a cikin maganin wannan CoV, likitoci sun ba da shawarar kawai maganin kulawa na gaba ga marasa lafiya na COVID-19 yayin da suke ƙoƙarin gwada yawancin magunguna waɗanda aka yi amfani da su ko kuma aka ba da shawarar su a baya don magance wasu ƙwayoyin cuta na coronaviruses (CoVs) kamar SARS-CoV, MERS-CoV, da sauran cututtukan ƙwayoyin cuta. (Table (Table2)).
Wadannan hanyoyin sun hada da maganin da ake da su a yanzu da kuma maganin da ake da shi ta hanyar maganin rigakafin cutar, maganin hana rigakafi, maganin steroids, plasma daga marasa lafiya da suka warke, maganin kasar Sin, da kuma bayar da taimakon tunani.
Ko da filastik daga marasa lafiya da suka warke an ba da shawarar amfani da shi don magani.
Kamfanonin magunguna da dama na fafatawa wajen samar da kwayoyin cuta da kuma allurar rigakafin cutar.
SARS-CoV-2 ya fara kai hari ga huhu a farkon matakin kuma ya ci gaba da kai hari ga sauran kwayoyin da ke fitar da ACE2, kamar tsarin narkewa da koda.
Duk da haka, rashin aiki da rashin numfashi suna da babbar barazana ga marasa lafiya kuma sune manyan abubuwan da ke haifar da mutuwa.
Don haka, tallafin numfashi yana da mahimmanci don rage alamun cutar da ceton rayuka kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai shigowa da fitarwa wanda ba ya narkewa, da iska mai iska wanda ke yaduwa ta hanyar shi dangane da tsananin cutar.
Marasa lafiya da ke da cututtukan cututtukan numfashi masu tsanani suna buƙatar kulawa da maganin extracorporeal membrane oxygenation (ECMO), wanda shine fasaha na inganta tsarin jijiyoyin zuciya da na huhu wanda ake amfani dashi wajen magance cututtukan zuciya da kuma rashin ƙarfi na numfashi wanda ke barazanar rayuwa.
Bugu da kari, kiyaye daidaiton lantarki, rigakafi da maganin kamuwa da cuta bayan kamuwa da cuta, da kuma amsawa ga cuta, da kuma kare ayyukan kwayoyin halitta duk suna da mahimmanci ga masu cutar SARS-CoV-2.
An san cewa cutar ta cutar ta Tsakiya ta samo asali ne daga tsananin amsawar tsarin garkuwar jiki ga masu cutar SARS da MERS.
Cytokine wani nau'i ne na tsarin amsawar kumburi wanda aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan sunadarai suna sa kwayoyin garkuwar jiki su fitar da manyan sinadarai masu guba wadanda suke da alhakin ARDS da kuma gazawar wasu kwayoyin.
Ana bukatar hana rigakafi wajen maganin cututtukan cytokine, musamman ma a cikin marasa lafiya masu ciwo mai tsanani.
Ana amfani da magungunan corticosteroids da tocilizumab, masu maganin IL6 na monoclonal, don magance cutar cytocin.
Sauran maganin rigakafi na cututtukan cytokine sun hada da daidaitawar amsawar rigakafin T-cell, hana IFN-γ, IL-1, da TNF, hana JAK, amfani da blinatumomab, hana cytokine mai fitar da sigina 4, da kuma hana HDAC.
Ana amfani da maganin rigakafi na steroid a cikin maganin SARS don rage mummunan cutar da ke haifar da kumburi.
Koyaya, magungunan steroid a cikin babban allurai ba su da amfani wajen magance mummunan rauni na hanta na SARS da COVID-19.
A akasin wannan, suna iya haifar da mummunan sakamako, musamman ma cututtukan kasusuwa, wanda ke shafar yanayin cutar.
Koyaya, gajeren lokacin shan magungunan hormone corticosteroids a cikin ƙananan zuwa matsakaici ana ba da shawarar yin amfani da shi tare da taka tsantsan ga marasa lafiya masu cutar COVID-19.
A lokacin rubuta wannan, babu wani magani na maganin rigakafin cutar da aka tabbatar da inganci.
Koyaya, an sami ingancin allurar ƙwayar cuta ta Remdesivir a cikin kwayar cutar COVID-19 a cikin Amurka.
Remdesivir wani sabon maganin rigakafi ne da kamfanin Gilead Biopharmaceuticals ya fara kirkirarsa don maganin cutar Ebola da Marlburg.
Daga baya, remdesivir ya nuna cewa yana iya hana kwayar cutar RNA mai haɗuwa, gami da MERS da SARS.
Bisa ga wannan, Gilead ta ba da kayan aiki ga China don gudanar da gwaje-gwaje biyu a kan mutane da ke dauke da cutar SARS-CoV-2, kuma ana tsammanin sakamakon.
Bugu da kari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an nuna su a matsayin magungunan da za su iya taimakawa marasa lafiya da ke fama da rashin lafiyar numfashi.
Rashin kumburi, kumburi, lalacewar kwayar cutar hanta da sauran halayen na iya faruwa bayan maganin haɗin lopinavir/ritonavir.
Ya kamata a kula da hulɗar waɗannan jiyya tare da sauran magunguna da ake amfani da su a cikin marasa lafiya.
Plasma da aka ba wa marasa lafiya da suka warke da kuma gina jikin mutum
Tattara jini daga marasa lafiya da suka warke daga kamuwa da cuta don kula da sauran marasa lafiya da ke fama da cutar ko kuma kare lafiya daga kamuwa da cutar ya kasance tun da daɗewa.
A gaskiya ma, marasa lafiya da suka warke suna da matakan rigakafin cutar a cikin jinin su.
Kwayoyin cuta sune immunoglobulin (ig) da kwayoyin B ke samarwa wajen yaki da kwayar cuta da kuma wasu abubuwa masu ban mamaki da ba a cikin jiki, kuma suna iya gano ko wane kwayoyin ne ke haifar da cutar kuma suna kashe kwayoyin kai tsaye.
Dangane da wannan, za a yi allurar filastik da aka tattara daga jinin marasa lafiya da suka warke daga COVID-19 a cikin marasa lafiya 10 masu matukar wahala.
Alamar su na inganta cikin awanni 24 ta hanyar rage kumburi da kuma kamuwa da kwayar cutar da kuma inganta iskar oxygen a cikin jini.
Duk da haka, ana buƙatar ƙira da tabbaci don ba da shawarar hanyoyin don amfani mai yawa kafin a sami takamaiman magani.
Bugu da ƙari, saboda tasirin warkarwa, wasu halayen da ke tattare da filastik ya kamata a yi la'akari da su sosai.
Misali, kwayar cutar za ta iya wuce haddi a tsarin rigakafi kuma ta haifar da bayyanar cututtukan cytokine, wanda zai iya haifar da guba mai mutuwa.
Yawan kwayoyin a cikin jini yawanci yana da ƙananan matakan kuma ana buƙatar plasma mai yawa don kula da marasa lafiya masu tsanani.
Yana da wahala a samar da takamaiman kwayoyin halitta da sauri don yaƙar yaduwar cutar a duniya.
Saboda haka, yana da mahimmanci kuma ya fi dacewa a ware kwayoyin B daga marasa lafiya da suka warke kuma a gano kwayoyin da suka sanya kwayoyin, ko kuma a bincika kwayoyin da ke aiki da kwayar cutar.
Ta wannan hanyar, zamu iya kara yawan kayan aiki da sauri.
An yi amfani da TCM wajen magance cututtuka a kasar Sin tun shekaru dubbai.
Koyaya, tasirin sa galibi ya dogara ne akan haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali na cutar, wanda ya dogara da ka'idodin TCM.
Yawancin abubuwan da ke da tasiri har yanzu ba a san su ba ko kuma ba a bayyana su ba saboda yana da wahala a cire da kuma adana irin waɗannan abubuwan ko kuma a adana su da kyau.
A halin yanzu, saboda rashin ingantaccen magani da takamaiman magani don COVID-19, TCM ya zama babban madadin magani ga marasa lafiya masu rashin lafiya ko matsakaici ko waɗanda suka murmure daga mawuyacin yanayi.
Misali, an gano cewa maganin sulfogenidine da maganin hujin jin na da tasiri wajen magance cutar COVID-19.
An lura da cewa mafi girman adadin masu warkewa na maganin COVID-19 a wasu larduna a China, tare da amfani da TCM a cikin kashi 87% na marasa lafiya, waɗanda suka fito daga Guangzhou (63.7%), Ningxi (50%) da Hunan (50%), yayin da Hubei, wanda ya yi amfani da TCM a cikin kusan kashi 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin adadin masu warkewa (13%).
Koyaya, wannan kwatancen mai sauri ne, saboda yawancin sauran abubuwan da ke haifar da cutar, kamar yawan marasa lafiya da tsananin su, ya kamata a sanya su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Bulyan da abokan aiki sun buga wani bincike don kwatanta maganin Yammacin Turai (WM) shi kaɗai tare da haɗin gwiwar WM da TCM.
Sun gano cewa lokacin da ake buƙata don sake dawo da yanayin zafin jiki, lalacewar bayyanar cututtuka da kuma asibiti don ƙungiyar WM + TCM sun fi na WM.
Abin sha'awa, ƙimar cutar ta ƙara muni (daga matsakaici zuwa mai tsanani) ya kasance mai ban mamaki ga ƙungiyar WM + TCM, ƙasa da ƙungiyar WM (7.4% vs. 46.2%), kuma ƙananan ƙimar mutuwa ga ƙungiyar WM + TCM, ƙasa da ƙungiyar WM (8.8% vs. 39%).
Koyaya, inganci da amincin TCM har yanzu suna jiran gwajin gwaji mai kyau, mai girma da kuma a cikin cibiyoyi da yawa.
Hakanan yana da ban sha'awa don ƙayyade yanayin aikin kuma tabbatar da ingancin kayan aikin TCM ko kuma haɗuwa da shi, idan zai yiwu.
Yawancin marasa lafiya da ake zargi ko tabbatar da COVID-19 suna da matukar tsoron kamuwa da cutar, kuma yana iya zama mai haɗari ga rayuwa, kuma mutanen da aka keɓe suna da damuwa, kadaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, tari da tari, da kuma tasirin sakamako na jiyya kamar rashin bacci da ke haifar da maganin corticosteroids na iya haifar da ƙarin damuwa da damuwa.
A farkon barkewar cutar SARS, an ba da rahoton wasu cututtukan da suka shafi tunanin mutum kamar su baƙin ciki, damuwa, tashin hankali, rashin jin daɗi, rashin jin daɗi, da kashe kansa.
Kulawa da keɓaɓɓun abubuwan da ke tattare da cutar da kuma yin takunkumi, wanda wani ɓangare ne na amsawar lafiyar jama'a ga barkewar COVID-19, na iya sa wasu mutane su zama masu damuwa da rashin fahimta game da tasirin kamuwa da cuta, yin takunkumi da kuma sanya alama ga danginsu da abokai.
Saboda haka, ya kamata a ba da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, da waɗanda ke hulɗa da su, da kuma jama'a da ke buƙatar kulawa.
Tallafin tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar ƙwaƙwalwa na ƙwararru, sadarwa mai ma'ana tare da sabuntawa na yau da kullun da daidai game da shirin magani da ɓarkewar SARS-CoV-2, da kuma amfani da na'urorin lantarki da ƙwararrun software don guje wa kusanci ko kusanci.
Ingantattun alluran rigakafi suna da mahimmanci wajen hana yaduwar kwayar cutar daga dabbobi da mutane zuwa kwayar cutar mai saurin yaduwa, kuma waɗannan alluran rigakafin yawanci suna ƙari ne ga maganin antiviral don sarrafa yanayin ɓarkewar cutar da sabbin ƙwayoyin cuta ke haifar da su.
An yi ƙoƙari don haɓaka allurar rigakafi daga S-protein don ƙirƙirar jiki mai ƙarfi da tsarin rigakafi na ɗan adam da ke da ƙarfi da daɗewa akan cutar SARS-CoV.
An gwada rigakafin mai rai a cikin samfurin dabba don cutar SARS.
Koyaya, ingancin allurar rigakafin da ke rayuwa a cikin waɗannan gwaji a cikin tsofaffi da samfuran haɗari da kariya daga kamuwa da kwayar cutar genitocin (dabba zuwa mutum) dole ne a ƙayyade kafin a fara nazarin gwaji na ainihi.
Wannan na iya zama saboda cutar SARS ta sake tashi shekaru 17 da suka gabata kuma ba a sake samun sabbin maganganu ba.
Akasin haka, wasu cututtuka da kuma cututtukan MERS na ci gaba da faruwa a Gabas ta Tsakiya da kuma sauran yankuna saboda rashin ci gaban asalin genotoxic (dabba zuwa mutum) a cikin yankin kamuwa da cuta.
An kirkiro dabarun samar da allurar rigakafi don cutar MERS ta amfani da kwayar cutar mai dauke da kwayar cutar DNA, masu daukar kwayar cutar, nanoparticles, microorganisms kamar kwayar cutar da kuma sabbin kayan aikin gina jiki, kuma an dauki wasu daga cikin dabarun don gwadawa da kimantawa akan dabbobi.
Ci gaban ingantaccen allurar rigakafin SARS-CoV-2 ga mutanen da basu da garkuwar jiki na da gaggawa da kuma muhimmiyar mahimmanci don hana barkewar cutar.
Koyaya, har yanzu yana da matsala wajen shawo kan wannan mawuyacin halin saboda tsawon lokaci (yawanci watanni 18) da ake buƙata don haɓaka allurar rigakafi da saurin canza nau'ikan CoVs.
Tun da yake sabon nau'in COVID-19 ne, ya fara bayyana a cikin gwaji lokacin da marasa lafiya suka riga sun kai dubbai.
A mafi yawan lokuta, mai haƙuri zai iya warkewa gaba ɗaya ba tare da wani matsala ba.
Duk da haka, cutar COVID-19, wacce take kama da SARS da MERS, tana da alaƙa da ƙaruwar rashin lafiya da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, samar da samfurin hasashen cutar ya zama dole ga hukumomin kiwon lafiya don fifita ayyukan su, musamman a yankunan da ba su da albarkatu.
Dangane da binciken gwaji na zahiri da aka ruwaito a baya, wasu daga cikin waɗannan abubuwan na iya shafar ko kuma suna da alaƙa da yanayin cutar na marasa lafiya na COVID-19 (tebur (tebur 33)):
Shekaru: Shekaru shine babban abin da ke haifar da yiwuwar cutar SARS da COVID-19.
COVID-19 ya fi faruwa a cikin mutanen shekaru 30-65, tare da kashi 47.7% na marasa lafiya sama da shekaru 50 a cikin binciken binciken 8,866, kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai mahimmanci suna iya samun daidaito da kuma rikicewar rashin lafiya, kuma sun fi tsofaffi waɗanda ba su da (matsakaicin shekaru 66 zuwa 51) wanda ke nuna cewa shekaru shine babban mahimmin abu don sakamakon cutar COVID-19.
Jima'i SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 vs. 0.27/100,000) kamar yadda aka bayyana a sama.
Rashin fahimta da rashin fahimta: Marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai mahimmanci suna iya fuskantar ciwo daga bugun zuciya da kuma bugun zuciya mai tsanani.
Matsalar zuciya ta kasance babbar hanyar mutuwar masu cutar SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya shiga cikin ACE2-positive cholangioctues, wanda ke haifar da tasirin rashin aiki na hanta na marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da cututtuka suna da alaƙa da juna wanda zai iya haifar da tasirin juna.
Binciken Lab na Rare: Matsakaicin kwayar C mai amsawa (CRP) a cikin jini yana nuna tsananin kumburi ko raunin kumburi kuma an ba da shawarar a matsayin mai faɗi game da yiwuwar cutar, amsawa ga magani, da dawowa daga ƙarshe.
An kuma ambata alaƙar matakan CRP da tsananin cutar COVID-19.
Bugu da ƙari, ƙaruwa a cikin lactate dehydrogenase (LDH), aspartate aminotransferase (AST), aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna nunawa sosai a cikin kwayoyin halitta da yawa, musamman zuciya da hanta, kuma ana fitar dasu yayin lalacewar ƙwayar cuta.
Saboda haka, su ne alamun rashin aiki na zuciya ko na hanta.
Alamomin Farko na Farko: Samfurin hoto na kirji da kuma sauyin yanayi na bayyanar cututtuka daga farfadowa na Farko ya kamata a yi la'akari da su tare da wasu batutuwa don hango sakamakon da kuma sakamakon cutar COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune abubuwan da ke rage karfin jiki, waɗanda ake amfani dasu a cikin maganin hadin gwiwa don wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Ana amfani da maganin corticosteroid a cikin manyan allurai don magance masu fama da cutar SARS. Masu tsira sun sha wahala daga jijiyoyin jini da ƙashi wanda ke haifar da nakasa rayuwa ko kuma rage ƙimar rayuwa.
Saboda haka, idan ya zama dole, ya kamata a yi amfani da steroids a cikin ƙananan ƙwayoyi da gajeren lokaci ga marasa lafiya na COVID-19.
Matsin lamba: Kamar yadda aka bayyana a sama yayin barkewar COVID-19, marasa lafiya da yawa sun sha wahala daga matsin lamba na musamman saboda sun daɗe suna jimrewa, rashin tabbas, da kuma ganin mutuwar dangi na kusa da sauran marasa lafiya.
Yana da mahimmanci a ba da shawara ta hankali da tallafi na dogon lokaci don taimakawa waɗannan marasa lafiya su shawo kan damuwa kuma su koma rayuwa ta yau da kullun.
Dangane da binciken alƙaluma na baya, COVID-19 ya bayyana yana da bambanci da cutar SARS.
Baya ga yaduwar cikin ƙananan na numfashi, SARS-CoV-2 na iya yaduwa ta hanyar na sama da kuma haifar da bayyanar cututtuka ko rashin bayyanar cututtuka a farkon matakin kamuwa da cuta wanda yayi kama da sauran coronaviruses waɗanda ke haifar da cutar mura ta yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko kuma a cikin lokaci mai zuwa na iya samar da adadin ƙwayoyin cuta masu yawa yayin ayyukan yau da kullun, wanda ke haifar da wahalar sarrafa cutar.
Koyaya, ana ɗaukar watsawa ko watsawa na SARS-CoV ya faru lokacin da mai haƙuri ya sami mummunan cuta, yayin da yawancin kamuwa da cuta ba ya faruwa a farkon matakin.
Saboda haka, annobar COVID-19 ta yanzu ta fi tsanani kuma ta fi wahalar sarrafawa fiye da annobar cutar sankara (SARS).
A halin yanzu, ana gudanar da gagarumin kokarin a kasar Sin, wanda ya hada da kulle birnin Wuhan da garuruwan da ke kewaye da shi da kuma yin gwajin kwayar cutar a kai a kai na kusan dukkan mazauna kasar, da fatan hana ci gaba da yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan ayyukan sun yi illa ga tattalin arziki da sauran bangarorin kasar, adadin sabbin masu kamuwa da cutar na raguwa, wanda ke nuna raguwar yaduwar cutar.
Kimanin hasashen da aka fi yi shi ne cewa barkewar cutar za ta kare a watan Maris, kuma lokacin raguwar cutar zai dauki watanni 3-4.
Duk da haka, wasu masana ba su da irin wannan ra'ayi.
Paul Hunter da sauransu sun yi hasashen cewa cutar COVID-19, wacce ta fi SARS yaduwa, ba za ta ƙare ba a shekarar 2020.
Ira Longini da sauransu sun kirkiro wani tsari don hango sakamakon barkewar cutar, kuma sun nuna cewa cutar SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano kwayar cutar SARS-CoV-2 a cikin hanci da hanci da kuma cikin ƙashin ƙugu na marasa lafiya da suka warke kuma suka bar asibiti makonni biyu da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama mai saurin kama da mura.
Koyaya, alamun farko sun bayyana a cikin China dangane da raguwar sabbin lamuran da ke nuna cewa dabarun yanzu na iya aiki.
An yi hasashen cewa cutar Ebola za ta iya haifar da kamuwa da cutar har zuwa miliyan daya tare da mutuwar mutane miliyan daya da rabi.
Koyaya, ta hanyar yin aiki da kuma keɓewa, cutar ta sami damar sarrafawa.
Zai yiwu saboda kamannin SARS-CoV cewa SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma daga ƙarshe ya rushe ko ya zama kwayar cuta da ba ta da yawa a cikin mutane.
Kwatanta tsakanin barkewar COVID-19 a duniya tare da SARS da MERS an nuna su a cikin tebur da ke ƙasa (Table 55)
Kwayar cutar SARS-CoV-2 tana da yawan yaduwa ta hanyar tari, ko kuma ta hanyar hulɗa kai tsaye da kayan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin hanci, wanda ke ƙara sabon yiwuwar kamuwa da hanci zuwa baki.
Wani sabon bincike kan mutane 138 ya ruwaito cewa kashi 41% na jimillar cutar na iya haifar da yaduwar cutar a asibiti, tare da marasa lafiya 17 da ke da cutar ta kamuwa da ita, da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a ɗauki matakan kariya mafi kyau don kare mutane, musamman masu ba da kiwon lafiya, ma'aikatan zamantakewa, membobin iyali, abokan aiki, da waɗanda ke hulɗa kai tsaye da marasa lafiya ko waɗanda ke da cutar.
Matakin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine ta hanyar sanya abin rufe fuska. Amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (sashi # 1860s) yana taimakawa wajen sarrafa yaduwar kwayar cutar.
Barga don tiyata yana hana ruwa daga mutane masu saurin kamuwa da cuta, yana hana wannan ruwan daga tafiya ta iska ko faɗuwa a saman wasu abubuwa inda za a iya watsa su ga wasu.
Koyaya, kawai nau'in N95 (seri # 1860s) yana iya karewa daga shigar ƙwayoyin cuta masu ƙananan girma daga 10 zuwa 80 nm, kuma kawai kashi 5% na ƙwayoyin cuta zasu iya shiga cikin wannan abin rufe fuska. SARS-CoV-2 yana da kamanceceniya da SARS-CoV, wanda girman kwayar cutarsa shine 85 nm.
Saboda ƙwayoyin cuta na iya shiga ko da ta hanyar rufe fuska biyar da aka sanya a jere, masu ba da kiwon lafiya waɗanda ke hulɗa kai tsaye da marasa lafiya dole ne su sanya abin rufe fuska na N95 (wanda aka saki a tsakiyar 1860), amma kada su sanya abin rufe fuska.
Baya ga sanya abin rufe fuska, masu ba da kiwon lafiya ya kamata su sanya takunkumin keɓewa don rage ƙarin haɗuwa kai tsaye da kwayar cutar.
Hakanan za'a iya yada cutar ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95.
Saboda haka, masu kula da lafiyar su ma su sanya abin rufe fuska ko abin rufe ido yayin aiki tare da marasa lafiya.
Ga talakawan da ke cikin yankunan da ke da kamuwa da cutar ko kuma masu kamuwa da cutar, ana ba da shawarar cewa kowa ya wanke hannuwansa da sabulu mai kashe ƙwayoyin cuta fiye da yadda ya kamata, kuma ya yi ƙoƙarin kasancewa a cikin gida don keɓewa da iyakance hulɗa tare da mutanen da ke da cutar.
An dauki mita uku a matsayin tazara mai kyau ga mutanen da ke bukatar su nisanta kansu daga marasa lafiya.
Waɗannan ayyuka hanya ce mai tasiri don rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake cutar SARS-CoV-2 ta zama sabuwar kwayar cutar ga dan adam, kamannin ta da cutar sankarar bargo (SARS-CoV) kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020 ya kamata ya sa kasar Sin ta yi taka tsantsan kuma ya kamata a tuna da barkewar cutar sankarar bargo (SARS) a 2003.
Koyaya, har zuwa 19 ga Janairu, 2020, daraktan Cibiyar Kula da Cututtuka ta Wuhan ya yaudari jama'a da cewa sabon kwayar cutar tana da ƙarancin yaduwa, kuma ci gaba da yaduwar ta yana da iyaka daga mutum zuwa mutum, kuma ba shi da matsala wajen rigakafi da juriya ga cutar.
Wannan ya sauƙaƙa sanarwar gaggawa ga jama'a, musamman a lokacin da duk ƙasar ke shirin bikin Kirsimeti, kuma lokaci ne mai mahimmanci da aka rasa don shawo kan cutar lokacin da take ƙarami a Wuhan.
Hukumar kula da cututtuka a China na iya ɗaukar wannan darasi mai wahala kuma ta inganta gaba.
Misali, waɗannan hukumomin yakamata su (1) kasance masu taka tsantsan yayin yin sanarwar jama'a, saboda duk kalmomin suna da mahimmanci ga 'yan ƙasa kuma suna iya canza halayensu da yanke shawara; (2) kasance masu fa'ida da amsawa da kyau ga bayanan da ba daidai ba daga masu asibiti maimakon jiran rahoto na hukuma daga likitoci ko jami'ai; (3) ƙarin takunkumi don hana yiwuwar barkewar cutar a farkon matakai maimakon ƙoƙarin yaudarar sauran jama'a; da (4) sau da yawa a cikin aiwatar da ingantaccen gwaji da tasiri don haɓaka fahimtar jama'a game da cutar da kuma inganta tsarin kulawa da zamantakewar jama'a.
Barkewar cutar COVID-19 da kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya bazu ko'ina cikin China da kusan ƙasashe 50 a duk duniya a lokacin rubuce-rubuce.
Saboda kwayar cutar ta yi kama da kwayar cutar SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, barkewar cutar ta COVID-19 ta haifar da jin cewa cutar ta SARS ta sake tashi.
Koyaya, akwai wasu mahimman bambance-bambance tsakanin COVID-19 da SARS waɗanda suke da mahimmanci don hana yaduwa da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa, maza fiye da mata, kuma yanayin rashin lafiya da mutuwar marasa lafiya da suka tsufa sun fi matasa.
SARS ya fi COVID-19 mutuwa (10.91% zuwa 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar cutar ga wasu ko da kuwa basu da alamun cutar, yayin da marasa lafiya na SARS basu da alamun cutar lokacin da suka kamu da cutar, wanda hakan ya sa ya fi wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wasu dalilai da yasa cutar SARS-CoV-2 ke yaduwa cikin sauri fiye da SARS-CoV.
Tsarin RNA na SARS-CoV-2 na iya zama ba ya wanzu a cikin wasu marasa lafiya na COVID-19.
A gefe guda, marasa lafiya da suka warke kuma suka sami cutar za su iya dawowa cikin lafiya.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
Tare da irin wannan saurin ci gaba a cikin binciken COVID-19, akwai wasu manyan matsaloli da za a magance su:
A ina ne cutar SARS-CoV-2 ta samo asali?
Duk da cewa an gano kamanceceniya tsakanin kwayoyin halittar kashi 96% tsakanin SARS-CoV-2 da kwayar cutar SARS daga bat, har yanzu ba za mu iya yin hasashen cewa SARS-CoV-2 ta fito ne daga bat.
Wadanne dabbobi ne a tsakanin da za su iya watsa kwayar cutar daga kwayar halitta, kamar su farar fata zuwa ga mutane?
Idan ba mu san amsoshin 1 da 2 ba, ba za mu iya rage ko kuma watsawa yadda ya kamata ba, kuma fashewar na iya sake faruwa a kowane lokaci.
Duk da cewa an yi gwajin kwayar halitta da kuma gwajin kwayoyin halitta, wanda ya nuna cewa SARS-CoV-2 na iya yin kwafi da shiga cikin ACE2, amma har yanzu ba a san yadda za a iya samun kwayar cutar a cikin kwayoyin numfashi ba.
Shin kwayar cutar zata iya haɗa kwayar da ke fitar da ACE2 zuwa wasu kwayoyin?
Idan babu amsoshin da suka dace ga waɗannan tambayoyin, ba za mu iya samun saurin ganewar asali da kuma ingantaccen magani ba.
"Na yi imani da cewa za a iya samun ci gaba mai kyau a cikin wannan yanayin.
Ta yaya kwayar cutar ta samo asali yayin yaduwar ta tsakanin mutane?
Shin za ta zama annoba ta duniya, ko kuma za ta sake dawowa kamar SARS, ko kuma za ta sake dawowa kamar zazzabin cizon sauro?
Yana da muhimmanci, amma zai iya ɗaukar lokaci don yin bincike don amsa tambayoyin da ke sama da sauran tambayoyi.
Koyaya, komai farashin, ba mu da wani zaɓi sai dai mu dakatar da yaduwar da sauri kuma mu dawo da rayuwarmu yadda take.
A cikin wannan labarin, an bayyana cewa, cutar coronavirus ta mutum ta kamu da cutar daga dabbobi zuwa mutane.
Canji da kuma ci gaba sun haifar da kwayar cutar coronavirus (CoVs) da kwayoyin halitta, ciki har da mutane, na dubban shekaru.
Kafin 2003, an gano mutane biyu da ke dauke da kwayar cutar HCoVs (HCoVs) wanda ke haifar da rashin lafiya kamar mura.
Barkewar cutar ta SARS da cutar ta MERS ta sauya hangen nesa don nuna yadda cutar HCoVs ke da haɗari da kuma barazana ga rayuwar ɗan adam.
"Buguwar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake sanya kwayar cutar a cikin yanayin zafi kuma ya ba mu mamaki game da yaduwarta, amma ya rage yiwuwar cutar idan aka kwatanta da 'yar'uwarta SARS-CoV.
Cutar HCoVs cuta ce ta kwayar cuta (ta zo daga dabbobi zuwa ga mutane), kuma fahimtar asalin kwayar cuta ta HCoVs na iya taimaka mana.
Yawancin kwayar cutar HCoVs sun samo asali ne daga fararen fata, wanda ba su da cutar.
An gano wasu kwayar cutar HCoVs a cikin matsakaicin matsakaici.
Gano dabbobi yana da tasiri kai tsaye kan rigakafin cutar mutum.
Binciken yadda CoV-host ke aiki a cikin dabbobi na iya ba da ƙarin mahimman bayanai game da cutar CoV a cikin mutane.
A wannan sauraren, za mu gabatar da ilimin da ake da shi game da kwayar cutar HCoVs bakwai, kuma za mu mai da hankali kan tarihin ganowa, da kuma asalin watsawa daga dabbobi zuwa mutane da kuma watsawa daga tsara zuwa tsara.
Mafi mahimmanci, mun gwada kuma mun gano bambance-bambance tsakanin kwayar cutar HCoVs da kuma yanayin juyin halitta na kwayar cutar da kuma sake tsara kwayoyinta.
An tattauna game da annobar cutar COVID-19 ta 2019 a cikin wannan mahallin.
Bugu da ƙari, sun jaddada buƙatar samun nasarar sauyawar da kuma tasirin juyin halittar kwayar cutar akan tsananin cutar.
Coronaviruses (CoVs) suna cikin Coronaviridae, wani rukuni na ƙwayoyin cuta masu RNA masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta.
Wadannan ƙwayoyin cuta suna ba da izini ga manyan kwayoyin 26 zuwa 32, wato, lobes a cikin RNA na kwayar cuta, waɗanda aka sani da suna  CoVs saboda yanayin su kamar na ƙura a cikin ƙwayoyin cuta masu amfani da lantarki.
Tsarin CoVs yana da sinosomes marasa sashi waɗanda ke ƙarƙashin nau'ikan nau'ikan.
Kimanin kashi biyu bisa uku na xenome suna da manyan siffofi guda biyu (ORF1a da ORF1b) waɗanda aka tura su cikin tsofaffin polypeptide pp1a da pp1ab.
An ƙara sarrafa polyprotein don samar da 16 na'urorin da ba a tsara su ba, waɗanda aka ƙayyade ta nsp1~16.
Sauran ɓangaren kwayar halitta na ɗauke da ORFs don sunadarai masu tsari, waɗanda suka haɗa da spike (S), envelope (E), membrane (M), da nucleoprotein (N).
Hakanan an sanya wasu masu taimakawa na wasu layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin layin.
Bisa ga bambancin da ke cikin jerin sunayen sunadarai, an rarraba COVs zuwa nau'i hudu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV), daga cikin waɗannan beta-CoVs suna da mafi yawan HCoVs, kuma an rarraba su zuwa wasu nau'i huɗu (A, B, C, da D).
Shaida da ke haifar da kwayar halittar mutum, shuka, da dabbobi sun nuna cewa tsuntsaye da kwari suna aiki a matsayin tushen asalin alpha-CoVs da beta-CoVs, yayin da tsuntsaye ke zama babban gida na gamma-CoVs da delta-CoVs.
Shekaru dubbai, CoVs sun ratsa cikin dabbobi da yawa, kuma wasu sun fito a matsayin manyan masu cutarwa ga mutane.
Ya zuwa yanzu, an gano masu dauke da kwayar cutar HCoV guda bakwai.
Daga cikinsu, HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cututtukan numfashi na yau da kullun, cututtukan numfashi na yau da kullun (SARS-CoV), cututtukan numfashi na tsakiyar Turai (MERS-CoV), da SARS-CoV-2.
HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 galibi suna haifar da alamun rashin lafiya kamar su ciwon hauka na yau da kullun da / ko kumburi.
Sabanin haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan sune manyan magungunan cuta, suna haifar da kamuwa da cutar ta hanyar numfashi mai tsanani a cikin marasa lafiya tare da babban kaso na ci gaba zuwa mummunar cutar numfashi (ARDS) da bayyanar cututtukan waje.
An fara gano kwayar cutar HCoV-229E, nau'in B814, daga hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ilimi mai yawa ta hanyar nazarin HCoV-229E da HCoV-OC43, waɗanda ƙwayoyin cuta biyu ke haifar da alamun da ke da ɗan lokaci.
A zahiri, an yarda da ra'ayin cewa kamuwa da kwayar HCoVs gabaɗaya ba shi da haɗari har sai an sami barkewar cutar SARS.
Barkewar cutar SARS da ta auku a 2003 ita ce ta fi muni a tarihin zamani, ta kamu da mutane sama da 8000 kuma ta yi mutuwar sama da kashi 10%.
Shekaru goma bayan haka, barkewar cutar numfashi ta tsakiya ta haifar da bazuwar yaduwar cutar a yankin Larabawa tare da yaduwar cutar a duniya.
Kwayar cutar HCoV na 2019 (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine babban mai haifar da cutar coronavirus na 2019 (COVID-19), wanda ya kashe mutane sama da 3120 kuma ya kamu da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
Muryoyin suna ta tashi, kuma duniya tana buƙatar shirya don annobar SARS-CoV-2 da ke gabatowa.
HCoVs bakwai sun fito ne daga jinsin da aka samo daga tsuntsaye, tururuwa, ko dabbobi.
Shaida mai yawa na goyon bayan asalin juyin HCoVs duka daga batirin, wanda kwayar cutar ke da sauƙin canzawa kuma ba ta haifar da cuta ba, amma tana nuna bambancin kwayar halitta mai ban mamaki.
Cutar COVID-19 ta gabatar da kalubale na musamman na likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin kwayar cutar HCoVs yana ba da tsari don fahimtar yanayin halitta, motsawa, da kuma yanayin yanayin kamuwa da cuta daga nau'in zuwa nau'in.
Wannan kuma zai iya taimakawa wajen gano ko sauƙaƙe gano manyan masu watsawa, matsakaita, da kuma masu riƙe SARS-CoV-2 tare da mahimman tasiri kan hana ɓarkewar nan gaba.
A cikin wannan bita, mun gabatar da wani babban ra'ayi game da asalin watsawa daga dabbobi zuwa mutane, watsawa daga nau'in zuwa nau'in, da kuma haifar da HCoVs.
Musamman, mun yi tsokaci da kuma tattauna batun da ya ce asalin kwayar cutar HCoVs ba ta haifar da cuta yayin da take rayuwa a cikin kwayar halittar ta, amma ta zama mai cutarwa bayan ta kamu da sabuwar kwayar cutar.
Mun kuma sake nazarin yanayin juyin HCoV inda karuwar watsawa na iya faruwa sau da yawa tare da raguwar abubuwan cutar.
Sakamakon barkewar cutar SARS-CoV-2 da ke gudana an kuma tattauna shi a cikin wannan mahallin.
An san CoVs a cikin dabbobi tun daga ƙarshen shekarun 1930.
Kafin farkon warewar kwayar cutar HCoV-229E B814 daga hanci na mutanen da ke fama da mura, an gano CoVs daban-daban a cikin dabbobi masu kamuwa da cutar, ciki har da turkeys, turkeys, shanu, aladu, da karnuka.
Shekaru da dama da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoV a cikin tsari (Table 1) zai ba da bayani da kuma jagora.
An fara ware kwayar cutar HCoV-229E daga cikin numfashin marasa lafiya da ke da kamuwa da cutar ta numfashi a shekarar 1966, kuma daga baya aka daidaita ta don haɓaka a cikin ƙwayoyin huhu na WI-38.
Marasa lafiya da ke dauke da kwayar HCoV-229E suna da alamun cutar mura da suka hada da ciwon kai, ciwon hanci, ciwon jini, da ciwon huhu tare da zazzabi da tari, wanda aka gano a cikin kashi 10 zuwa 20%.
Daga baya, a cikin 1967, an ware HCoV-OC43 daga al'ada kuma an sake yin kwayar halitta a cikin kwakwalwar jariri.
Halin asibiti na kamuwa da cutar HCoV-OC43 ya yi kama da na HCoV-229E, wanda alamun cutar ba su bambanta da na kamuwa da wasu cututtukan numfashi kamar su mura A da rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 suna da rarraba a duniya kuma suna da saurin yaduwa a cikin yanayin zafi na hunturu.
A cikin al'ada, tsawon lokacin farkawa na waɗannan ƙwayoyin cuta guda biyu bai kai mako guda ba, sannan kuma kusan makonni biyu na kamuwa da cuta.
A cewar binciken da aka yi a kan mutane, mutanen da ke da lafiya kuma suna dauke da kwayar HCoV-229E sun samo asali ne daga cutar mura ta yau da kullun.
Sai dai marasa lafiya masu rauni na tsarin rigakafi ne ke nuna kamuwa da cutar ta hanyar numfashi mai tsanani a cikin ƙananan ƙananan ƙwayoyin numfashi.
SARS, wanda aka fi sani da "Reaired Form Syphilis", an rubuta shi a matsayin annoba ta farko da HCoV ya haifar a tarihin ɗan adam, kuma kwayar cutar ta SARS-CoV, ita ce HCoV na uku da aka gano.
Halin farko na cutar SARS ya iya faruwa tun daga ƙarshen 2002 a Guangdong, China.
Sakamakon barkewar cutar SARS, an samu mutum 8096 da suka mutu, kuma mutum 774 sun mutu, wanda ya kai ga yaduwar cutar zuwa kasashe da nahiyoyi da dama.
Baya ga yaduwar cutar, an kiyasta cewa kowane mutum zai iya haifar da kusan mutane biyu masu zuwa a cikin kwanaki 4 zuwa 7, kuma mafi girman kwayar cutar ta bayyana a ranar 10 lokacin da cutar ta kamu.
Marasa lafiya da ke dauke da cutar SARS-CoV suna fara da ciwon tsoka, ciwon kai, zazzabi, da kuma rashin ƙarfi, sannan kuma suna da tari da kuma kumburi, alamun da ke zuwa.
Lymphedema, gwajin cutar hanta da kuma karuwar Creatine kinase, su ne abubuwan da ba su dace ba a cikin gwajin SARS.
An lura da marasa lafiya da cutar SARS suna da yawan zubar da jijiyoyin huhu, saurin girma da kwayar epithelial, da kuma yawan jini.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa mai mahimmanci da kuma iskar iska.
Baya ga kamuwa da cutar ta hanyar numfashi, wasu kwayoyin ciki, ciki har da hanji, hanta da hanji na iya kamuwa da cutar a wasu lokuta masu tsanani, yawanci tare da hauhawar cytokines, wanda zai iya zama mai haɗari ga marasa lafiya masu rauni.
An fara gano kwayar cutar ne daga kwayar cutar huhu ta dangin marasa lafiya da suka yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don binciken HCoV.
An ware HCoV-NL63 daga jariri mai wata 7 daga Netherlands a ƙarshen 2004.
An fara gano shi a cikin yara ƙanana, tsofaffi, da marasa lafiya masu rauni tare da cututtukan numfashi.
Bayyanar cututtukan hanci da hanci, coryza, cutar ido, zazzabi da kuma ciwon huhu na yau da kullun ne a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike na zaman kansa ya bayyana gano irin wannan kwayar cutar daga samfurin hanci na wani yaro mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, an rarraba shi a duk duniya.
An kiyasta cewa HCoV-NL63 yana da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma mafi girman haɓakarsa yana a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cututtukan kumburi da kumburi, wanda aka sani da cutar Croup.
A wannan shekarar ne aka ware HCoV-HKU1 daga wani mutum mai shekaru 71 da ke kwance a asibiti saboda ciwon huhu da ciwon huhu a Hong Kong.
Baya ga cutar pneumonia da cutar pneumonia da al'umma ta samu, an bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da cututtukan zuciya masu tsanani.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 an gano shi a duk duniya, wanda ke haifar da ƙananan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut
Dukkanin wadannan kwayar cutar HCoVs guda hudu sun daidaita sosai a cikin mutane kuma ba su da wata illa ga kamuwa da cuta, kodayake an sami wasu abubuwan da ba a san dalilin su ba, kamar su wani sabon nau'in kwayar cutar HCoV-NL63 da aka ruwaito kwanan nan da ke haifar da mummunar kamuwa da cutar ta hanyar numfashi a kasar Sin.
Gabaɗaya, lokacin da waɗannan HCoVs suka sami damar isar da kwayar cutar yadda ya kamata kuma suna riƙe da kansu a cikin mutane, suna zama masu saurin kamuwa da cuta ko rashin cutarwa.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da cutar sankarar hanta da kuma rashin karfin koda a Saudi Arabia.
A cikin mafi yawan shari'o'in da aka tabbatar da cewa lab din sun samo asali ne daga yankin Gabas ta Tsakiya, an bayar da rahoton cewa an shigo da wasu lokuta tare da yaduwar ta biyu a baya saboda kusanci a cikin ƙasashen Turai da Tunisia.
Wani barkewar cutar ta biyu ya faru ne a Koriya ta Kudu a shekarar 2015 tare da tabbatar da mutane 186.
Alamar asibiti na cutar MERS tana da kama da ta SARS, ana nuna ta ta hanyar kumburi na huhu wanda ke kara tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke da cutar MERS sun kuma samo asali ne daga cutar ta MERS, wanda ke da bambanci ga cutar MERS da ke haifar da HCoV.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtukan ciki kamar su ciwon hauka da kuma tari.
Ya zuwa 14 ga Fabrairu, 2020, an bayar da rahoton fiye da lab-tabbatar da mutane 2500 tare da yawan mutuwar mutum 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da mutane suka taba fuskanta.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano rukunin masu cutar huhu waɗanda suka taɓa hulɗa da cutar SARS-CoV-2 a Wuhan, Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a ta duniya, kuma ta sanya sunan cutar COVID-19.
Ya zuwa ranar 3 ga Maris, 2020, an tabbatar da shari'o'in a duniya 90,053, tare da kashi 3.4% na mutuwar.
A cikin wannan labarin, an bayyana cewa, a cikin kasar Sin, an samu mutuwar mutane 4.2% a birnin Hubei, kuma a wasu yankuna, kashi 1.2% ne suka mutu.
SARS-CoV-2 kuma yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, waɗanda aka nuna su da zazzabi, tari da kuma gajiya.
Sun kuma gano wasu marasa lafiya da ke da cutar kansa.
Ciwon huhu na iya zama wani daga cikin cututtuka masu tsanani kuma yana iya ci gaba da sauri zuwa mummunar matsalar numfashi.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya saboda kamanceceniya na babban kwayar halitta na kashi 82%, sun fito ne daga rassa daban-daban a cikin tarin bayanan kwayoyin.
SARS-CoV-2 ba shi da cutarwa, amma yana iya yaduwa da sauri idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton batutuwa marasa alamun cutar SARS-CoV-2 kuma yana iya taimakawa ga saurin yaduwar sa a duniya.
Kwatanta da bambanci tsakanin SARS-CoV-2 da sauran rukuni shida na HCoVs sun nuna kamance da bambance-bambance masu fa'ida.
Na farko, lokutan farkawa da lokutan juyin halitta na HCoVs suna da kamanceceniya sosai.
A wannan ma'anar, SARS-CoV-2 ya bi tsarin da aka tsara na sauran HCoVs shida.
Na biyu, tsananin bayyanar cututtukan COVID-19 ya dogara ne akan SARS-CoV da kuma dukkanin nau'ikan HCoVs guda huɗu (misali HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, cutar SARS-CoV-2 ta nuna wasu halaye masu kama da na cutar HCoVs, tare da rashin fahimta ko rashin bayyanar cututtuka.
A wasu kalmomin, ana iya ganin ƙananan ƙananan shari'o'in COVID-19 masu tsanani kamar yadda ake gani a cikin SARS-CoV, kodayake tare da ƙananan rabo.
Na uku, kwafin SARS-CoV-2 ya kuma nuna wani tsari mai ban sha'awa na HCoVs da SARS-CoVs da aka samo daga al'umma.
A gefe guda, aƙalla, ƙwayar SARS-CoV-2 na iya zama mai yawa kamar HCoVs da ke samun al'umma.
A gefe guda, har yanzu ana buƙatar sake yin bayani game da ko akwai raguwar kamuwa da cutar SARS-CoV-2 bayan watsawa ga wasu mutane, kamar yadda ya faru a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin ƙwayar cuta.
Ko watsawar kumburin SARS-CoV-2 tana taka muhimmiyar rawa kamar yadda yake a cikin SARS-CoV, aƙalla a ƙarƙashin wasu yanayi waɗanda har yanzu za a tabbatar da su ta hanyar nazarin gaba.
Hakanan yana da ban sha'awa a ga ko SARS-CoV-2 na iya bayyana a yanayi kamar yadda yake tare da HCoVs da aka samu a cikin al'umma.
Koyaya, yanayin SARS-CoV-2 mai cutarwa, gami da kamuwa da cuta, cutar, da yaduwar mutum zuwa mutum, zai haifar da barkewar COVID-19.
Dukkanin HCoVs huɗu da aka samo daga al'ummomin da ke haifar da rashin bayyanar sun daidaita da kyau a cikin mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da kyau ga dukkanin nau'ikan HCoVs guda huɗu.
A wasu kalmomin, dukansu na iya zama masu tsira daga annoba ta HCoV na zamanin da.
HCoVs da ke haifar da mummunar cuta a cikin mutane da kuma mutane waɗanda suka canza zuwa mummunar HCoVs an kawar da su.
Don wannan ya faru, HCoVs dole ne su rarraba kansu a cikin jikin mutum don samun isasshen ƙarfin da zai iya haɗuwa da tsarin rigakafin ƙwayoyin cuta.
A wannan ma'anar, yayin da barkewar SARS-CoV-2 ke da tsawo kuma mutane da yawa suna kamuwa da ita, zai sami damar daidaitawa da mutane.
Idan cutar ta daidaita da kyau, zai yi wuya a hana yaduwar ta ga mutane, ko da kuwa an aiwatar da keɓewar jama'a ko wasu matakan hana yaduwar cuta.
A cikin 'yan shekarun nan, dukkanin nau'ikan CoVs guda huɗu sun kamu da mutane da ke da alamun cutar sankarar bargo, tare da tsarin rigakafin jiki mai ƙarfi.
Wadannan ƙwayoyin cuta ba sa bukatar ƙwayoyin cuta a cikin dabbobi.
A gefe guda, SARS-CoV da MERS-CoV, wadanda ke haifar da cutar, ba su daidaita sosai a cikin mutane ba, kuma ba za a iya tabbatar da daidaitawar su a cikin jikin mutum ba.
Suna buƙatar kiyayewa da kuma haɓaka a cikin tsararren tsirrai na tsirrai kuma suna neman damar yin yaduwa zuwa ga masu saurin kamuwa da cuta kamar yadda zai yiwu ta hanyar matsakaici da kuma ci gaba da haɓaka.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV / MERS-CoV da kuma dukkanin nau'ikan HCoVs huɗu.
Yana yaduwa cikin sauri kamar yadda HCoVs ke yaduwa a cikin al'umma, aƙalla a yanzu.
Koyaya, yana da ƙarfi fiye da HCoVs da aka samo a cikin al'umma kuma yana da ƙasa da cutar SARS-CoV ko MERS-CoV.
Har yanzu ana ganin ya dace da jikin mutum kuma yana gudana a cikin mutum ba tare da buƙatar ƙwayoyin cuta ko ƙwayoyin dabbobi ba.
Kafin mu tattauna asalin dabbobi na HCoVs, zai taimaka mana sosai mu tattauna ma'anar da kuma yanayin juyin halitta, na tsakiya, na tsakiya, da na gaba na HCoVs.
Dabbobi suna nuna kamanceceniya da HCoVs idan suna da alaƙa da juna da kuma babban kamannin asalin da ke cikin jerin kwayoyin halitta.
Yawancin lokaci tsofaffin ƙwayoyin cuta suna daidaitawa kuma ba sa shafar wannan.
Hakanan, wurin ajiyar kwayar cutar HCoV zai ci gaba na dogon lokaci.
A cikin waɗannan lokuta, kwayar cutar ta zama kwayar halitta ta HCoV ko kuma kwayar cutar da ta haifar.
A gefe guda, idan sabon kwayar cutar HCoV ta bayyana a cikin kwayar cutar nan da nan ko kuma a lokacin bayyanarta ga mutane, ba za ta iya daidaitawa da kyau ga sabon kwayar cutar ba kuma ba ta haifar da cutar ba.
Wannan matsakaiciyar kwayar cuta ce ke haifar da kamuwa da kwayar cutar daga dabbobi zuwa mutane kuma tana aiki a matsayin mai yaduwa ta hanyar ba da damar kwayar cutar ta rarraba kanta kuma ta ci gaba da yaduwa ga mutane don ƙara yaduwar cutar.
HCoV zai iya dakatar da yaduwa idan cutar ba ta iya yaduwa daga matsakaiciyar kwayar halittar ta ba.
A gefe guda, HCoVs na iya daidaitawa zuwa matsakaiciyar matsakaici kuma suna haifar da yaduwar dogon lokaci.
A wannan yanayin, matsakaicin matsakaici ya zama matsakaici na kayan abinci na halitta.
Bayanai daga binciken cututtukan cututtuka sun nuna cewa a baya, cututtukan SARS suna da tarihin haɗuwa da caca ta dabbobi.
Sakamakon samfurin jini ya nuna cewa masu safarar dabbobi suna da ƙimar IgG mai ƙin SARS-CoV mafi girma idan aka kwatanta da talakawa.
Dabbobi da kuma sharar gida da aka sayar a kasuwannin sayar da dabbobi masu rai sune farkon wuraren da aka gano cewa suna dauke da kwayar cutar SARS-CoV, wacce kusan ta yi kama da kwayar cutar SARS-CoV.
An kuma tabbatar da hakan ne ta hanyar cewa ba a sake samun rahoton cutar SARS ba bayan da ta kashe dukkan dabbobin da ke kasuwa.
Koyaya, an ba da rahoton cewa dabbobi daga daji ko gonaki waɗanda ba a fallasa su zuwa kasuwa ba suna da ƙarancin ƙarancin cutar SARS-CoV, yana nuna cewa dabbobi na iya zama matsakaiciyar hanyar watsawa amma ba kayan aikin SARS-CoV ba.
Ya kamata a lura cewa saboda kashi 80% na dabbobi daban-daban a kasuwa a Guangzhou suna da kwayoyin anti-SARS-CoV, ba za a iya tantance yiwuwar cewa ƙananan dabbobi da yawa na iya zama babban mai watsa SARS-CoV ba.
Dukkanin waɗannan suna kama da na ƙarshe na SARS-CoV.
Binciken da ake yi na ci gaba da gano kwayar cutar SARS-CoV ya nuna kusanci da CoV a cikin kifaye, wanda ake kira SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin kifayen da ke da kafafu na kasar Sin.
Wadannan dabbobin sun nuna cewa suna da kwayar cutar SARS-CoV da kuma kwayar cutar SARSr-Rh-BatCoV HKU3.
Wannan kwayar cutar da sauran nau'ikan CoVs na wucin gadi suna da kashi 88-92% na kamanceceniya na tsarin kwayar nucleotide.
Wadannan binciken sun kafa tushe ga sabon ra'ayi cewa fararen fata suna da cutarwa ga mutane.
An kuma gano wasu nau'ikan SARS-like CoVs (SL-CoVs) daga batsa, amma an gano WIV1 guda ɗaya wanda zai iya rarrabuwa a matsayin kwayar cutar mai rai.
An gano enzyme na angiotensin mai canza enzyme 2 (ACE2) a matsayin mai karɓar SARS-CoV.
An nuna WIV1 da aka samo daga samfurin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Abin sha'awa, serum na SARS yana da ikon hana WIV1.
Saboda haka, WIV1 tana wakiltar mafi kusanci ga SARS-CoV a cikin fararen fata, wanda ke raba kashi 95% na jerin kwayoyin halittar nucleotide.
Duk da kamanceceniya tsakanin wadannan nau'ikan kwayar cutar, an yi imanin cewa WIV1 ba asalin kwayar cutar SARS-CoV ba ne, kuma ba a yarda da cewa fararen hula ne matsakaiciyar kwayar cutar SARS-CoV ba.
An rarraba MERS-CoV zuwa rukuni guda kamar CoV-HKU4 da CoV-HKU5 na bat.
Bat CoV-HKU4 da MERS-CoV suna amfani da kwayar mai karɓa guda ɗaya, peptidase 4 (DPP4), don shigar da kwayar cutar.
Tsarin RNA mai dogara da RNA polymerase na MERS-CoV ya fi kusa da kwatankwacin beta-CoV a cikin bat da aka gano daga Turai da Afirka.
Ya zuwa yanzu, ba a gano kwayar cutar MERS-CoV a cikin dabbobin daji ba.
MERS-CoV da CoV-HKU25 a cikin kifaye, dangi mafi kusa, suna da daidaiton jerin blue kawai 87%.
Saboda haka, ƙila ba za a iya cewa tsuntsaye ne matsakaicin mai watsa MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa, dabbobi masu tsaron gida suna da takamaiman tsarin rigakafi ga MERS-CoV kamar dabbobi masu tsaron gida na Gabas ta Tsakiya a kasashe da dama na Afirka.
An gano kwayar cutar MERS-CoV mai rai mai kama da wanda aka gano a cikin mutane a cikin samfurin hancin dabbar Mediterranean, wanda ya kara nuna cewa dabbar tana aiki a matsayin ainihin kwayar cutar MERS-CoV.
Ya kuma kamata a lura cewa yawanci cutar ta fi kowa, amma an lura da yaduwar kwayar cutar a cikin gwaje-gwajen gwaje-gwajen da ke dauke da cutar MERS-CoV.
Ya kamata a lura cewa tsuntsayen da ke dauke da cutar ba kawai suna yada kwayar cutar ta hanyar numfashi ba, har ma ta hanyar hanci zuwa baki, wanda shine babban hanyar watsa kwayar cutar daga tsuntsayen.
Duk da haka, tambayoyi sun kasance saboda yawancin waɗanda aka tabbatar da su na MERS ba su da tarihin haɗuwa da dabbobi kafin farawar bayyanar cututtuka waɗanda aka tabbatar da cewa za a iya watsa su daga mutum zuwa mutum ko kuma hanyoyin watsawa da ba a sani ba waɗanda suka shafi nau'in dabbobi da ba a sani ba wanda ke ba da damar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayar cutar ta kwayar cuta tare da CoV RaTG13 a cikin ƙwayoyin cuta na Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, jerin nau'ikan SARS-CoV-2 da RaTG13 sun yi yawa har ba za a iya tantance alaƙar da ke tsakanin su ba.
Wannan yana nuna cewa ba za a iya samun nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
A ka'ida, kwayar cutar SARS-CoV-2 ta kasance cikin nau'ikan dabbobin daji da aka sayar da kashe a kasuwannin sayar da kayan kifin na Hunan, inda aka danganta yawancin shari'o'in farko na COVID-19, wanda ke nuna yanayin watsawa daga dabbobi zuwa mutane.
Yawancin binciken da aka yi kwanan nan bisa jerin metagenetic sun nuna cewa ƙananan ƙananan dabbobi masu rarrafe da aka sani da dabbobi masu rarrafe (Manichoanchyron) na iya zama tushen beta-CoVs na tsohuwar SARS-CoV-2.
CoVs a cikin waɗannan sabbin ƙwayoyin cuta suna da daidaiton nucleotide na kashi 85-92% tare da SARS-CoV-2.
Duk da haka, suna da kusancin daidaitawa tare da RaTG13, wanda ke da kusan kashi 90% na ainihi a matakin tsarin nucleotide.
Sun hada da ƙananan kwayar cutar SARS-CoV-2 a cikin kwayar cutar, wanda ke da kwayar cutar mai kama da SARS-CoV-2 da kuma amino acid 97.4%.
A gefe guda, RBDs na SARS-CoV-2 da RaTG13 sun bambanta, kodayake jerin kwayar cutar iri ɗaya sun fi girma.
Wani sabon bincike da aka yi a kan dabbobi masu cutar ya nuna cewa akwai kwayar cutar a cikin kwayar cutar huhu da ke da kama da SARS-CoV-2.
Wannan binciken ya yi amfani da wasu hanyoyin tattarawa, kamar su ƙara wani sashi na kwayar halitta, wanda ya kai kashi 86.3% na girman kwayar cutar.
Ba za mu iya lissafta tsuntsaye a matsayin masu ci gaba da cutar SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da za ta goyi bayan asalin SARS-CoV-2 daga tsuntsaye kai tsaye saboda jerin jerin SARS-CoV-2 da SARS-CoV-2-da ke da alaƙa da beta-CoVs a cikin tsuntsaye.
Bugu da ƙari, tazarar tsakanin SARS-CoV-2 da RaTG13 ya fi tazarar tsakanin SARS-CoV-2 da SARS-CoV-2-related beta-CoVs a cikin namomin kaza.
Har yanzu ba a iya gano hanyar SARS-CoV-2 a cikin tsuntsaye, dabbobin daji da sauran dabbobi masu shayarwa ba.
Yayin da aka sami mafi girman daidaiton tsari a cikin RBDs tsakanin SARS-CoV-2 da SARS-CoV-2-da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 sun ba da gudummawar mafi girman daidaiton jerin sararin samaniya.
An yi hasashen cewa babban matakin kamanceceniya tsakanin RBDs na SARS-CoV-2-da ke da alaƙa da beta-CoVs a cikin dabbobi da SARS-CoV-2 ana iya danganta shi da juyin halitta na haɗin kai wanda ke daidaita zaɓin.
Shawarwarin da aka yi ya maye gurbinsa da haɗuwa tsakanin SARS-CoV-2-da ke da alaƙa da beta-CoV a cikin dabbobi da RaTG13 a cikin dabbobi na uku.
Wani abin motsawa a juyin halitta, sake haɗuwa, shine yawan beta-CoVs.
Har yanzu ba a yanke hukunci kan asalin asalin SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin asalin genotoxic na HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaida mai yawa ta nuna cewa HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs a cikin fararen tsuntsaye, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin kwari.
An bayar da rahoton cewa an gano CoV a cikin bat, wanda ake kira ARCoV.2 (Appalachian Ridge CoV), a cikin wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
A gefe guda, HCoV-229E yana da kwayoyin halittar kama da wani CoV na namomin kaza mai suna Hipposideros/GhanaKwam/19/2008 wanda aka gano a Ghana, kuma ana zargin cewa dabbar da aka yi amfani da ita a cikin dabbar da ke dauke da cutar tana iya yada cutar.
Don ƙarin haske, an taƙaita ilimin yanzu game da asalin HCoVs a cikin dabbobi a cikin Hoto na 1 da Table na 2.
Nazarin kwayar halittar mutum, dabbobi, da tsirrai sun ba da tabbacin abubuwan da suka faru na kwayar cutar HCoVs daga dabbobi zuwa ga mutane a tarihi.
An rubuta barkewar cutar numfashi lokacin da HCoV-OC43 ya wuce daga dabbobi zuwa mutane daga dabbobin gida a kusan 1890.
Ba a san ainihin hanyar watsa kwayar cutar HCoV-229E daga dabbobi zuwa mutane ba.
An gano cewa alpha-CoVs a cikin kifaye suna da alaƙa da HCoV-229E.
Daga cikinsu akwai alpha-CoV alpaca.
Yawancin shaidu sun yarda da watsa kwayar cutar daga kifaye zuwa mutane kai tsaye.
Da farko dai, mutane ba alpacas ba ne, wanda zai iya zama mai jan hankali ga tsuntsaye a cikin yanayin da suke da shi.
A wani bangare kuma, mutane suna da kusanci da alpacas.
Na biyu, alpha-CoVs na bat-da-gidanka da ke da alaƙa da HCoV-229E suna da ƙwayoyin cuta kuma ba su haifar da cuta a cikin bat-da-gidanka, yayin da alpha-CoV na alpaca ke haifar da barkewar cututtukan numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano alpha-CoV alpaca a cikin dabbobi marasa rai.
Saboda haka ba za a iya ware yiwuwar alpacas sun sami HCoV-229E-da-alafa-CoV daga mutane ba.
A gaskiya, tsuntsaye sune tushen cututtukan cututtukan da ke cutar da mutane, ciki har da cutar ciwon daji, Ebola, Nipah, da kuma Gender.
Saboda haka, ba abin mamaki bane cewa tsuntsaye na iya watsa kwayar cutar HCoV-229E kai tsaye ga mutane.
Bugu da ƙari, yayin da alpha-CoVs a cikin batirin ke aiki a matsayin kwayoyin HCoV-229E a cikin Alpaca da Mediterranean, na iya zama matsakaici wanda ke watsa kwayar cutar ga mutane fiye da yadda yake a cikin MERS-CoV.
MERS-CoV yana aiki a matsayin misali mai kyau na watsawa daga dabbobi zuwa mutane, daga batutuwan zuwa dromedary da kuma daga dromedary zuwa mutum.
An san asalin MERS-CoV daga tsuntsaye a farkon gano shi, kuma an fadada shi ta hanyar binciken da aka yi.
A bayyane yake cewa tsuntsaye suna samar da ƙwayoyin cuta masu yawa don sauya fasalin kwayoyin halitta da kuma watsawa daga nau'in zuwa nau'in.
Rayuwa mai tsawo, manyan garkunan dabbobi, ƙaura tare da hawan jirgin sama da ƙwarewar tashi sune abubuwan da ke ba da damar tsuntsaye su zama manyan 'yan watsa kwayar cuta.
A gefe guda, an riga an watsa MERS-CoV zuwa dabbobi masu kama da dabbobi shekaru da yawa.
Ya dace sosai da waɗannan dabbobin da suka canza daga matsakaiciyar matsakaici zuwa na yau da kullun masu rarrafe.
MERS-CoV yana haifar da rashin lafiya mai tsanani kuma yana kiyaye ƙananan canji a cikin waɗannan dabbobi.
Canzawar kai tsaye zuwa ga mutane ya kasance mai saurin faruwa, kuma mutane sun kasance iyayen ƙarshe na MERS-CoV wanda ba za a iya daidaita watsawar ba.
Idan akwai wasu bambance-bambance tsakanin matsayin raƙuman ruwa a cikin watsa kwayar cutar MERS-CoV da kuma matsayin tsuntsaye a cikin watsa kwayar cutar SARS-CoV-2, to akwai bambanci.
A musamman, beta-CoVs na namomin kaza sune manyan masu cutarwa a cikin namomin kaza.
Suna iya zama na ƙarshe ga beta-CoVs masu alaƙa da SARS-CoV-2, waɗanda suke kama da dabbobi a cikin yanayin SARS-CoV.
Yawancin yiwuwar watsawa daga dabbobi zuwa ɗan adam na SARS-CoV-2 dole ne a sarrafa ko kuma a kawar da su a cikin binciken gaba.
Da farko, ƙwayoyin cuta na iya zama nau'in SARS-CoV-2 wanda ya yi kama da SARS-CoV-2.
Mutane na iya raba matsayin yanayin halittu tare da kifaye ta hanyar neman nama ko kuma shuka.
Na biyu, namomin kaza na iya zama wani ɓangare na matsakaiciyar matsakaiciyar inda cutar da ke da alaƙa da SARS-CoV-2 ta fara yaduwa.
Mutane suna kamuwa da cutar ta hanyar kashe dabbobi da cin naman dabbobin.
Yana yiwuwa cewa dabbobi da dama, ciki har da dabbobin gida, suna iya kamuwa da cutar SARS-CoV-2.
An tabbatar da binciken dabbobin gida da na namun daji don halittu masu rai.
Na uku, kamar yadda aka bayyana a sama, sake haɗuwa da kuma ɓoye SARS-CoV-2 na iya faruwa a cikin nau'in dabba na uku wanda ke da alaƙa da bat da kuma tururuwa.
Binciken asalin SARS-CoV-2 a cikin dabbobi yana ci gaba.
Baya ga nau'ikan dabbobi, manyan abubuwa uku a cikin kwayar cutar suna da mahimmanci wajen daidaita CoVs a cikin shinge na dabbobi.
Na farko, atria suna da sauyi sosai dangane da kwafin RNA.
A cikin kwatancen wasu ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar canjin canjin CoVs na iya zama  matsakaici  high  tare da matsakaicin sauyawar sau 10 zuwa 4 a shekara a cikin wuri guda 2 dangane da matakin daidaitawar CoV zuwa sabon kwayar halitta.
CoVs suna da kwayar cutar nucleic acid wanda ke da aikin sarrafawa, wanda ke haifar da ƙarancin ƙarfi da raguwa ko ma rashin iyawa.
Abin sha'awa shine, an san kwayar cutar Remdesivir ta hana kwayar cutar ta CoV ta hanyar hana enzyme exoribonuclease da RNA-dependent RNA polymerase.
Remdesivir na ɗaya daga cikin ingantattun magungunan cutar SARS-CoV-2 da aka gwada a cikin gwajin gwaji.
Koyaya, ƙimar canzawar kwayar cutar ta COVID ta ninka sau miliyan fiye da bambancin da ke cikin kwayar cutar.
Bugu da ƙari, yawan juyawa sau da yawa yana da girma lokacin da CoVs ba su daidaita da juna ba.
Idan aka kwatanta da SARS-CoV tare da babban canjin canji, canjin SARS-CoV-2 ya kasance mafi ƙarancin gaske, yana nuna babban matakin daidaitawa ga mutane.
Ana iya cewa ya daidaita da sauran takwarorinsa da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan ma ya shafi MERS-CoV wanda ya dace da kwayar cutar.
A ka'ida, ba shi yiwuwa a yi amfani da kwayar halittar don samar da maganin rigakafin SAES-CoV-2 mai saurin aiki.
Na biyu, babban sinamonin RNA a cikin CoVs yana da sassauci wanda ke haifar da rarrabuwa da sakewa. Saboda haka, juyin halitta daga nau'in zuwa nau'in zai iya faruwa wanda ke haifar da fashewar CoVs a cikin lokaci mai dacewa.
An goyi bayan shi ta hanyar cikakken tsarin karantawa daban-daban da kuma aikin gina jiki wanda aka tsara zuwa karshe na 3rd.
Na uku, CoVs suna canza tsari a hankali da kuma sau da yawa yayin rarrabuwa ta RNA ta hanyar hanyoyin rarraba daban-daban.
A cikin ƙwayoyin cuta waɗanda ke aiki a matsayin hanyar ƙira, sauya layin sau da yawa yakan faru yayin kwafin RNA na CoV.
Haɗuwa mai ƙarfi na cikakken tsayi da RNAs na sinadarin na iya haɗuwa don ƙirƙirar sabon CoV.
An sami tabbacin juyin halitta na sake fasalin halitta a cikin HCoV-HKU1 da HCoV-OC43 da kuma CoVs na dabbobi kamar SL-CoV na bat da CoV-HKU9 na bat.
Kwayar cuta da kuma halayen da ke tattare da ita suna da alaƙa da yaduwa
Baya ga abubuwan da aka ambata a sama guda uku, hulɗar kwayar cuta tare da ƙwayoyin ƙwayar cuta na ƙwayar cuta wani muhimmin abu ne wanda ke tasiri a kan watsawa daga dabba zuwa mutum.
A nan, an yarda da sake hada SARS-CoV a matsayin misali na yau da kullun wanda kuma ya nuna hujja na zaɓi mai kyau yayin abubuwan da suka faru na watsawa daga dabbobi zuwa mutane.
Dangane da kwatancen bincike tsakanin keɓaɓɓun mutane da SARS-CoVs na dabbobi, ana tunanin SARS-CoV yana fuskantar saurin daidaitawa a cikin masu riƙewa daban-daban, musamman tare da canje-canje a cikin RBD na S-protein.
RBD a cikin kwayar S na CoV tana hulɗa da mai karɓar kwayar halitta kuma an zaɓi shi a cikin amsawar kwayar halittar ɗan adam.
A cikin SARS-CoV, RBD yana cikin amino acid 318 zuwa 510 a kan S1 wanda ke haɗuwa da ACE2 na ɗan adam da kuma masu karɓar ƙwayar cuta don shiga kwayar cutar.
RBD na SARS-CoV yana da ikon gane kwayoyin masu karɓar ACE 2 na dabbobi daban-daban, gami da karnuka, beraye, dabbobin daji, da karnuka, wanda ke ba da damar kamuwa da kwayar cutar.
A zahiri, kawai ragowar amino acid 6 ne aka lura da su daban-daban daga kwayar cutar ɗan adam da civet a cikin RBD, kuma dukansu huɗu suna cikin layin haɗin ƙwayoyin mai karɓar mai karɓar don hulɗa tare da ƙwayoyin mai karɓar ACE2.
SARS-CoV a cikin namomin kaza yana da canje-canje na kwayoyin K479N da S487T a cikin RBD ɗinsa, wanda zai iya haɓaka yiwuwar hulɗar manyan sunadarai tare da mai karɓar ACE2 na ɗan adam.
A takaice dai, maye gurbin wadannan amino acid guda biyu na iya zama da muhimmanci wajen daukar kwayar cutar zuwa ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da irin wannan tsarin karɓar kwayar cutar kamar SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin kwafin S1 na kwayar S ya nuna cewa daidaiton kwayar S ɗin sa tare da ɗan adam tare da ACE2 na iya canzawa.
A zahiri, nazarin cryo-EM ya nuna kusan sau 10 zuwa 20 mafi girma na wannan haɗin tsakanin mutane da ACE2 da kwayar S na SARS-CoV.
Hakanan yana da ban sha'awa don ƙayyade ko za a iya neman wasu ƙwayoyin masu karɓar mai karɓar SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana da alaƙa da ACE2, amma tare da wani ɓangare na S.
Akwai wasu ƙwayoyin cuta don karɓar HCoVs kamar aminopeptidase N don HCoV-229E da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama alhakin nasarar daidaita CoVs a cikin mutane bayan yaduwar su daga dabbobi zuwa mutane daga kwayar halittar su.
Baya ga ƙwayoyin cuta don karɓar ƙwayoyin cuta, sakamakon kwayar cutar HCoVs daga dabba zuwa ɗan adam ana sarrafa shi ta hanyar dogaro da sauran masu ɗaukar hoto da sauran abubuwan da ke hana su.
Bambancin kwayar halittar tsakanin mutane da kuma masu riƙe da kwayar HCoVs na halitta kamar su ƙudaje, dromedary da kuma ƙwayoyin cuta na iya zama cikas ga watsawa tsakanin nau'in zuwa nau'in.
HCoVs dole ne su mallaki abubuwan da ke haifar da mahaɗan mahaɗan kuma su daidaita abubuwan da ke haifar da mahaɗan don isar da kwayar halitta mai nasara.
A wannan ma'anar, abubuwan ƙayyadaddun kwayoyin a cikin babban ɓangaren ƙwayar cuta na wannan kwayar cutar har yanzu suna da ƙayyadaddun asali da halaye.
Binciken bazuwar kwayar halitta na daidaiton kwayar halitta da abubuwan da ke hanawa SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya samun nasara.
Bayyanar sabon HCoVs: Komawa zuwa sifili
Haɓaka CoVs a cikin tsuntsaye yana ba da dama ga fitowar sabon HCoV.
A wannan ma'anar, CoVs na Bat suna aiki a matsayin kwayoyin HCoVs.
Bugu da ƙari, saurin sauyawa da sake fasalin kwayar halitta suna haifar da juyin HCoV kuma suna taka muhimmiyar rawa a cikin wannan tsari.
Alal misali, samun ko rasa wani kwayar halitta da ke tsara sabon furotin na iya kawo sauyi mai yawa a cikin kwayar halitta.
ORF8 na wasu ƙwayoyin SARS-CoVs an gano cewa yana da mahimmanci a cikin daidaitawa a cikin jikin mutum kamar yadda cutar SARS-CoVs da aka ware daga batutuwan, amma an gano cewa sun canza ORF8 daban.
An gano fasalin 29-nucleotide na SARS-CoVs a cikin layin da aka ware a farkon barkewar cutar a cikin mutane.
Wannan cirewar ya raba ORF8 zuwa ORF8a da ORF8b, wanda aka fahimta a matsayin bambancin kai wanda ke haifar da canjin ciki (jiki mai ɗaukar hoto).
Bugu da ƙari, SARS-CoV yana da alaƙa da jerin alpha da gamma-CoVs, inda aka gano ƙananan yankuna masu yawa a cikin RNA-dependent RNA polymerase.
An kuma gano wuraren sake haɗawa a cikin nsp9, yawancin nsp10, da kuma sassan nsp14.
Haka kuma, an nuna cewa yaduwar cutar MERS-CoV ta fuskanci wani abu na sake haɗuwa tsakanin layin da aka yi a cikin dromedary dwarf a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da sake fasalin abubuwa a cikin wasu HCoVs, wanda HCoVs ke haɗuwa da sauran CoVs na dabbobi a cikin kwayar halitta mara tsari.
Ya kamata a yi zabin da aka yi da hankali saboda yana iya haifar da sauye-sauyen kwayar cutar da ba da gangan ba, wanda zai iya haifar da raguwar kwayar cutar ta hanyar matsin lamba a cikin zabin kamar tsarin rigakafin ɗan adam.
Misali na waɗannan tasirin shine asarar girman ORF4 a cikin layin samfurin HCoV-229E wanda ya haifar da cire nucleotides biyu.
Yayin da za a iya gano ORF4 gaba ɗaya a cikin ƙwayoyin cuta a cikin bat da kuma HCoV-229E-da ke da alaƙa da alpaca, alpha-CoV yana nuna shigarwar nucleotide guda ɗaya wanda ke haifar da canjin tsari.
A ƙarshe, juyin halittar sabbin HCoVs kuma ya haifar da zabin matsin lamba a cikin kwayar cutar su.
An gano rashin bayyanar cututtuka ko bayyanar cututtuka lokacin da batutuwan suka kamu da CoVs, wanda ke nuna daidaituwa tsakanin CoVs da batutuwan.
Ya nuna cewa tsuntsaye sun daidaita sosai ga ilimin lissafi da kuma ilimin halittu na CoVs.
Misali, bambance-bambance a kunna martani na rigakafin kumburi a cikin fararen hula ya rage tasirin cutar da CoVs ke haifarwa.
Bugu da ƙari, aikin ƙwayoyin kisa na halitta a cikin fararen fata an hana shi saboda ƙaruwa a cikin amsawar ƙwayoyin cuta na ƙwayoyin cuta masu karɓar kwayar halitta na NKG2/CD94 da ƙananan matakan juriya na ƙwayoyin halittar farko na daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun.
Bugu da ƙari, nau'ikan oxygen masu aiki mai ƙarfi (ROS) waɗanda ke haifar da babban aikin metabolism na bat za su iya hana yaduwar CoV da tasiri akan ƙirar ƙwayoyin cuta ta hanyar exoribonuclease, don haka samar da zaɓi mai ƙarfi don samar da ƙwayoyin cuta masu cutarwa lokacin da suka shiga cikin sabon kwayar halitta.
Sauran ƙwayoyin cuta da yawa na CoVs na iya juyawa ta hanyar sake haɗuwa, wanda ke haifar da sabon kwayar halitta ko kwayar halitta da ke da halaye na musamman na turawa zuwa takwarorinta.
Saboda haka ba daidaituwa ba ce cewa akwai nau'ikan HCoVs guda uku da suka bayyana a cikin shekaru biyu da suka gabata.
CoVs ba su da kwayar cuta ko kuma suna haifar da cututtuka ne kawai a cikin kwayar cuta kamar su albasa da albasa.
Suna yin kwafi sosai ba tare da haifar da amsawar rigakafin ƙwayar cuta ba.
Ga asirin gano kwayar cutar da ba ta da alamun cutar da kuma dalilin kamuwa da cutar.
Mafi yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A gefe guda, idan ka kamu da cutar amma ba ka da alamun cutar, hakan na nufin cewa tsarin garkuwar jikinka bai yi aiki ba game da kwayar cutar CoV.
Irin wannan dabarar na hana tsarin garkuwar jiki amsawa na iya zama mai tasiri wajen maganin cutar SARS-CoV-2.
Amsar antiphoric tana da ƙarfi musamman a cikin tsuntsaye.
Saboda haka, amfani da nau'in I na furotin mai ba da siginar interferon aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya zama mai fa'ida.
Bugu da ƙari, kunna NLRP3 a cikin ƙwayoyin cuta ba shi da tasiri.
Saboda wannan dalili, hana kumburi NLRP3 tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
An yi amfani da SARS-CoV-2 a matsayin hanyar da SARS-CoV da MERS-CoV ke faruwa.
Beta-CoV ya raba kashi 95% na nucleotides masu kama da SARS-CoV da muka gano. Haka kuma, Beta-CoV ya raba kashi 96% na nucleotides masu kama da SARS-CoV-2.
An gano wasu dabbobi da sauran dabbobi a kasuwa suna dauke da kwayar cutar da ta yi kama da SARS-CoV, amma ba a gano ainihin matsakaiciyar cutar ba ga SARS-CoV-2.
An gano cewa beta-CoVs a cikin namomin kaza suna da kamanceceniya da SARS-CoV-2, wanda ke nuna cewa namomin kaza na iya zama ɗaya daga cikin manyan masu ɗaukar hoto, ko kuma beta-CoVs na iya taimakawa wajen samar da kayan halittar zuwa ƙarni na ƙarshe na SARS-CoV-2.
Duk da cewa har yanzu akwai shakku, babu wata hujja da ta nuna cewa cutar SARS-CoV-2 ta samo asali ne ta hanyar kuskuren ɗan adam ko ta hanyar haɗari.
CoVs sun dawo cikin yanayi mai kyau saboda barkewar cutar SARS-CoV-2 na kwanan nan.
Nazarin CoVs a cikin kifaye da sauran dabbobi ya canza ra'ayinmu sosai game da mahimmancin asalin watsawar dabbobi zuwa ɗan adam da kuma wurin ajiyar HCoVs a cikin watsawar ɗan adam.
Shaida ta yaduwa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga batsa kuma an watsa su ga mutane ta hanyar kwayar cutar.
Saboda cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da civet (kayan daji) a kasuwa, rufe kasuwanni da wuraren cin nama da kashe civet ya kamata ya kawo ƙarshen barkewar cutar SARS.
Saboda wannan dalili, ya kamata a cire naman alade daga kasuwa wanda ke da gishiri don hana kamuwa da kwayar cutar (dabbobin zuwa mutane) saboda ganin yawancin masu amfani da rukunin dabbobi masu zaman kansu waɗanda beta-CoVs na naman alade ke da alaƙa da SARS-CoV-2.
Koyaya, yadda kuma ko SARS-CoV-2 ya yadu ga mutane ta hanyar dabbobin daji da sauran dabbobi har yanzu ya zama dole a tabbatar da shi a cikin binciken gaba.
A gefe guda, MERS-CoV ya kasance tare da dromedary don dogon lokaci.
Wadannan dabbobi suna taka muhimmiyar rawa wajen sufuri, da kuma samar da nama, madara, fata da kuma ulu ga mazauna yankin.
An yada su sosai a duk faɗin Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a kashe dukkan dabbobi masu kama da dabbobi ba don sarrafa cutar MERS, kamar yadda aka yi a kasuwar namun daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake fashewar cutar MERS, ya kamata a sami hanyar da za a yi don haɓaka ingantaccen allurar rigakafin MERS-CoV don ducks a cikin haɗin kai tare da sauran matakan kula da kamuwa da cuta.
Saboda ba za mu iya kawar da wadannan kwayoyin ba, za a iya samun sabbin nau'o'in kwayoyin da za su haifar da barkewar cutar.
CoVs da ke yadawa daga dabbobi zuwa mutane iri-iri suna yawo a cikin gandun daji.
Musamman ma, CoVs a cikin kifaye waɗanda za a iya watsawa daga dabbobi zuwa mutane sun bambanta.
Akwai damar da yawa da za su iya juyawa ko sake dawowa, wanda zai haifar da sabbin CoVs waɗanda zasu iya haifar da yaduwa da mutuwa a nan gaba.
Ya kamata kasar Sin ta yi watsi da al'adun cin nama a wasu sassan kasar domin rage hulda da ba dole ba tsakanin mutane da dabbobi.
Ya kamata a sami shiri da kuma shirin amsawa mafi kyau tare da mummunan yanayin SARS, MERS da COVID-19.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a duniya na dogon lokaci.
Suna ci gaba da zama a cikin al'adarsu har sai sun sami damar yin kwafi.
Kodayake dabbobin suna da halaye da yawa waɗanda ke taimakawa wajen yaduwar kwayar cutar, mutane na iya rage damar hulɗa da dabbobin da sauran nau'ikan namun daji zuwa mafi ƙarancin idan an koya musu su nisanta kansu daga waɗannan dabbobin.
Kulawa na yau da kullun na masu ba da izinin dabbobi yana da mahimmanci don ƙarin fahimtar yanayin halittu na CoVs da wuraren ajiyar su na halitta, wanda zai nuna fa'idodi a cikin hana yaduwar dabbobi zuwa mutane da ɓarkewar gaba.
A takaice dai, hanya mafi inganci don hana cututtukan dabbobi shine mutane su nisanta kansu daga yanayin halittu, inda ƙwayoyin cuta ke iya cutar da mutane.
Har yanzu ba a gano wasu abubuwa da yawa a cikin kwayar cutar SARS-CoV-2 ba.
Na farko, idan dabbobin daji sun watsa kwayar cutar SARS-CoV-2 zuwa dabbobin daji, yana da ban sha'awa a ga yadda dabbobin daji da dabbobin daji za su iya zama daidai da yanayin yanayin halittu.
Na biyu, idan dabbobin suna taka rawa wajen watsawa ga mutane, ya kamata a duba yadda mutane ke hulɗa da dabbobin.
Na uku, idan dabba ta uku tana aiki a matsayin mai kula da tsakiya, kawai ta bayyana yadda ta ke hulɗa da nau'ikan dabbobi, ciki har da mutane, tsuntsaye, da namomin kaza.
A ƙarshe, wasu dabbobi, gami da dabbobin gida, suna iya kamuwa da cutar SARS-CoV-2, kuma ya kamata a yi sa ido da kuma gwajin kamuwa da cutar.
Idan tsuntsaye ne, tsuntsaye, ko wasu dabbobi masu rarrafe, ana sa ran SARS-CoV-2 ko kuma kwayar cutar da ta haifar, wanda kusan iri ɗaya ne, za a gano a cikin kwayar cutar ta gaba.
Ci gaba da bincike a cikin wannan sashin zai taimaka wajen bayyana yadda SARS-CoV-2 ke haɓaka a cikin dabbobi, wanda ke da alaƙa da mahimmancin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta yanayin cutar COVID-19 da waɗanda ake zargi da waɗanda suka kamu da cutar.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta ba da sanarwar gaggawa game da ganewar asali da maganin cutar coronavirus na 2019 (2019-nCoV), kuma wannan jagorar ta ba da kwarewarmu kuma ta zama takaddar jagora don yaƙar cutar a duniya.
Amma cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, fahimtarmu da iliminmu suna ƙaruwa a hankali bisa sakamakon bincike da ake gudanarwa da kuma kwarewar aikace-aikacen. Saboda haka, dabarun ganewar asali da magani ana sabunta su akai-akai.
A cikin wannan wasika, mun amsa wani tsokaci game da jagororinmu kuma mun ba da sabon fasalin bincike na "matsalolin da ake zargi" da kuma "matsalolin da ke da alaƙa" bisa ga sabon jagorar ganewar asali da magani na COVID-19 (na bakwai) da Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin ta fitar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta haifar da barkewar abin da yanzu aka sanya masa suna a hukumance cutar coronavirus ta 2019 (COVID-19), kuma an sanya wa kwayar cutar sunan mummunar cutar numfashi mai suna coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta sanya COVID-19 a matsayin annoba.
Don yaƙar kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka ƙa'idodi cikin sauri kuma an buga su ta yanar gizo a cikin binciken likitancin soja a ranar 06 ga Fabrairu, 2020.
Ya jawo hankalin mutane tun lokacin da aka fitar da shi.
Duk da haka, lura cewa COVID-19 sabon cuta ne, fahimtarmu da iliminmu suna ƙaruwa koyaushe bisa ga sakamakon bincike da ke gudana da kuma ƙwarewar asibiti, don haka dabarun ganewar asali da magani ana sabunta su akai-akai.
Misali, jagororin kan ganewar asali da magani don cutar COVID-19 da Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin ta fitar (Janairu 16, 2020 zuwa Maris 3, 2020), sun fitar da sanarwa guda bakwai, wasu daga cikin su an canza su sosai.
Yanzu, ka'idodinmu sun sami hujja daga Zhou et al. Sun ba da shawarar yin ƙididdiga mai sauƙi bisa ga kwarewarsu ta asibiti.
Aikin su ya kara sabbin bayanai ga ka'idodinmu kuma ya kasance muhimmin bayani game da cutar a duniya.
Muna goyon bayan muhimmin aikin da suke yi kuma muna godiya.
Amma kuma aikin su na bukatar sabuntawa bisa ga sabbin ka'idoji na ganewar asali da magani na COVID-19 (na bakwai) da kuma wasu bincike na baya-bayan nan.
A cewar fitowar ta bakwai (Maris 3, 2020), don tabbatar da yanayin da ake zargi, ana buƙatar haɗa wani ɓangare na yanayin cutar tare da abubuwa biyu na bayyanar cututtuka don yin cikakken bincike, ko kuma ana buƙatar cika alamomi uku idan ba a bayyana tarihin cutar ba:
Tarihin annoba: (1) Tarihin tafiya ko zama a Wuhan da kewayenta ko wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da masu zazzabi ko bayyanar cututtuka daga Wuhan da kewayenta ko wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa da cutar (≥ 2 lokuta da zazzabi ko cututtuka sun faru a cikin makonni 2, kamar su ƙananan ofisoshin gida).
Nuna alamun asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da bayyanar cutar COVID-19. (3) Adadin ƙwayoyin jini yana nuna raguwar al'ada ko raguwar lambobin lymph a farkon farawa.
Gano cutar ya kamata ya dogara da abin da ake zargi tare da kowane abu mai cutarwa ko kuma shaidar da ke biyo baya: (1) gwajin PCR na lokaci mai kyau don SARS-CoV-2 (2) jerin jerin kwayoyin cuta na gaba ɗaya sun nuna daidaito mai yawa ga ƙwayoyin corona da aka sani (3) rashin daidaito ga takamaiman IgM da takamaiman IgG antigen ga SARS-CoV-2 a cikin gwajin magani ko canza takamaiman IgG na SARS-CoV-2 daga tabbatacce zuwa tabbatacce ko haɓaka 4≥ a cikin lokacin farfadowa wanda ke cikin matakin farko na gwaji.
Za mu iya ganin cewa an saka gwajin gwajin polymerase chain reaction na nucleic acid a cikin kwayar cutar ko samfurin jini a cikin bugu na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An saka ganowar cututtukan jini a cikin bugu na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020), sannan kuma an saka hujjojin nazarin jini a cikin bugu na bakwai.
Waɗannan canje-canjen sun dogara ne akan masu bincike suna ci gaba da aiki don nemo mafi kyawun na'urar gano nucleic acid don saurin ganewar asali, kamar samfurin daga cikin huhu, gami da ɗaukar samfuran jini, wanda ke haɓaka wadatar samfuran daban-daban da kuma taimakawa kawo sakamako mai kyau na antiretroviral cikin yanayin ganewar asali.
Bugu da ƙari, akwai ƙarin shaidar da ke gargadi mu mu yi taka tsantsan da marasa lafiya da ke da alamun rashin lafiya da rashin alamun.
Saboda haka, ya kamata a sabunta teburin gudanawar Zhou et al. domin sun sanya mutanen da ba su da alamun asibiti a matsayin masu hadarin gaske.
Tsarin maki yana buƙatar daidaitawa a cikin ƙarin aiki da nazarin asibiti.
A ƙarshe, muna fatan ƙarin tabbaci na kai tsaye zai zo, kuma muna kira ga masu karatu su ba da ra'ayoyinsu.
A cikin ganewar asali na "kasashe masu shakku" da "kasashe masu kamuwa da cutar", muna ba da shawarar su bi kuma su bi sabbin ƙa'idodin ƙasarsu.
Ƙungiyarmu za ta sabunta shawarwarinmu a kan lokaci don samar da taimako.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu daga COVID-19, wanda shine mafi girman adadin yau da kullun.
A jiya, Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu saboda cutar COVID-19 a wannan ranar.
Wannan shi ne adadin mutane da suka mutu a rana guda saboda cutar.
Kamar jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka (IEDCR) ta Bangladesh ta ba da rahoton adadin waɗanda suka kamu da cutar, ciki har da masu aiki 114, da masu warkewa 33 da ke zaune a gida.
An samu mutuwar mutane 17.
A wani shirin labarai na kan layi, Daraktan IEDCR, Dr. Meerjady Sabrina Flora, ya ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr. Meerjady, akwai mutane biyu da suka haura shekaru 60, biyu da ke tsakanin shekaru 51 zuwa 60, da kuma mutum 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda suka mutu daga Dhaka ne.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Jami'an asibiti sun shaida wa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, shugaban kwamitin yaki da cin hanci da rashawa na Bengal, wanda ake kula da shi a asibitin Kuwait da ke Maitri.
A cikin wata sanarwa ta bidiyo a ranar Asabar, Ministan Sufuri da Hanyoyin Hanyar Bangalore Obaidul Quader ya ce za a rufe sufuri na jama'a na tsawon lokaci fiye da yadda aka tsara har zuwa ranar Asabar.
An fara rufe zirga-zirgar jama'a ne a ranar 26 ga Maris kuma an shirya za a kawo karshen ranar Asabar, 4 ga Afrilu.
Ana ci gaba da ba da izinin jigilar kayayyaki masu mahimmanci kamar likitoci, mai da abinci.
Wani rikodin farko na 8 ga Maris ya nuna cewa an sami wasu mutane biyu da suka kamu da cutar ta Covid-19 a Bangladesh, wadanda suka dawo daga Italiya, mace, matar wani mutum, wanda kuma ya kamu da cutar.
Dukkanin su uku sun warke, kamar yadda aka yi a ranar 19 ga Maris.
SARS-CoV-2 ya kamu da mutane sama da miliyan a duniya
A cewar bayanan da Jami'ar Johns Hopkins ta fitar a ranar Alhamis, adadin masu kamuwa da cutar SARS-CoV-2 ya haura miliyan daya a duniya.
Akalla mutane dubu 52 ne suka mutu dangane da cutar COVID-19 da kwayar cutar Corona ta haifar.
Wani muhimmin abu ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar ta farko, kuma Uzbekistan ta sami mutuwar farko da ke da alaƙa da cutar coronavirus.
Koriya ta Arewa ta yi ikirarin cewa ita ce daya daga cikin kasashe kalilan da ba ta da cutar coronavirus.
A jiya ne dai Hukumar Lafiya ta Duniya ta bayar da rahoton cewa an samu mutum 1,051,635 da suka kamu da cutar, 79,332 daga cikinsu a cikin sa'o'i hudu kafin karfe 10 na safe (0800 UTC) na tsakiyar Turai a ranar 4 ga Afrilu.
A Amurka, an samu fiye da mutane 244,000 da suka kamu da cutar coronavirus, kuma akalla mutane 5,900 sun mutu sakamakon cutar.
CBS ta ruwaito, tana mai ambaton bayanan Jami'ar Johns Hopkins, cewa sama da mutane 1,000 ne suka mutu a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe da yawa sun ba da sanarwar tsauraran matakai don hana cutar yaduwa.
A ranar Alhamis, gwamnan Moscow Sergei Sobyanin ya ci gaba da rufe birnin har zuwa ranar 1 ga watan Mayu.
A duk fadin kasar, Shugaba Vladimir Putin ya sanar da cewa 'yan kasar Rasha za su samu albashi ba tare da zuwa aiki ba har zuwa 30 ga watan Afrilu.
Portugal ta yi zabe don tsawaita dokar ta baci na kwanaki 15, an amince da kuri'un, tare da kuri'u 215 a kan 10 a kan 1 a kan 1.
Saudi Arabiya ta kara dokar hana zirga-zirga a manyan wuraren taruwa na Makka da Madina, wanda ya dauki tsawon yini guda.
Thailand na shirin aiwatar da dokar hana fita tsakanin karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike DeWine ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Shaguna a Australia suna da karancin amfani da takarda a kowane aiki
A ranar Lahadi da kuma Talata da yamma, kantunan Woolworths da Coles na Australia sun rage sayayya ta takarda zuwa biyu da kuma kunshin daya a kowane aiki a duk shagunan da ke kasar.
A ranar Litinin, kasuwar zamani ta ALDI ta ba da shawarar iyakancewar fakiti ɗaya.
An sanya waɗannan kwanakin a matsayin saƙonni a kan tashoshin kula da kuma dandalin Facebook.
An bayar da rahoton cewa abokan ciniki suna sayen kayan ajiya saboda tsoron COVID-19 idan har suna buƙatar keɓewa.
A ranar Laraba, Woolworths ya iyakance sayen takarda don isar da gida zuwa fakiti ɗaya a cikin oda.
An yi waɗannan canje-canjen ne bisa ga matakan ƙuntatawa na huɗu a cikin sayayya ta farko da Woolworths da Coles suka gabatar a ranar 4 da 5 a keɓaɓɓu.
"A cikin sanarwar da ta fitar a kafofin watsa labarai a ranar 8 ga Maris, Coles Modern Market ta ba da rahoton cewa tare da iyakance adadin fakitoci huɗu, ""yawancin shagunan sun cika cikin sa'a guda na isar da kaya"," kuma ta kira wannan buƙatar "ba a taɓa gani ba" yayin da Aldi Market ta kira ta "ba zato ba tsammani" a cikin post ɗin Facebook a ranar Talata. "
A cewar mai magana da yawun Woolworths, tallace-tallace sun yi tashin gwauron zabi a makon da ya gabata.
Shagon Costco a Canberra ya kafa adadin da aka yarda da shi na kwantena biyu a makon da ya gabata.
Don rage rashi, Coles ya ba da umarnin manyan kwantena daga masu samarwa da kuma hanzarta jigilar kayayyaki, Woolworths ya ba da umarnin ƙarin ajiya, yayin da ALDI ya kafa ajiya don ayyukan da aka tsara don musamman batura na farko.
Russell Zimmerman, shugaban kungiyar 'yan kasuwar Australiya, ya ce 'yan kasuwar suna kokarin shigo da motocin lantarki, amma dokar da majalisar ta kafa a yankin ta sanya wa motocin lantarki matsala.
Ya yi tsammanin farashin samarwa zai tashi saboda masu samarwa suna ƙoƙarin biyan buƙatu kuma suna da ƙwarewar ƙwarewa.
A ranar Talata, ALDI ta sanar da cewa bayan fitowar kantin farko, wasu shagunan ba za su iya gudanar da shirin na musamman na Laraba ba.
A wani rahoto da News.com.au ya fitar, Dr. Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Finland, ya ce wadannan shagunan suna cike da kaya a kowane dare.
Ya lura cewa takardar wanka ta kasance kayan kwalliya biyu, wanda ke haifar da ƙarancin adadin kaya, kuma lokacin da aka sayar, barin babban akwatin ajiya yana ba da ma'anar rashin amfani.
Russell Zimmerman ya shaida wa ABC cewa, "Colos da Volvo suna da ra'ayi [cewa] idan akwai abubuwa da yawa a kan kayan, idan ana iya siyan kayayyaki kamar su kayan wanka da magungunan wanka, kuma a cikin adadi mai yawa, za ku iya rage yawan tsoro".
Kamfanin Who Gives a Crap, wanda ke kera takarda mai kwalba da aka sake amfani da ita, ya ce a ranar Laraba sun gama kayayyaki daga kantin sayar da kayayyaki.
Kamfanin Kimberly-Clark, wanda ke kera Kleenex Toilet Tissue da Solaris da kuma kayan kwalliyar kwalliya, ya tabbatar da cewa suna aiki 24/7 don kiyaye wadatar, kamar yadda News.com.au ta ruwaito.
Shafin yanar gizo na dukiya, Domain.com, ya ruwaito cewa dillalai na gida sun ba da takardar wanka kyauta ga masu yin takarda na farko a cikin gwanjo a Melbourne lokacin da aka yi takaddama biyu ko uku saboda masu siye sun yi hutu a ƙarshen ranar Labor Day.
Labarin da jaridar NT News ta wallafa a ranar Alhamis, wanda ake bugawa a kullum a Darwin, ya hada da shigar da shafuka takwas da ake son a yanke su a yi amfani da su a matsayin takarda.
Da farko, bankuna sun yi jinkirin sanya wannan takunkumin, a cewar rahoton ABC Australia a ranar 3 ga Maris, inda suka ce ba su da shirin gabatar da takunkumin sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna cikin babban bukatar, ciki har da abin rufe fuska, kayan shafawa, kayan bushewa, bushe hannu da kayan masarufi.
Hakazalika, a yammacin ranar Lahadi a waje da Australia, an lura da cewa kasuwar Ocado ta yanar gizo ta Burtaniya ta sanya iyakance kan siyan takarda don kwalban Andres har zuwa kwantena 12.
Hukumar Lafiya ta Duniya ta sanar da annobar COVID-19
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta sanar da barkewar cutar COVID-19 da kwayar cutar SARS-CoV-2 ke haifarwa.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yadu, kuma ba kawai tana nufin takamaiman yanayi mai haɗari ba, amma Hukumar Lafiya ta Duniya ta lura da buƙatar tura gwamnatoci don ɗaukar matakan:
Duk ƙasashe na iya canza yanayin cutar.
Tedros Adhanom Ghebreyesus, babban daraktan WHO, ya ce idan kasashen suka gano cewa ana gudanar da gwajin, za a ware su kuma a tara jama'a domin amsawa.
"Muna matukar damuwa da irin yaduwar dokar ta baci da kuma tsananin ta, da kuma irin gaggawa da rashin aikin yi".
A cewar Dr. Tom Frieden, tsohon daraktan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, annobar ta "ba a taɓa ganin irinta ba".
A cikin jawabinsa da aka buga ta gidan talabijin na CNN a watan Fabrairu, ya ce "ban da mura, babu wani kwayar cutar numfashi da aka lura da ita tun daga fitowar ta har sai da ta ci gaba da yaduwa a duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana mai cewa: "Ba mu taɓa ganin annobar cutar coronavirus ba a baya".
Ya ci gaba, "kuma ba mu taɓa ganin wata annoba da za a iya sarrafawa a lokaci ɗaya ba".
Sabbin cututtukan da suka biyo bayan shawarar WHO a watan Janairu, wanda ya ayyana yaduwar cutar a matsayin gaggawa ga lafiyar jama'a, na da matukar damuwa a duniya.
Dokta Anthony Fauci, darektan Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar C
A ranar Alhamis, hukumar ta ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya yi sanadiyar mutuwar mutane sama da 4,600.
Cutar cutar korona ta 2019/20 ci gaba ce ta cutar korona ta 2019 (COVID-19), wadda ta haifar da cutar sankarar bargo mai saurin kamuwa da cuta ta korona 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin dokar ta baci ta duniya ta damuwa a ranar 30 ga Janairu, 2020, kuma an gane ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, an samu karuwar cutar COVID-19 da kimanin mutane miliyan 1.61, wadanda suka fito daga kasashe da yankuna 210, inda aka samu mutuwar mutane 97,000.
An samu kusan mutane 364,000 da suka warke.
Yawan mutuwar mutane ya kai kashi 4 cikin 100 a kasar Sin, yayin da na duniya ya kai 13.04% a Aljeriya zuwa 0.08% a New Zealand.
Alamun da aka saba da su sun hada da zazzabi, tari, da kuma gajiya.
Abubuwan da ke iya faruwa sun hada da ciwon huhu da kuma cututtukan numfashi.
Daga lokacin da aka sadu da mai cutar zuwa lokacin bayyanar cututtuka, ana iya gano su a cikin kwanaki biyar, amma ana iya gano su tsakanin kwana biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko magani na musamman na maganin cutar.
Jiyya na farko shine maganin da ya dogara da bayyanar cututtuka da tallafi. Hanyoyin da aka ba da shawarar sun hada da wanke hannu, rufe baki yayin tari, nisantar mutane, da kuma lura da kuma ware waɗanda suka yi zargin cewa suna da kamuwa.
Hukumomi a duk duniya sun amsa ta hanyar aiwatar da takunkumin tafiye-tafiye, keɓewa, hanawa, sa ido kan haɗarin aiki da rufe wurare.
Cutar ta haifar da rikice-rikice na tattalin arziki, zamantakewar duniya, jinkiri ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma farfaganda, da rashin wadataccen sayayya da ke haifar da tsoro.
Makarantu da jami'o'i sun rufe a ko'ina cikin ƙasa ko yanki a cikin ƙasashe 193, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Rashin gaskiya game da kwayar cutar ya bazu a yanar gizo, kuma ya kara da cewa akwai al'amuran tsoratar da baƙi da nuna bambanci ga Sinawa, wasu mutanen da suka fito daga Gabashin Asiya da Gabas ta Tsakiya, da masu kama da juna, da sauransu daga yankunan da cutar ta kamu da su.
Ta hanyar rage tafiye-tafiye da rufe masana'antu masu nauyi, an sami raguwa a cikin gurɓataccen iska da fitar da carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton wani kwatsam na cutar huhu ta sanadin da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin waɗannan lamuran sun shafi kasuwar abincin teku ta Hunan, saboda haka ana tsammanin cutar ta samo asali ne daga Huno.
Kwayar cutar da ta haifar da barkewar cutar, wacce aka sani da SARS-CoV-2, ita ce sabuwar cutar da aka gano wacce ke da alaƙa da coronavirus a cikin beraye, coronavirus a cikin dabbobi, da SARS-CoV. An gano cewa mutumin da ya fara kamuwa da cutar ya yi rashin lafiya a ranar 1 ga Disamba, 2019, kuma mutumin bai kasance cikin hulɗa kai tsaye da rukunin ƙwayoyin cuta da aka samo a kasuwar kayan masarufi ba.
A cikin farkon shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku na marasa lafiya sun samo asali ne daga wannan kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya nuna cewa wani mutum mai shekaru 55 da haihuwa wanda ya faru a ranar 17 ga Nuwamba, 2019, daga lardin Hubei, yana iya zama farkon lamarin.A ranar 26 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta ba da rahoton cewa sabbin shari'o'in da aka ruwaito sun ragu a China, amma nan da nan akwai karuwa a Italiya, Iran da Koriya ta Kudu, sabon adadin wadanda ba a kasar Sin ba ya wuce sabon adadin wadanda ke kasar Sin a karon farko.
Wataƙila ba a taɓa samun rahoton kamuwa da cuta ba, musamman a cikin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga watan Fabrairu, an samu wasu cututtuka a tsakanin matasa masu shekaru 19 da ke ƙasa da kashi 2.4% na cututtukan duniya. Patrick Vallance, mai ba da shawara kan ilimin kimiyya na Burtaniya, ya kiyasta cewa kashi 60% na mutanen Burtaniya za su kamu da cutar kafin a sami rigakafin da ke aiki a matsayin rukuni.
Lamarin ya shafi adadin mutanen da suka yi gwajin COVID-19 kuma gwajin su ya tabbatar da tabbatacce, a cewar wani taron hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa sun ba da ƙa'idodin doka na rashin gwadawa ga waɗanda ke da ƙananan alamun, kamar Italiya, Netherlands, Spain da Sweden.
Wani bincike da aka buga a ranar 16 ga Maris ya gano cewa a kasar Sin har zuwa ranar 23 ga watan Janairu, kusan kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma wannan kamuwa da cutar da ba a rubuta ba ita ce tushen watsa kashi 79% na wadanda aka rubuta.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi adadin wadanda aka ruwaito.
Hasashen farko na lambar kwayar halitta (R0) don COVID-19 shine 1.4 zuwa 2.4.
Wani bincike da Cibiyoyin Kula da Cututtuka da Rigakafin Amurka suka fitar ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 sun warke.
Ga kasashen da ba su da lokaci, lokacin bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
A ranar 10 ga Afrilu, 2020, an samu mutuwar mutane 97,000 sakamakon cutar COVID-19.
A kasar Sin, a ranar 5 ga watan Fabrairu, kimanin kashi 80% na waɗanda suka mutu sun haura shekaru 60, kuma kashi 75% suna da cututtukan zuciya da ciwon sukari.
Lambar mutuwar COVID-19 na gaske na iya zama mafi girma saboda ba ta ƙidaya mutanen da suka mutu ba tare da gwaji ba - misali, a gida, a wuraren kulawa, da sauransu.
Wani bangare na bayanai daga Italiya ya gano cewa adadin mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar da sabis na hukuma ya rufe ta hanyar 4-5x.
"Shugaban hukumar kula da cututtuka ta Amurka (CDC) ya yarda cewa, "Mun san cewa [yawan mutuwar] wani abu ne na yau da kullun", wata sanarwa da aka tabbatar da rahoton ƙididdigar Amurka. Irin wannan yawon shakatawa yana faruwa sau da yawa yayin annobar, misali, kamar cutar H1N1 a shekarar 2009.
Mutuwa ta farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a kasar Philippines, kuma ta farko a wajen Asiya a kasar Faransa a ranar 14 ga watan Fabrairu.
Har zuwa 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane da dama a Iran, Koriya ta Kudu da Italiya.
Ya zuwa ranar 13 ga Maris, sama da kasashe da yankuna arba'in sun ba da rahoton mutuwar a duk nahiyoyi ban da Antarctica.
Wadannan lambobin sun bambanta ta yanki da lokaci kuma suna da tasiri ta hanyar girman cutar, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar, da yanayin alƙaluma kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai 6.0% (97,039/1617,204) a ranar 10 ga Afrilu, 2020.
Adadin ya bambanta a yankuna daban-daban.
A China, kimantawar yawan mutuwar ta ragu daga 17.3% (ga waɗanda ke da alamun farawa daga 1 zuwa 10 ga Janairu, 2020) zuwa 0.7% (ga waɗanda ke da alamun farawa bayan 1 ga Fabrairu, 2020). Sauran matakan sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan masu kamuwa da cuta (an gano su kuma ba a gano su ba) waɗanda suka mutu daga cutar.
Waɗannan ba su da lokaci kuma suna bin takamaiman mutane daga kamuwa da cuta ta hanyar magance lamura.
Wasu karatu sun yi kokarin kirga wadannan lambobi ga wasu mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin cutar gaba daya ya kasance tsakanin 0.1% da 0.39%.
Wannan kimantawa ta sama ta yi daidai da sakamakon gwajin farko na COVID-19 a Jamus da kuma nazarin tasirin gwajin akan kimantawar CFR.
WHO ta yi ikirarin cewa za a iya sarrafa cutar.
Lokacin da aka fara da kuma lokacin da aka fara fashewa ba a san su ba kuma suna iya bambanta da wuri.
Maciej Boni a Jami'ar Jihar Penn ya tabbatar da cewa, saboda rashin kulawa, annobar ta tashi sama, sannan ta fara raguwa lokacin da cutar ta ƙare.
Amma kusan ba zai yiwu a yi hasashen daidai ba a yanzu game da lokacin da zai faru.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China Zhong Nanshan ya yi ikirarin cewa, za a iya kawo karshen cutar a watan Yuni idan an hada kan dukkan kasashe wajen bin shawarar da Hukumar Lafiya ta Duniya ta bayar kan matakan dakile yaduwar cutar.
"A ranar 17 ga watan Maris, Adam Kucharski, daga Makarantar Magunguna da Magunguna ta Tropical, ya ce SARS-CoV-2 ""zai iya ci gaba da yaduwa cikin shekara daya ko biyu. ""
"A cewar wani binciken kwalejin Imperial College da Neil Ferguson ya gudanar, za a bukaci yin gwajin jiki da sauran matakan ""har sai an samu maganin rigakafi (watakila na tsawon watanni 18 ko fiye da haka"]".
William Schaffner daga Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar korona, saboda ta riga ta shirya don yaduwa, ba za ta tafi gaba daya ba, kuma za ta iya canzawa zuwa cutar yanayi, ta hanyar dawowa kowace shekara".
Rashin ƙarfi na sake fashewar cutar zai dogara ne akan ƙarfin garkuwar jama'a da girman bambancin.
Alamar COVID-19 na iya zama mai alaƙa da rashin tabbas, kuma mai cutar na iya zama ba shi da alamun.
Alamomin biyu da suka fi kowa su ne zazzabi (88%) da tari (68%).
Alamun da ba safai ba sun hada da gajiya, samar da ruwa a cikin numfashi (phlegm), rashin jin ƙanshi, gajeren numfashi, ciwon tsoka da jijiyoyi, rashin jin daɗi, ciwon kai, ciwon daji, ciwon hauka, kumburi, ko kuma canza launin fata.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ba da jerin alamun farko kamar su tashin hankali na numfashi, ciwon kirji mai ɗorewa ko matsin lamba, wahalar farkawa da fuska ko ƙyamar baki. Ana ba da shawarar kulawar likita na gaggawa idan waɗannan alamun sun kasance.
Wasu masu kamuwa da cutar na iya zama marasa alamun cutar amma suna da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa duk wanda ya kasance cikin kusanci da wanda ya kamu da cutar ya kamata a bincika shi kuma a sanya ido sosai don hana kamuwa da cutar.
Kimanin kasar Sin game da yawan rashin nunawa ya yi kasa da kashi 44 cikin dari.
Lokaci na farkawa (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) yana daga kwana ɗaya zuwa kwanaki 14, misali na kwanaki biyar. Misali na rashin tabbas, kimantawa kashi na mutanen da ke da COVID-19 waɗanda suka fara rasa ƙanshin ƙanshi shine 30% kuma daga baya ya faɗi zuwa 15%.
Wasu bayanai game da yadda cutar ke yaduwa har yanzu ba a bayyana su ba.
An yi imanin cewa cutar tana yaduwa ne a cikin kusanci da kuma ta ƙananan ruwa da aka samar yayin da ake taɓawa ko magana, tare da kusanci tsakanin mita 1 zuwa 2 (3 zuwa 6 feet).
Nazarin ya gano cewa yin ihu ba tare da an rufe bakinsa ba na iya haifar da zubar da jini daga nisan mita 4.5 (15 feet) zuwa mita 8.2 (27 feet).
Wasu sun ba da shawarar cewa za a iya yada kwayar ta hanyar ƙananan ɗigon ruwa da ke cikin yanayi na dogon lokaci, wanda za a iya samarwa yayin magana. Za a iya samar da ɗigon ruwa mai guba a lokacin numfashi, gami da lokacin magana, kodayake kwayar ba ta yaduwa ta iska.
Ruwan bakin zai iya shiga bakin ko hancin mutane da ke kusa ko kuma ya shiga cikin huhu ta hanyar numfashi.
Wasu hanyoyin kiwon lafiya kamar su jini a cikin kwakwalwa da kuma cPR na iya haifar da numfashi wanda ke cire iska kuma yana iya haifar da yaduwar iska.
Hakanan za a iya yada shi lokacin da mutum ya taɓa wani abu da ya shafi fata, ciki har da fata, sannan ya taɓa idanunsa, hanci, ko bakinsa.
Duk da yake akwai damuwa cewa ana iya yada shi ta hanyar ruwa, an yi imanin cewa wannan haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar kai tsaye na SARS-CoV-2. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun gwada tabbatacce har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya kamuwa da cutar kafin bayyanar cututtuka.
Akwai wasu rahotanni na marasa alamun da aka tabbatar da su ta hanyar dakin gwaje-gwaje, amma wasu ƙasashe sun ƙaddamar da ƙaddamar da ƙaddamarwa a lokacin binciken.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce, yayin da ba a san yadda cutar ke yaduwa ba, mutum ɗaya zai iya yaduwa zuwa mutane biyu ko uku.
A bayyane yake, an gano cewa kwayar cutar na iya rayuwa a kan filastik na polypropylene na tsawon kwanaki uku da awanni 304 a kan karfe na zinc, rana ɗaya a kan takarda, har zuwa kwanaki huɗu a kan sanduna.
Duk da haka, wannan ya bambanta dangane da ƙanshi da zafin jiki. Dabbobi da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ke nuna cewa dabbobi na iya yada kwayar cutar zuwa ga mutane, duk da cewa hukumomin Burtaniya sun ba da shawarar wanke hannayensu bayan hulɗa da dabbobi, kamar yadda suke yi bayan wasu hulɗa na waje da mutane da ke iya kamuwa da cutar.
Cutar cutar huhu mai saurin kamuwa da cuta ta coronavirus 2 (SARS-CoV-2) ita ce kwayar cutar da ba a taɓa gani ba, ta fara ware kanta daga mutane uku da ke da cutar huhu da ke da alaƙa da cutar huhu mai saurin kamuwa da cuta a Wuhan.
Dukkanin halayen SARS-CoV-2 suna cikin kwayar cutar da ke da alaƙa da kwayar cutar corona a yanayi. A waje da jikin mutum, za a iya kawar da kwayar cutar ta hanyar sabulu na gida wanda zai iya lalata kariya. SARS-CoV-2 yana da alaƙa da kwayar cutar SARS-CoV.
An yi tunanin cewa cutar ta samo asali ne daga kamuwa da dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta Corona tana da alaƙa da kwayar cutar betacoronavirus a cikin kwayar cutar B tare da kwayar cutar da ta samo asali daga nau'ikan batirin biyu.
Yana da kashi 96 cikin ɗari na kama-da-wane a matakin kwayar halitta zuwa wani nau'in cutar bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambancin amino acid guda daya a wasu sassan kwayoyin halittar tsakanin kwayar cutar daga dabbobi da kwayoyin halittar mutum.
Kimanin dukkanin kwayoyin sun gano cewa kusan kashi 92% na kayan halittar da aka rarraba tsakanin namomin kaza da kwayar cutar SARS-CoV-2, wanda bai isa ya tabbatar da cewa namomin kaza sune matsakaitan masu masaukin baki ba.
Ana iya yin rigakafin cutar ta hanyar cutar ta hanyar cutar ta farko, kodayake tabbatarwa ta ƙarshe dole ne ta kasance ta hanyar gwajin rRT-PCR na kayan da aka kwafa ko CT.
Nazarin kwatancen polymerase chain reaction zuwa Citrate a Wuhan ya nuna cewa Citrate yana da ƙarfi fiye da polymerase chain reaction, yana da halaye da yawa na yanayin da ke haɗuwa da ciwon huhu da sauran hanyoyin cutar, kodayake ba takamaiman ba.
Ya zuwa watan Maris na 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don gano ko kuma a yi amfani da shi a matsayin zaɓi na farko na gwajin COVID-19.
Hukumar Lafiya ta Duniya ta fitar da jerin gwaje-gwajen RNA da yawa don SARS-CoV-2, tare da fitowar farko a ranar 17 ga Janairu.
Ana yin gwajin ta hanyar yin amfani da maganin polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ne a kan samfurin numfashi ko jini.
A yawancin lokaci, ana samun sakamako cikin sa'o'i kadan zuwa rana.
Yawancin lokaci ana yin gwajin ne a kan bututun hanci, kodayake ana iya amfani da bututun hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin ruwa wanda ke gano kwayoyin halitta.
Ya zuwa ranar 6 ga Afrilu, 2020, waɗannan takardun ba su tabbatar da cewa sun isa ba don a amince da su don amfani da jama'a.
A Amurka, ana ba da izinin amfani da gwajin siliki na gaggawa kawai ta hanyar ingantaccen dakin gwaje-gwaje.
Abubuwan da ke cikin hoton da aka yi a kan kyamarar X-ray da kuma na'urar daukar hoto (CT) a kan mutanen da ke da alamun sun hada da gilashin gilashi a ƙasa da kuma yanayin da ba a haskaka ba.
The Italian Radiological Society tana tattara bayanan yanar gizo na duniya game da gano hoto don tabbatar da shari'ar.
Saboda daidaituwa da sauran kamuwa da cuta kamar adenovirus, bin diddigin hoto ba tare da tabbatar da PCR ba yana da mahimmanci wajen gano cutar COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake hoton bai dace da yaduwa ba, yana da sauri kuma yana da ƙarfi, yana ba da shawarar cewa gwajin sa na iya zama kayan aiki a cikin yankin annoba.
An kirkiro cibiyoyin neuron da ke kan kwakwalwar kwakwalwa don kama hoton kwayar cutar tare da duka X-rays da CT.
Dabaru don hana yaduwar cuta sun hada da kiyaye tsabtar jiki, wanke hannu, guje wa taɓa idanu, hanci, ko baki ba tare da wanke hannu ba, yin tari ko yin tari, amfani da tawul, da jefa tawul ɗin nan da nan cikin kwandon shara.
Duk wanda ya riga ya kamu da cutar an shawarce shi da ya sanya abin rufe fuska a cikin jama'a.
An kuma bada shawarar a yi keɓewa domin hana yaduwar cutar. Gwamnatoci da dama sun sanya takunkumi ko hana tafiye-tafiye marasa mahimmanci daga ko zuwa ƙasashe da yankuna da cutar ta shafa.
Koyaya, cutar ta kai ga yaduwar al'umma a manyan sassan duniya.
Wannan yana nufin cewa kwayar tana yaduwa a cikin al'umma kuma wasu membobin al'umma ba su san inda suka kamu da cutar ba ko kuma ta yaya. An shawarci masu ba da kiwon lafiya da ke kula da wanda ke iya kamuwa da kwayar ta yi amfani da matakan tsaro, hulɗa, da kariya ta ido. Binciken hulɗa hanya ce mai mahimmanci ga hukumomin kiwon lafiya don gano tushen kamuwa da cuta da kuma hana ƙarin kamuwa da cuta.
Amfani da bayanan wayar salula ta gwamnati don wannan manufar ya haifar da damuwa game da sirrin, inda Amnesty International da wasu kungiyoyi sama da 100 suka fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu daban-daban ko kuma an ba da shawarar yin amfani da su da son rai, kuma tun daga ranar 7 ga Afrilu, 2020, ƙungiyoyi da yawa suna aiki kan mafita na sirri kamar amfani da Bluetooth don gano kusanci ga masu amfani.
Masu amfani za su sami saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Rashin fahimta da ake yadawa game da yadda za a hana kamuwa da cuta, misali, wanke hanci da wanke baki da ruwan sha na bakin ba su da tasiri.
Babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da dama na kan aikin samar da ita.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa aƙalla na mintuna biyu, musamman bayan wanka ko lokacin da hannayensu suka zama marasa tsabta kafin cin abinci da kuma bayan shan hanci, tari ko busassun abubuwa.
Wannan saboda a waje da jikin mutum, kwayar cutar ta kashe ta sabulu na cikin gida wanda ke haifar da fashewar rigakafinta.
CDC ta kara ba da shawarar yin amfani da wanke hannu tare da aƙalla kashi 60% na giya lokacin da sabulu da ruwa ba su da isasshen.
WHO ta shawarci mutane su guji taɓa idanunsu, hanci, ko bakinsu da hannuwansu da ba a wanke ba.
Za'a iya wanke farfajiyar ta hanyar wasu matattara (a cikin minti daya bayan an yi amfani da maganin kashe ƙwayoyin cuta don farfajiyar ƙarfe) ciki har da ethanol 6271% isopropanol 50100% sodium ipoglulite 0.1% hydrogen peroxide 0.5% da iodine polypropylene 0.27.5%.
Sauran hanyoyin kamar benzalkonium chloride da chrohexidine gluconate ba su da tasiri sosai.
Cibiyoyin Kula da Cututtuka (CDC) sun ba da shawarar cewa idan akwai wata cuta ko tabbatacciyar cutar COVID a wurare kamar ofis ko wuraren kula da yara kamar ofisoshin, wuraren wanka, wuraren taruwa, kayan aikin lantarki da aka raba kamar su kwamfutar hannu, na'urorin taɓawa, masu amfani da na'urorin sarrafawa, na'urorin sarrafawa, da ATM da mai haƙuri ke amfani da su, ya kamata a yi musu allurar rigakafi.
Hukumar Lafiya ta ba da shawarar cewa mutane su yi ta shanyewa da kuma hanta da hanci a ƙarƙashin hannu ko kuma su yi amfani da tawul lokacin da suke yin tari ko fitsari kuma su jefar da takarda nan da nan.
An ba da shawarar yin amfani da abin rufe fuska na likita ga waɗanda ke da yiwuwar kamuwa da cuta, yayin da sanya abin rufe fuska zai iya rage yawan kamuwa da cuta da fitar da ruwa yayin magana, tari da tari.
Hukumar Lafiya ta Duniya (WHO) ta fitar da shawarwari kan lokacin da kuma yadda ake sanya abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cutar a Jami'ar Leeds, sanya abin rufe fuska na iya rage yawan mutane daga hulɗa da fuska, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba. An kuma ba da shawarar yin amfani da abin rufe fuska ga masu kula da waɗanda ke da cutar.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa mutanen da ke da lafiya su sanya abin rufe fuska a lokuta masu haɗari, kamar masu kula da marasa lafiya na COVID-19.
Wasu kasashe sun fara karfafawa jama'a gwiwa kan amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska daga abin rufe fuska wanda ba na likita ba. China ta ba da shawarar musamman ga jama'a, musamman waɗanda ke da kusanci (mita 1 (ƙafa uku) ko fiye) tare da wasu, su yi amfani da abin rufe fuska na likita wanda za a iya zubar da shi.
Hong Kong ta ba da shawarar sanya abin rufe fuska yayin da mutane ke tafiya a cikin jigilar jama'a ko kuma a wuraren da mutane ke da yawa.
Jami'an kiwon lafiya na Thailand sun karfafawa mutane gwiwa su yi abin rufe fuska daga fata a gida kuma su wanke shi kullum.
Jamhuriyar Czech da Slovakia sun hana fita a fili ba tare da sanya abin rufe fuska ba ko kuma tare da abin rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta ba da shawarar cewa ku sanya abin rufe fuska lokacin da kuke cikin jama'a don kare kanku da wasu.
Gwamnatin Austria ta umarci duk wanda ya shiga kantin sayar da kayayyaki ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan mutane su sanya abin rufe fuska a fili.
Taiwan, wacce ke kera abin rufe fuska na zinare miliyan goma a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da motocin birni su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta bukaci sanya abin rufe fuska a duk lokacin da ta fita waje, kuma ta ba da shawarar samar da abin rufe fuska da hannu ga waɗanda ba za su iya sayan abin rufe fuska ba.
Ana amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Keɓewar jama'a (ko kuma sanannen keɓewa) ya ƙunshi matakan sarrafa kamuwa da cuta da nufin jinkirta yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da keɓewa, ƙuntatawa kan tafiye-tafiye da rufe makarantu, wuraren aiki, filayen wasa, masana'antu ko cibiyoyin sayar da kayayyaki, da sauransu.
Mutum zai iya yin amfani da dabarun nisantar zamantakewa ta hanyar zama a gida, rage yawan tafiya, guje wa wuraren jama'a, yin hulɗa ba tare da taɓa juna ba, da kuma nisantar da kansa daga wasu.
Yanzu gwamnatoci da dama suna tsara ko kuma bada shawarar yin zaman lafiya a yankunan da cutar ta shafa.
Matsakaicin girman taron da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar an rage shi da sauri daga mutane 250 (idan ba a sami yaduwar cutar COVID-19 a yankin ba) zuwa 50 kuma daga baya zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane biyu ko sama da haka. Manya da waɗanda ke da cututtuka kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, cututtukan jini, da raunin rigakafi suna fuskantar haɗarin kamuwa da cuta mai tsanani da sakamako masu yawa. A ƙarshen Maris, 2020, Hukumar Lafiya ta Duniya da sauran kungiyoyin kiwon lafiya sun fara amfani da kalmar "matsakaici" tare da "tsare jiki" don tabbatar da cewa manufar ita ce rage yiwuwar haɗarin jiki yayin kiyaye hulɗa ta kusa ko ta nesa.
Amfani da kalmar "tsabtace zamantakewar" ya haifar da tasirin cewa mutane suna da alaƙa da keɓewa daga zamantakewar gaba ɗaya maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da shawarar kiwon lafiya na jima'i don amfani yayin annobar.
Waɗannan sun haɗa da shawarwari na yin jima'i kawai da waɗanda kuke zaune tare da su waɗanda ba su da kwayar cutar ko alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda aka gano suna da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakken bayani game da keɓewa da ya dace. Gwamnatoci da yawa sun ba da umarni ko kuma ba da shawarar keɓewa ga duk mutanen da ke zaune a yankunan da cutar ta bulla.
An ba da shawarar keɓe kai ga waɗanda ke cikin rukunin haɗari.
Wadanda suka iya kasancewa cikin hulɗa da waɗanda ke da COVID-19 da waɗanda suka yi tafiya zuwa ƙasa ko yanki mai ƙaruwar yaduwar cutar an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin da aka yi musu ƙarshe.
Dabaru don sarrafa barkewar cutar shine sarrafawa, hanawa da rage tsanani.
Ana aiwatar da wannan a farkon matakan yaduwar cutar kuma ana nufin saka idanu da keɓewar waɗanda ke da cutar, da kuma gabatar da sauran matakan sarrafawa, watsawa da allurar rigakafi don hana cutar yaduwa ga yawan jama'a.
Lokacin da ba za a iya dakatar da yaduwar cutar ba, ƙoƙarin na gaba ya kai ga matakin ragewa: an ɗauki matakai don rage yaduwar cutar da rage tasirin ta ga tsarin kiwon lafiya da zamantakewar jama'a.
Ana iya aiwatar da haɗin haɗuwa da matakan sarrafawa da rage haɗari a lokaci guda.
Dakatarwar na bukatar karin matakan hana barkewar cutar ta hanyar rage yawan masu ci gaba zuwa kasa da kashi 1 cikin dari na yadda za a iya sarrafawa. yaduwar cutar ta na kokarin rage yawan yaduwar cutar, wanda aka sani da "bakin karuwa".
Wannan yana rage haɗarin rashin lafiya da kuma ba da ƙarin lokaci don samar da allurar rigakafi da magani.
Hanyoyin hanawa na rashin magani da za su iya sarrafa barkewar cutar sun hada da matakan kariya na mutum kamar sunadarai, sanya abin rufe fuska da keɓewa, matakan al'umma da ake nufi da nisantar da mutane daga jiki, kamar rufe makarantu da soke manyan tarurruka.
Sauran ƙasashe sun kuma kafa wasu matakan da ake so don rage yaduwar cutar.
Koriya ta Kudu ta aiwatar da babban bincike da keɓewa a kan tushe kuma ta ba da sanarwar motsi na mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar, sun yi allurar rigakafi, kuma sun sanya manyan tarar ga waɗanda ba su bi ba.
Taiwan ta kara samar da abin rufe fuska da kuma tara kayayyakin kiwon lafiya. Bayanan da aka bayar ga Burtaniya da Amurka sun nuna cewa rage (amma ba a dakatar da yaduwar cutar) da hana (yanayin cutar) suna da manyan kalubale.
Manufofin rage yawan cutar da suka fi dacewa na iya rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku da mutuwar da rabi, amma har yanzu yana haifar da dubban dubban mutuwar, kuma tsarin kiwon lafiya yana fuskantar lalacewa.
Za a iya zaɓin aiwatar da matakan aiki kuma ya zama dole a aiwatar da su har sai cutar ta yadu ga mutane (ko kuma har sai an sami rigakafi, idan akwai) lokacin da watsawar ta tashi da sauri lokacin da aka sassauta matakan.
Dogon lokaci na shiga tsakani don hana annobar ya haifar da asara ga al'umma da tattalin arziki.
Babu takamaiman maganin rigakafin cutar da aka amince da shi don amfani da COVID-19, amma ana ci gaba da kokarin ci gaba, gami da gwajin maganin da ake da shi.
Yin amfani da maganin sanyi da yawa, shan ruwa da hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, maganin fiber, da taimakon numfashi.
Yin amfani da steroids na iya sa sakamakon ya zama mafi muni.
Ana binciken abubuwa da yawa da aka riga aka amince dasu don magance cututtukan da ke haifar da wasu ƙwayoyin cuta don amfani dasu wajen magance COVID-19.
Hukumar Lafiya ta Duniya ta kuma bayyana cewa wasu hanyoyin gargajiya da na gida na iya ba da taimako daga alamun cutar SARS-CoV-19.
Ƙarfafawa da daidaitaccen kiwon lafiya ga samfurin marasa lafiya na COVID-19 an bayyana shi ta Hukumar Lafiya ta Duniya a matsayin matakin farko na amsawa ga barkewar cutar.
ECDC da WHO a Turai sun sanar da sauya fasalin asibitoci da manyan wuraren kiwon lafiya zuwa sauya albarkatu a matakai da yawa, wanda ya haɗa da mai da hankali kan sabis na gwaji don gwajin COVID-19, soke tafiye-tafiye, zaɓi na lokaci-lokaci, keɓewa da keɓewa, da haɓaka ƙwarewar kulawa ta hankali ta hanyar horar da ma'aikata da haɓaka kayan aikin iska da gadaje.
Akwai ra'ayoyi daban-daban game da inda farkon yanayin (wanda ake kira marasa lafiya marasa lafiya) zai iya samo asali.
Halin farko da aka sani da sabon kwayar cutar zai iya faruwa a ranar 1 ga Disamba, 2019, a Wuhan, lardin Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar Zika a Hubei ya tashi a hankali.
Yawancin waɗannan cututtukan sun kasance suna da alaƙa da kasuwar abincin teku ta Huanan, wanda ke sayar da rayayyun dabbobi, kuma wata majiya ta nuna cewa cutar ta fito ne daga nau'in dabbobi a cikin waɗannan dabbobi, ko kuma a ce, ta samo asali ne daga dabbobi. An gano cutar huhu da ba a san asalin ta ba a ranar 26 ga Disamba, kuma an kula da ita ta hanyar Dr. Zhang Jixian a asibitin lardin Hubei, inda ya kai rahoton zuwa Cibiyar Kula da Cututtuka da Rigakafin Wuhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, likitocin asibitin Wuhan sun sanar da abokan aikinsu game da SARS, kamar yadda cutar coronavirus take.
An yi gargadin likitoci takwas, ciki har da Li Wenliang, da yada jita-jita, kuma an yi wa wani mai suna Ai Fen, da laifin tayar da zaune tsaye.
Hukumar Lafiya ta Wuhan daga baya ta ba da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da Hukumar Lafiya ta Duniya.
An bayar da rahoton isassun shari'o'in cutar pneumonia da ba a taɓa gani ba ga hukumomin kiwon lafiya a Wuhan don kafa bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, sakamakon ƙaura a lokacin bikin Sabuwar Shekara ta Sin, kuma Wuhan babbar cibiyar sufuri ce da cibiyar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana, ciki har da mutum biyu a Beijing da kuma daya a birnin Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun fara nuna alamun cutar a ranar 20 ga Janairu, 2020.A ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya.A ranar 9 ga Afrilu, 2020, an sami sama da kamuwa da cuta miliyan 1.61, sama da mutane 97,000 sun mutu, kuma sama da mutane 364,000 sun warke.
A kusan kasashe da yankuna 200 akwai akalla mutum daya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun takaita motsi kyauta kuma sun shirya binciken kan iyakoki.
Amsar kasa ta hada da matakan kariya kamar su keɓewa (wanda aka sani da oda daga gida, oda daga wurin zama, ko kuma ƙofar ƙofa) da kuma kulle-kulle.A ranar 2 ga watan Afrilu, mutane miliyan 300, ko kuma kusan kashi 90% na jama'a suna ƙarƙashin ƙofar ƙofa a Amurka.Fiye da mutane miliyan 50 suna cikin gida a Philippines, kimanin mutane miliyan 59 suna cikin gida a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin gida a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kasance a karkashin wani nau'i na tsare a gida, wanda ya kai miliyan 2.6 a cikin kwanaki biyu masu zuwa, wanda ya kai kashi uku na yawan mutanen duniya.
Lamarin farko na COVID-19 ya faru ne tun daga ranar 1 ga Disamba, 2019 a Wuhan, kuma wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya faru ne a ranar 17 ga Nuwamba.
Dr. Zhang Jixian ta bi sawun wani rukunin masu fama da cutar huhu da ba a san asalinsa ba a ranar 26 ga watan Disamba, wanda asibitinta ta sanar da Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin kwayar halitta na farko na samfurin mai haƙuri a ranar 27 ga Disamba, 2019 ya nuna kasancewar kwayar cutar coronavirus kamar SARS.
Wani sanarwa ta jama'a da hukumar lafiya ta Wuhan ta fitar a ranar 31 ga watan Disamba.
An sanar da Hukumar Lafiya ta Duniya a ranar.
"Lokacin da aka gabatar da wadannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan kan "yaɗa jita-jita" game da barkewar cutar".
Hukumar Lafiya ta kasar Sin ta fara da cewa babu tabbacin kamuwa da cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri da shugaban jam'iyyar kwaminis ta kasar Sin Xi Jinoing ya bayyana a matsayin "yaƙin mutane" don magance annobar.
A cikin abin da aka bayyana a matsayin "babban keɓewar wuri a tarihin ɗan adam", an sanar da rufewar a ranar 23 ga Janairu, dakatar da zirga-zirga a ciki da wajen Wuhan, wanda aka faɗaɗa zuwa birane 15 a Herbei, wanda ke shafar jimillar mutane kusan miliyan 57.
An haramta amfani da motoci masu zaman kansu a cikin birni.
An soke bikin Sabuwar Shekarar Sin (Janairu 25) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin gaggawa, asibitin Huoshenshan, wanda aka rushe cikin kwanaki 10.
Daga baya, an gina wani asibiti, asibitin Leishenshan don karɓar ƙarin marasa lafiya.
Baya ga sabon asibitin da aka gina, kasar Sin ta sake sauya wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa zuwa asibitoci na wucin gadi.A ranar 26 ga Janairu, gwamnati ta gabatar da karin matakan dakile yaduwar cutar COVID-19, ciki har da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun hutun Kirsimeti.
Jami'o'i da makarantu a duk fadin kasar sun rufe.
Yankin Hong Kong da Macau sun kafa matakan da yawa, musamman dangane da makarantu da jami'o'i.
An kafa hanyoyin aiki ta nesa a yankuna da dama na kasar Sin.
An kafa takunkumin tafiye-tafiye a ciki da wajen Hubei.
An gyara sufuri na jama'a, kuma an rufe gidan kayan gargajiya na kasar Sin na ɗan lokaci.
"An aiwatar da takunkumin tafiye-tafiye na jama'a a cikin birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumin waje. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun aiwatar da tsauraran matakai don hana kwayar cutar daga "" shigowa "" daga wasu ƙasashe. "
A ranar 23 ga watan Maris, kasar Sin ta samu mutum daya da ya kamu da cutar a cikin kwanaki biyar da suka gabata, wanda ya fito ne daga Istanbul zuwa Guangzhou.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an hana yaduwar cututtukan gida kuma an sarrafa barkewar cutar a cikin kasar Sin.
A cikin kwana ɗaya na sanya takunkumin, an rage tafiye-tafiye a Hubei sai dai Wuhan, watanni biyu bayan farawar dokar hana zirga-zirga. Ma'aikatar harkokin wajen kasar Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar da masu biza ko masu riƙe da izinin zama daga ranar 28 ga Maris, ba tare da cikakken bayani kan lokacin da wannan dokar za ta ƙare ba.
Duk wanda ke son zuwa China dole ne ya nemi takardar visa a ofishin jakadancin China ko ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, kuma ta ba da kudaden karfafa gwiwa ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki don farawa da hutun minti uku na kasa a karfe 10:00 na ranar 4 ga watan Afrilu, daidai da bikin cin abinci, duk da cewa gwamnatin tsakiya ta bukaci iyalai su bi hanyar sadarwa ta hanyar yin aikin keɓe kai don gujewa barkewar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar Lafiya ta Kasa ta ba da rahoton karuwar lamuran da aka tabbatar a ranar 20 ga Fabrairu, wanda yawancinsu ya samo asali ne daga taron Daegu na ayyukan addini da aka sani da Shincheonji Jesuit.
Shincheonji, wanda ya shiga Daegu daga Wuhan, ana zargin shi ne tushen barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin masu bin addini 9,336, 1,261 ko kusan 13% sun ba da rahoton alamun.Koriya ta ayyana gaggawa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an sami sama da mutane 2,000 da aka tabbatar da su a Koriya, wanda ya kai 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka gwada sojoji uku da suka kamu da cutar.
An kuma shafi jadawalin kamfanonin jiragen sama, don haka an canza su.Koriya ta kawo abin da ake ganin shine mafi girma kuma mafi kyawun shirye-shirye a duniya don bincika mutane don cutar da ke ware waɗanda ke da cutar, da kuma bin diddigin waɗanda suka haɗu da masu cutar.
Hanyar tantancewa ta hada da bayar da rahoton kai tsaye game da alamun cutar ga sabbin masu zuwa daga kasashen waje ta hanyar manhajar wayar hannu, yin gwajin gano kwayar cutar tare da sakamakon da za'a iya samu a rana mai zuwa, da kuma kara karfin gwajin da zai bawa mutane 20,000 damar yin gwaji a kowace rana.
Shirin na Koriya ta Kudu ya kasance mai nasara wajen sarrafa barkewar cutar duk da rashin tabbacin cewa birnin gaba daya.
Yawancin 'yan Koriya sun yi rajistar takardun shaida da ke dauke da zaɓuɓɓuka biyu, kamar su zargi Moon game da abin da suka ce gwamnatin ba ta magance matsalar cutar ba daidai ba ko kuma yabonsa don magance matsalar.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu kamuwa da cutar a kowace rana a cikin makonni huɗu da suka gabata.
A ranar 29 ga Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu, duk sabbin masu shigowa daga ƙasashen waje za a tilasta musu keɓewa na tsawon makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun tallafin gwaji daga ƙasashe daban-daban 121.
Iran ta ba da rahoton kamuwa da cutar SARS-CoV-2 da aka fara tabbatar da ita a ranar 19 ga Fabrairu a Qom, inda mutane biyu suka mutu, a cewar Ma'aikatar Lafiya da Ilimin Likita.
Matakan da gwamnatin ta sanar a baya sun hada da soke kide kide da wake-wake da sauran al'adu, wasannin motsa jiki da bikin ranar Juma'a da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta shirya dala tiriliyan biyar don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na sanya yankunan da cutar ta shafa, kuma an kebe mutane ne kawai.
An sanar da shirin a watan Maris na sanya takunkumin tafiye-tafiye daga gari zuwa gari duk da cewa ana ci gaba da yin zirga-zirga daga gari zuwa gari kafin bikin Sabuwar Shekara na mutanen Biritaniya.
Wurin ibada na Shia a Qom ya ci gaba da kasancewa a bude ga masu gudanar da ayyukan ibada har zuwa ranar 16 ga Maris, 2020.
A game da ikirarin rufe yanayin barkewar cutar a Iran, sama da kasashe goma sun bi diddigin wadanda suka dawo Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa yanayin barkewar cutar na iya zama mai tsanani fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
Majalisar dokokin Iran ta rufe, tare da mambobi 23 daga cikin mambobinta 290 da aka ruwaito sun yi gwajin cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kula da gidan yarin na Iran da su saki masu kare hakkin dan adam da aka tsare da tashin hankali wadanda ke aiki da zanga-zangar lumana, da kuma sakin dukkan fursunoni da suka cancanci hakan.
An ce cutar na da matukar hadarin yaduwa a wuraren da aka rufe kamar cibiyoyin tsare mutane, inda kuma ake samun karancin kulawar lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana, wanda shine mafi girma a kasar tun lokacin da annobar ta fara.
Akalla 'yan siyasa da jami'an gwamnati 12 sun mutu sakamakon cutar a ranar 17 ga watan Maris.
Har zuwa ranar 23 ga watan Maris, Iran ta sami sabon kamuwa da cuta 50 a kowace awa, kuma ta sami sabon mutuwa a kowane minti goma daga cutar coronavirus.
A cewar jami'an Hukumar Lafiya ta Duniya (WHO), a Iran akwai yiwuwar kamuwa da cutar sau biyar fiye da yadda aka ruwaito.
Ya kuma ba da shawarar cewa takunkumin Amurka a kan kasar ta Urugwani na iya shafar ikon kasa na kudi wajen magance barkewar cutar.
Babban jami'in kare hakkin dan adam na Majalisar Dinkin Duniya ya bukaci a sanya takunkumin tattalin arziki kan kasashen da cutar ta shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu na kasar Sin suka gwada tabbatacce ga SARS-CoV-2 a Rome.
Cutar ta fara ƙaruwa, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke tashi zuwa da daga China nan take kuma ta ba da sanarwar dokar ta baci.
An gano wasu cututtukan COVID-19 da ba su da alaƙa da juna a baya, farawa da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, Majalisa ta ba da sanarwar sabon tsari don hana barkewar cutar, gami da tsare mutane sama da 50,000 daga birane 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, a cikin yankin da cutar ta bulla, ba za a ba da izinin shiga da fita ba.
An kuma umarci dakatar da ayyukan aiki da wasannin motsa jiki a yankunan. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, tare da mutuwar mutane 100 a cikin ƙasar.
Duk manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, ana gudanar da su ba tare da masu kallo ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da duk ayyukan kasuwanci, ban da kasuwanni da kantuna. A ranar 6 ga Maris, Kwalejin Italiya ta Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da
A ranar 19 ga watan Maris, Italiya ta zarce kasar Sin a matsayin kasar da ta fi kowacce mace-mace a duniya bayan da ta samu mutuwar mutane 3,405 sakamakon cutar.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama na soja guda tara tare da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga watan Afrilu, an sami mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, mafi yawansu a yankin Lombardy.
Rahoton CNN ya nuna cewa haɗuwa da yawan tsofaffi da rashin yiwuwar yin gwaji ga waɗanda ke da cutar har zuwa yanzu duk na iya haifar da hauhawar cutar.
Amsar Burtaniya ga cutar ta fito a matsayin ɗaya daga cikin ƙasashe masu sassaucin ra'ayi, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta gabatar da wani nau'i na kiyaye zamantakewar jama'a ko kuma matakan keɓewa na tilastawa ga manyan 'yan ƙasa ba.
A sakamakon haka, an soki gwamnati saboda rashin daidaito da kuma rashin fahimta a cikin martani ga rashin jin daɗin da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar bayar da shawarar kauce wa duk tafiye-tafiye da zamantakewar da ba dole ba, yana ba da shawarar mutane su yi aiki daga gida idan za su iya, kuma su guji wurare kamar shaguna, gidajen cin abinci, da gidajen silima, da sauransu.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar shaguna da wuraren motsa jiki dole ne su zama na gaggawa, kuma ta yi alƙawarin biyan ma'aikata albashi har zuwa kashi 80 cikin ɗari zuwa iyakar £ 2500 a wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nuna bambancin zamantakewar jama'a, ta hanyar hana taron mutane sama da biyu, da kuma hana tafiye-tafiye da ayyukan waje da ake ɗauka da mahimmanci.
Ba kamar matakan da suka gabata ba, 'yan sanda sun karfafa wannan matakin ta hanyar sanar da tarar da tarurruka.
"An umarci yawancin kasuwancin su rufe, sai dai kasuwancin da aka ɗauka ""mai mahimmanci"" sun haɗa da manyan kantuna, asibitoci, bankuna, shagunan kwamfuta, tashoshin mai da tashar jirgin sama".
A ranar 20 ga watan Janairu, an tabbatar da farkon cutar COVID-19 a cikin jihar Pacific ta Arewa maso Yammacin Washington, wanda ya faru ne a kan wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar yaki da cutar korona ta fadar White House a ranar 29 ga watan Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya kuma ta sanya takunkumin shiga ga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa sun kirkiro na'urar gwajin kanta.
Duk da haka, Amurka ta fara jinkirin gwajin da ya ɓoye ainihin yanayin barkewar cutar a lokacin.
Gwajin ya lalace ne ta hanyar gwajin cutar da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan aikin gwaji na gwamnati (ta masana'antu, kamfanoni da asibitoci) har zuwa karshen watan Fabrairu, da kuma tsauraran sharudda ga mutanen da suka cancanci yin gwajin har zuwa farkon Maris (ana neman umarnin likita daga baya).
Har zuwa ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwaje-gwaje kasa da 4,000 a Amurka.
Har zuwa 13 ga Maris, yankunan Atlantika sun ba da rahoton cewa an yi gwaji ƙasa da 14,000.
A ranar 22 ga watan Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa, "Mutane da dama suna da alamun cutar, kuma likitocin sun jira sa'o'i ko kwanaki don yin gwaji".Bayan an samu rahoton mutuwar farko a Amurka a Washington a ranar 29 ga watan Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, kuma sauran jihohi sun bi wannan matakin nan take.
Makarantu a yankin Seattle sun soke karatun su a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe.A ranar 6 ga Maris, 2020, an ba da shawarar Amurka ta yi kimantawa game da tasirin sabon coronavirus a cikin ƙasar ta hanyar ƙungiyar masana cututtuka a Imperial College London.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Amincewa da Shirye-shiryen Cutar Korona, wanda ya ba da dala biliyan 8.3 na kudade ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun sanya takunkumin hana ma'aikata tafiya, sun soke tarurruka, kuma sun karfafa ma'aikata suyi aiki daga gida.
An soke wasanni da abubuwan da suka faru na yanayi. A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye na kwanaki 30 ga yawancin Turai, ban da Burtaniya, tare da tsawon watanni 13.
Kashegari, ya fadada iyakancewar zuwa Birtaniya da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya ba da damar kasafin kudin tarayya ya amsa matsalar.
Farawa a ranar 15 ga Maris, kamfanoni da yawa sun rufe ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar kwayar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a cikin jihohi 50 da Gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar fiye da adadin waɗanda ke Koriya ta Kudu.
A ranar 25 ga Maris, magajin garin ya ce, ana ganin an fara aikin kwantar da hankula yayin da kimar masu kamuwa da cutar ta ninka daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an tabbatar da kamuwa da cutar a New York City, inda aka samu mutum 32,308 da suka kamu da cutar, kuma mutane 672 suka mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta tabbatar da cewa ita ce kasar da ta fi kowacce kasar kamuwa da cutar a duniya, bayan da ta hada da China da Italiya.
A cewar rahotannin kafofin watsa labarai na ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita ka'idojin sa ido kan zamantakewar al'umma har zuwa ranar 30 ga Afrilu.
A wannan ranar ne jirgin USNS Comfort, asibitin jirgin ruwa mai gado 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta samu mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A New York, an samu sama da mutum 100,000 da suka kamu da cutar a ranar 3 ga Afrilu. An soki Fadar White House saboda mayar da martani kan barazanar da kuma sarrafa saƙonnin kai tsaye daga ma'aikatan kiwon lafiya da masana kimiyya don shirya jawabai na jama'a da kuma wallafe-wallafe game da cutar tare da Mataimakin Shugaban Kasa Mike Pence.
Tallafin da aka samu game da yadda Trump ya magance matsalar ya rabu biyu a cikin masu ra'ayin mazan jiya.
Jami'an Amurka da wasu masu sharhi sun soki Amurka kan dogaro da shigo da kayan masarufi, ciki har da kayayyakin kiwon lafiya da ake bukata daga China.
An yi amfani da nazarin tsarin tafiye-tafiye na iska don tsarawa da kuma duba yanayin yaduwar cutar kuma an buga shi a cikin mujallar Likita ta Balaguro a tsakiyar watan Janairun 2020.
Dangane da bayanan 2018 daga Transportungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne kuma an bayar da rahoton cewa sune wuraren da aka fi so ga matafiya daga Wuhan.
An bayar da rahoton cewa tsibirin Bali shine mafi ƙarancin yiwuwar cikin shahararrun biranen balaguro 20 dangane da shirye-shirye, yayin da biranen Australiya aka ba da shawarar su zama mafi nasara.Australia ta fitar da shirin gaggawa na gaggawa don cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Sanarwar ta ce, yawancin masu kamuwa da cutar COVID-19 ba a gano su ba, kuma Australia za ta ba da hankali kan gudanar da harkokin sadarwa da kuma hanyoyin da za a bi a kan iyakoki a matsayin amsar cutar.
A ranar 21 ga watan Maris, an ayyana dokar ta baci ta mutum a Australia.
Ta hanyar yin amfani da hanyoyin sufuri na jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, galibi ta jirgin sama na kasashen da ke karbar bakuncin, tare da izinin hukumomin kasar Sin.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand na cikin kasashen da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu, tare da ƙarin 'yan Poland huɗu, ɗan China ɗaya da ɗan Indiya ɗaya.
'Yan kasar Poland, Sin da Indiya sun sauka daga jirgin a Poland, inda jirgin Brazil ya tsaya kafin ya nufi Brazil.
'Yan Brazil da suka je Wuhan an keɓe su a sansanin soja kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta shirya) daga Wuhan zuwa sansanin CFB Trento don ware su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a sansanin sojin CFB Trenton.
Hukumomin Australiya sun kwashe mutane 277 a ranar 3 da 4 ga watan Fabrairu zuwa gidan yarin na tsibirin Kirsimeti, wanda aka canza zuwa wurin da za a sake yin aiki da shi, inda za su zauna na tsawon kwanaki 14.
Jirgin jirgin saman New Zealand ya isa Auckland a ranar 5 ga Fabrairu. An keɓe fasinjojinsa (ciki har da wasu daga Australiya da Pacific) a wani sansanin sojan ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess wanda ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, wani jirgin saman fasinjoji na kamfanin jiragen sama na South African Airlines, wanda gwamnatin Afirka ta Kudu ke gudanarwa, ya kwashe 'yan Afirka ta Kudu 112.
An gudanar da binciken lafiyar kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu masu bayyanar cututtukan coronavirus don rage haɗarin.
'Yan Afirka ta Kudu ne kawai suka gwada ba su da cutar da aka yi wa kwayar cutar.
Sakamakon gwajin ya kori dukkan 'yan Afirka ta Kudu, ciki har da matukan jirgin sama, ma'aikatan jirgin sama, jami'an 'yan sanda da sojoji da ke cikin ayyukan jin kai, wadanda ke da matukar muhimmanci, duk sun kasance a karkashin sa ido da rashin lissafi na kwanaki 14 a cibiyar watsa labarai ta Wassara.
A ranar 20 ga Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda yaduwar cutar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen Sin ta tabbatar da cewa kasashe 21 (ciki har da Belarus, Rasha, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da agaji zuwa China.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen isar da kayan agaji ga bangarorin da cutar ta addabi a kasar Sin, tare da karin kungiyoyin agaji a yankin Chicago da ke bayar da rahoton cewa sun kai kayan agaji na N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga Hukumar Lafiya ta Duniya (WHO) don tallafawa kokarin bincike kan allurar rigakafi da magani tare da kare mutane masu fama da cutar a Afirka da kudu maso gabashin Asiya.
Kamfanin dillancin labarai na Interaksyon ya ruwaito cewa gwamnatin China ta ba da kayan rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da kayan rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar 'yan kwaminis ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 na tallafi zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska na zinare miliyan daya zuwa yankin Wuhan, Turkiyya ta ba da kayan aikin likita cikin gaggawa, Rasha ta aika da tan 13 na kayan aikin likita zuwa yankin Wuhan, Malaysia ta ba da gudummawar takunkumin likita miliyan 18 zuwa China, Jamus ta ba da kayan aikin likita da suka hada da kayan rufe fuska 10,000, Amurka ta ba da gudummawar kayan aikin likita 17.8 ton, kuma ta yi alkawarin samar da ƙarin dala miliyan 100 na ruwa don tallafawa waɗanda ke fama da cutar daga China bayan an kai su kasar Sin.
A watan Maris, China, Cuba da Rasha sun aika da kayayyaki da kwararrun likitoci don taimakawa Italiya wajen shawo kan barkewar cutar coronavirus.
Mai siyar da kaya Jack Ma ya aika da kayan gwajin gwaji miliyan 1.1, abin rufe fuska miliyan 6 da kayan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, masks 100,000 da kuma famfunan iska 5 zuwa Panama.
Ma'aikatar Lafiya ta kuma ba da gudummawar kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwajin da China ta yi.
Misali, Spain ta yanke kayan gwajin cutar coronavirus 58,000 da aka yi da kasar Sin, wadanda suke da kashi 30 cikin 100 na daidaito, yayin da Netherlands ta dawo da 600,000 na takunkumin zinare na kasar Sin.
Belgium ta tattara kayan kwalliyar 100,000 da ake ganin sun fito ne daga China amma a zahiri daga Colombia.
A gefe guda, an sami karbuwa sosai a taimakon da China ke bayarwa a sassan Latin Amurka da Afirka. A ranar 2 ga watan Mayu, Bankin Duniya ya kaddamar da wani aikin gaggawa na tallafawa kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da hukumomin China ke yi na sarrafawa da kuma shawo kan annobar.
Hukumar Lafiya ta Duniya (WHO) ta lura da bambanci tsakanin barkewar cutar SARS a 2002-2004, inda aka zargi hukumomin kasar Sin da yin ɓoye-ɓoye da suka hana hana hanawa da sarrafawa, da kuma halin da ake ciki yanzu, inda gwamnatin tsakiya ke ba da sabuntawa akai-akai don kauce wa rikicewa kafin bikin Sabuwar Shekarar Sin.
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da takunkumin tafiye-tafiye a Wuhan, wakilin WHO Gauden Galea ya lura cewa yayin da ba ainihin shawarar da WHO ta bayar ba, amma kuma muhimmin nuni ne na jajircewa don magance cutar a wuraren da cutar ta fi yawa, kuma ya kira cutar "ba a taɓa ganin irinta ba a tarihin lafiyar jama'a".
Darakta-janar na WHO Tedros Adhanom ya ce PHEIC na da hadarin yaduwa a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
"A cikin martani ga aiwatar da takunkumin tafiye -tafiye, Tedros ya tabbatar da cewa ""babu wani dalili na matakan da ke hana balaguron balaguro da kasuwancin ƙasa da ƙasa"" kuma cewa ""WHO ba ta ba da shawarar ƙuntatawa da ƙaura ba"."
"A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da dala miliyan 675 domin samar da kudade ga shirye-shiryen dabaru a kasashe masu karamin karfi, tare da nuna gaggawa wajen tallafawa kasashen da ba su da hanyar gano wadanda suka kamu da cutar, duk da yadda ta bulla".
"Tedros ya kara da cewa, ""dukkanin al'ummai idan akwai wani mai rauni, ya zama mai rauni ga kowa"," kuma ya bukaci al'umma ta duniya da ""su saka hannun jari a yau, ba za su yi asara ba daga baya"."A wani taron manema labarai na ranar 11 ga Fabrairu, WHO ta ba da sunan cutar COVID-19".
A wannan ranar Tedros ya tabbatar da cewa Sakataren Majalisar Dinkin Duniya António Guterres ya amince da ba da ikon dukkan tsarin Majalisar Dinkin Duniya a cikin martani.
"An kafa ƙungiyar kula da rikice-rikicen Majalisar Dinkin Duniya, wanda hakan zai ba da damar daidaitawa na amsawar Majalisar Dinkin Duniya, wanda WHO za ta ba da damar mayar da hankali kan amsar lafiya, yayin da sauran hukumomi za su iya kawo ƙwarewarsu don tallafawa zamantakewar tattalin arziki da tasirin tasirin barkewar cutar"."
A ranar 14 ga watan Fabrairu, an kafa wani kwamitin horar da ma'aikatan WHO tare da kasar Sin don samar da kwararru na kasa da kasa da na WHO game da halin da ake ciki a kasar Sin don taimakawa wajen kula da cutar a yankin da kuma tantance "taurin cutar da kuma yiwuwar yaduwar cutar" ta hanyar kafa bita da tarurruka tare da manyan cibiyoyin kasa da gudanar da ziyarar kai tsaye don fahimtar tasirin matakan mayar da martani a larduna da yankuna, gami da birane da karkara. A ranar 25 ga watan Fabrairu, WHO ta sanar da cewa duniya ta kamata ta dauki matakai masu yawa don shirya annobar cutar ta kwayar cutar, inda ta yi kira ga dukkan kasashe da su kasance cikin shiri cikin gaggawa.
"A cikin martani ga yaduwar barkewar cutar a Iran, WHO ta aika da wata hadin gwiwa zuwa can don kimanta halin da ake ciki.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara kimanta barazanar cutar coronavirus a duniya daga" sosai ", wanda shine mafi girman matakin tsaro da kimantawa.
Mike Ryan, daraktan shirin gaggawa na WHO, ya tuna a cikin wata sanarwa cewa: "Wannan shi ne abin da ya kamata gwamnatoci a duniya su sani: Ku farka.
"Wannan kwayar cuta na iya kasancewa a kan hanyarsa, don haka ya kamata ku kasance cikin shiri, kuna mai cewa matakan da suka dace na iya taimakawa duniya ta guji mafi munin sakamako".
"Ryan ya kara da cewa ba a tabbatar da bayanan na yanzu ba don jami'an kiwon lafiyar jama'a su ayyana barkewar cutar a duniya, yana mai cewa irin wannan sanarwar za ta nuna cewa ""mun amince da cewa kowa a duniya zai kamu da kwayar cutar""".
A ranar 11 ga watan Maris ne Hukumar Lafiya ta Duniya ta sanar da barkewar annobar cutar coronavirus.
Darakta Janar ya ce WHO ta damu matuka game da matakin gaggawa na yaduwar cutar da kuma tsananin rashin daukar matakan. WHO ta fuskanci kakkausar suka saboda rashin isasshen maganin cutar, gami da bayyana gaggawa na gaggawa ga lafiyar jama'a da kuma sanya cutar a matsayin annoba.
Amsar ta hada da umarni ga Tedros Adhanom, babban jami'in WHO, don neman ya yi murabus daga mukaminsa, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, dubun-dubatar masana 'yancin dan adam na Majalisar Dinkin Duniya sun jaddada girmama hakkin kowane mutum a lokacin annobar COVID-19.
Kwararru sun ce kowa na da hakkin ya yi aikin ceto, kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa rashin wadata ko inshorar lafiya ba za a iya ɗauka a matsayin hujja ta nuna bambanci ga kowane rukuni ba.
Kungiyar ta ce kowa na da hakkin samun lafiya, ciki har da nakasassu, wadanda ke cikin 'yan tsiraru, tsofaffi, wadanda aka tilasta musu yin hijira a kan iyakoki, marasa gida da ke rayuwa a cikin mawuyacin hali, wadanda ke cikin tsare, da kuma 'yan gudun hijira da sauran kungiyoyin mutane da ba a tabbatar da sunansu ba da ke bukatar taimakon gwamnati.
Kungiyoyin kasa da kasa suna magance tasirin tattalin arziki da zamantakewar cutar COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kirkiro wata hanyar samar da cikakken bayani kan yadda ake daukar matakan siyasa a kasashe daban-daban a duniya, da kuma ra'ayoyi da shawarwari.
Ta hanyar inganta tsarin kiwon lafiya da tattalin arzikin duniya, don magance tasirin kulle-kulle da ƙuntatawa kan tafiye-tafiye, Cibiyar Dijital, gami da shirye-shiryen bin diddigin manufofin ƙasa, da nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan harkokin wajen kasar Michael Gove da Eduardo Bolsonaro, dan shugaban kasar Brazil Jair Bolsonaro, saboda yadda suka magance annobar da ta barke a lardin Hubei na kasar Sin.
Wasu hukumomin lardin na jam'iyyar kwaminis ta kasar Sin (CPC) sun samu cikas a yadda suke gudanar da aikin killacewa a yankin tsakiyar kasar Sin, wanda ke nuna rashin jin dadin yadda aka mayar da martani ga barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan ne don kare sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a kan barkewar cutar.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da amincewar da aka yi a baya game da barkewar cutar da ta fara a birnin Wuhan, amma sun goyi bayan ka'idar cewa cutar COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Amurka karkashin Donald Trump ta yiwa cutar korona lakabi da "kwayar cutar Sin" ko kuma "kwayar Wuhan", inda ta ce "tashin hankalin kasar Sin kan cutar da ta zama annoba ta duniya" an soki irin wannan furucin da nuna wariyar launin fata da kuma nuna rashin nasarar gwamnatinsa wajen shawo kan cutar".
Jaridar Daily Beast ta samu wani sabon siginar sadarwa na gwamnatin Amurka da ke nuna cewa akwai wata matsala ta sadarwa da ke da tushe a cikin kwamitin tsaron kasa, inda aka yi da'awar cewa duk game da China ne.
Ya ce ya kamata mu yi kokarin isar da wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma fitowar talabijin. Jaridu kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na kai agaji ga kasashen da ke fama da cutar wani bangare ne na yunkurin daukar matakin hukuntawa ga duniya baki daya.
"Shugaban manufofin kasashen waje na EU Josep Borrell ya yi aiki don tunatar da cewa akwai abubuwan da ke haifar da siyasa, ciki har da matsalolin tasiri ta hanyar canji da 'siyasa ta alheri.'"
Borrel ya kuma ce, "Ba kamar Amurka ba, China ta yi wa'azin cewa ita ce ta yi rashin gaskiya kuma abokin tarayya ne mai aminci".
China ta kuma bukaci Amurka da ta janye takunkumin da ta kakaba kan Syria da Venezuela da kuma Iran, yayin da ake zargin ta tura taimakon ga kasashen biyu.
An dakatar da kyautar abin rufe fuska na 100,000 na Jack Ma ga Cuba ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da tallafin da aka tanadar wa wasu kasashe don amfanin kansu.
An kuma samu rigingimu kan abin rufe fuska a wasu kasashe kamar Jamus, Austria, Switzerland, Czech Republic da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan injunan iska masu shigowa da ke zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai tare da Italiya da cutar ta Corona ta shafa.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce China ce kawai ta mayar da martani ta hanyar tattaunawa.
Hakika, ba alama ce mai kyau ta hadin kan Turai ba.
A ranar 22 ga watan Maris, bayan tattaunawar wayar tarho da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya umarci sojojin Rasha su aika da likitoci, jiragen sama, na'urorin kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta nakalto wani majiya mai suna "Senior Policy" wanda ya ce kashi 80 cikin 100 na taimakon Rasha "ba shi da amfani ko kuma yana da amfani ga Italiya".
Wannan majiyar ta zargi Rasha da kaddamar da wani hari na neman 'yancin kai a fannin siyasa da kuma diplomasiyya.
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen kasar Luigi Di Maio sun musanta rahoton da kafofin watsa labarai suka fitar kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin ruwa mai dauke da kayan agaji zuwa Amurka.
"Mai magana da yawun fadar Crimea, Dmitry Peskov, ya ce, ""Lokacin da yake ba da tallafi ga sojojin Amurka, [Putin] ya ɗauka cewa yayin da kamfanonin likitancin Amurka da na'urorin ke haɓaka, za su iya samun sakamako mai kyau idan ya cancanta"."
Yaƙin soja na NATO na 2020 na karewa, wanda aka shirya a Jamus, Poland da Baltic States, wanda shine yaƙin NATO mafi girma tun ƙarshen Cold War, za a yi shi a kan ƙananan ƙananan.
Babban sakataren yakin neman kawar da makaman nukiliya, Kate Hudson, ta soki yakin 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana haifar da haɗarin rai ba kawai ga sojoji daga Amurka da ƙasashen Turai da yawa ba, har ma da jama'a a cikin ƙasashen da suke aiki". Gwamnatin Iran ta sami mummunan rauni daga cutar, tare da 'yan majalisa hudu da suka kamu da cutar, da kuma wasu' yan siyasa goma sha biyar na baya da na yanzu.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na fama da matsalar yaki da yaduwar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran. Yaduwar cutar ta tilasta wa Amurka ta dauki muhimman matakai nan take wajen aiwatar da manufofin zamantakewar da aka saba amfani da su a wasu kasashe masu arziki, ciki har da samar da kiwon lafiya na duniya, kula da yara, dakatar da dokokin kiwon lafiya ga iyalai masu karamin kudi da kuma samar da tsarin kiwon lafiya na jama'a.
Kungiyoyin masana siyasa na tsammanin hakan na iya yin illa ga damar da Donald Trump zai samu na sake zabarsa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "ƙoƙarin keɓewar Japan da ba shi da ma'ana" bayan da Japan ta sanar da cewa duk wanda ya fito daga Koriya ta Kudu za a keɓe shi na tsawon makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai, al'ummar Koriya ta Kudu sun rabu biyu game da yadda Shugaba Moon Jae-in ya mayar da martani ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardu kamar su kira ga zargin Moon kan abin da suka ce rashin adalci ne na gwamnati game da barkewar cutar ko kuma yabon martani.
Wasu masu sharhi sun nuna damuwa cewa hakan na iya bai wa gwamnati damar karfafa ikonta.
A Hungary, majalisar dokoki ta kada kuri'ar ba da damar firaministan kasar Viktor Orbán ya yi mulki ba tare da wani lokaci ba, ta dage majalisar, ta gudanar da zabe, ta kuma hukunta wadanda ake zargi da yada labaran karya game da cutar da kuma yadda gwamnati ke magance matsalar.
An zargi barkewar cutar ta coronavirus da dalilai da dama, kamar rashin wadata, daga karuwar amfani da kayayyaki don yaki da cutar, sayayya cikin tsoro da matsaloli ga masana'antu da aiwatarwa, jigilar kayayyaki a duniya.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadin karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma takunkumin da aka sanya wa masu samar da kayayyaki.
Yankunan da dama kuma sun ga cinikin kayan lambu, wanda ya haifar da sayayya gaba daya a kan kayan masarufi na kayan lambu, kamar abinci, takarda, da ruwan wanka, wanda ke haifar da karancin wadata.
An gargadi wasu masana'antun fasaha game da jinkirin isar da kayan lantarki.
A cewar Tedros Adhanom, Darakta-Janar na WHO, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da hauhawar farashi har sau biyu na al'ada kuma ya haifar da jinkirin samar da kayan aikin likita na tsawon watanni hudu zuwa shida.
Hakanan ya haifar da karancin kayan kariya na mutum a duk duniya, tare da Hukumar Lafiya ta Duniya ta yi gargadin cewa zai iya haifar da haɗari ga ma'aikatan kiwon lafiya.
A Ostiraliya, annobar ta ba da sabon dama ga masu siye da siyarwa don sayar da kayayyakin ƙasar zuwa China.
Wannan ya haifar da karancin jarirai a manyan kasuwanni kuma daga karshe gwamnatin Australia ta dakatar da shi.Duk da cewa cutar ta COVID-19 ta yi yawa a arewacin Italiya da Wuhan, kuma bukatar kayayyakin abinci na ci gaba da ƙaruwa, an sami gagarumin karancin abinci a yankunan biyu.
Matakan da China da Italiya suka dauka kan cinikin kayayyakin haram da na haram sun yi nasara wajen kaucewa karancin abinci mara kyau da ake tsammani a Turai da kuma Arewacin Amurka.
Arewacin Italiya, babban kayan aikin gona, ba su ragu sosai ba, amma farashin na iya tashi, a cewar wakilan masana'antu.
Abincin ya ƙare a kantunan abinci na ɗan lokaci, har ma a Wuhan, yayin da jami'an gwamnatin China suka fitar da naman alade don tabbatar da samar da abinci ga jama'a.
Akwai irin wannan doka a Italiya da ke buƙatar masu samar da abinci su adana kayan abinci don irin wannan gaggawa.
An ga lalacewar tattalin arzikin duniya a China: A cewar rahotanni na kafofin watsa labarai na ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a cikin watanni biyu na farko na shekarar 2020 saboda matakan gwamnati na rage yaduwar kwayar cutar da kuma tallace-tallace. tallace-tallace sun ragu da kashi 20.5%.
Tare da babban yankin China yana da mahimmanci ga tattalin arziƙi da masana'antu, ana ganin barkewar cutar ta haifar da babbar barazana ga rashin daidaito ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwannin za su kasance cikin kwanciyar hankali har sai an ga wani kyakkyawan sakamako.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa koma bayan tattalin arziki na duniya na iya wuce barkewar cutar SARS ta 2002-2004.
Wani kimantawa daga masana a Jami'ar Washington a St. Louis ya ba da tasirin sama da dala biliyan 300 a kan layin samar da kayayyaki na duniya wanda zai iya wucewa har zuwa shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur ta OPEC ta ce akwai tashin hankali bayan faduwar farashin mai saboda karancin bukatar da kasar Sin ke bukata.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar cutar COVID-19 da ke faruwa a kasashen waje.
A ranar 27 ga watan Fabrairu, yayin da ake ƙara damuwa game da barkewar cutar coronavirus, wasu kamfanonin jari na Amurka, ciki har da NASDAQ-100, S&amp;P 500 Index da Dow Jones Industrial Average, sun buga raguwa mafi sauri tun shekara ta 2008, tare da Dow ta faɗi maki 1,191, mafi yawan raguwa a rana ɗaya tun bayan rikicin kuɗi na 2007-08.
Tattaunawar uku sun ƙare a wannan makon ƙasa da 10%.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta tabbatar da matsayin martabar kasar Sin amma ta ci gaba da kasancewa mai ra'ayi mara kyau.
Kasuwancin hannayen jari sun sake yin birgima saboda tsoron cutar coronavirus, mafi girman faɗuwa ya faru a ranar 16 ga Maris.
Mutane da yawa suna tunanin cewa koma bayan tattalin arziki na iya zama abin da ba za a iya guje wa ba.
Wani masanin tattalin arziki Mohamed El-Erian ya yaba da matakin gaggawa da babban bankin kasar da kuma gwamnatin kasar suka dauka.
Babban bankin ya yi aiki a hanzari fiye da yadda suka yi kafin matsalar kudi ta 2008.
Bangaren yawon bude ido ya sha wahala mafi muni a tsakanin sauran bangarorin saboda takunkumin hana tafiye-tafiye, rufe wuraren taruwar jama'a, gami da jan hankalin yawon bude ido, da kuma shawarwarin gwamnati game da tafiye-tafiye a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke jirage saboda karancin buƙatu, gami da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya yi kasa.
Tasirin da ke kan masana'antar jirgin ruwa na da girma sosai.
An kuma rufe tashoshin jirgin kasa da tashar jiragen ruwa da dama.
Cutar ta faru ne a daidai lokacin bikin Yunnan, babban lokacin tafiye-tafiye da ke da alaƙa da hutun shigowar shekara ta China.
Yawancin abubuwan da suka shafi taron jama'a sun soke ta gwamnatocin ƙasa da na yanki, gami da bikin Sabuwar Shekara, tare da kamfanoni masu zaman kansu suna rufe shaguna da wuraren shakatawa, kamar su Disneyland a Hong Kong da Shanghai.
An rufe bukukuwan Sabuwar Shekara da wuraren shakatawa da yawa don hana manyan tarurruka, gami da Forbidden City a Beijing da kuma bukukuwan gargajiya.
A larduna 24 daga cikin 31 na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa 10 ga watan Fabrairu, tare da ba da shawarar cewa yawancin wuraren aiki ba za su sake buɗewa ba har sai wannan kwanan wata.
Wadannan yankuna suna wakiltar kashi 80% na GDP na kasar da 90% na fitarwa.
Hong Kong ta kara yawan maganin cutar zuwa matsakaicin matakin kuma ta ayyana dokar ta baci, tare da rufe makarantu har zuwa watan Maris da soke duk bukukuwan bikin.
Shiga wurin dillalai a Turai da Latin Amurka ya ragu da kashi 40%.
'Yan kasuwa a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50-60%.
Wannan kuma ya haifar da raguwar kashi 33.43% na zirga-zirgar ƙafa zuwa kantin sayar da kayayyaki a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da kasuwancin duniya sun gabatar da ƙarin matakan kamar haɓaka tsabta, shigar da na'urori masu duba zafin jiki don bincika yanayin zafin jiki na masu siye, da kuma soke abubuwan da suka faru.A cewar ƙididdigar Kwamitin Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, rikicin da ya haifar da yaduwar cutar na iya kasancewa tsakanin mutane miliyan 14 da 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda yake a cikin yanayin da babu cutar.
A cikin Janairu da Fabrairu na 2020, yayin barkewar cutar a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin ma'aikatan karkara na kasar Sin, kusan miliyan 300, an tsare su a gida ko kuma an tsare su a lardin Hubei.
Cutar ta Corona na iya janye ayyuka miliyan 47 a Amurka, kuma yawan marasa aikin yi na iya kaiwa 32%, a cewar hasashen da Bankin Tarayya na St. Louis ya yi. Rashin gida a Indiya ya sa dubun dubatan ma'aikatan baƙi na Indiya su rasa ayyukansu (waɗanda suke karɓar albashi na yau da kullun).
A tsakiyar watan Maris, ma'aikatan Faransa miliyan 4 ne suka nemi fa'idodin rashin aikin yi na wucin gadi, kuma ma'aikatan Burtaniya miliyan 1 sun nemi shirin bashi na duniya.
An amince da shirin ɗan gajeren lokaci na Jamus ta Faransa da Ingila.
Fasaha da ilimin al'adu sun sha wahala sosai daga annobar, wanda ya shafi ayyukan ƙungiyoyi da kuma na mutane - duka biyu aiki da 'yanci - a duk duniya.
Kungiyoyin al'adu da al'adu suna ƙoƙari su haɓaka aikin su (sau da yawa ana ba da kuɗin jama'a) don ba da damar samun damar al'adun al'adu ga al'ummomi, kiyaye lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha a duk inda zai yiwu.
Ya zuwa watan Maris na 2020, a duk duniya da kuma a kowane mataki, gidajen tarihi, dakunan karatu, gidajen wasan kwaikwayo da sauran cibiyoyin al'adu sun rufe gaba ɗaya, tare da soke ko jinkirta nune-nunen su, abubuwan da suka faru da kuma wasan kwaikwayo.
A cikin martani, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Rage cutar ya kasance mai sauri da sauri a cikin 'yan kwanakin nan, tare da soke ayyukan addini, manyan abubuwan wasanni da abubuwan zamantakewa kamar bukukuwa da wasan kwaikwayo, taron fasaha da nunin mota.
Har ila yau, masana'antar fim ta fuskanci rikici. Vatican ta sanar da cewa an soke bikin mako mai tsarki a Rome, wanda ya faru a makon karshe na lokacin bukukuwan Kirista.
Yankunan da ke karkashin shugabancin bishops a cikin addinan Kirista da yawa sun ba da shawarar tsofaffin Kiristocin su zauna a gida maimakon tarurruka a ranar Lahadi. Wasu majami'u suna ba da sabis ta hanyar rediyo, watsa shirye-shiryen yanar gizo, ko talabijin, yayin da wasu majami'u na iya ba da bautar ta hanyar buɗe motar.
Tare da rufewar Cocin Roman Katolika na Roman Catholic da kuma karamin cocin, da kuma St. Peter's Square, ba tare da masu bautar Kirista ba, sauran Kiristocin sun soke bautarsu, kuma an iyakance tarurrukan jama'a a cikin majami'u, masallatai, majami'u, majami'u, da kuma wuraren bautar Sikh.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, sannan kuma an rufe wuraren ibadar, yayin da Saudi Arabiya ta sanya takunkumi kan masu yawon bude ido da ke shiga kasar, da kuma hana 'yan kasar zuwa wuraren ibadar a Makka da Madina.
Cutar ta haifar da babbar matsala ga teburin wasanni na duniya tun bayan Yaƙin Duniya na biyu.
Yawancin manyan wasannin wasanni an soke su ko kuma an jinkirta su, gami da 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA season, and 2019-20 NHL season.
Cutar ta hana shirin gasar wasannin Olympics na bazara na 2020, wanda aka shirya fara shi a ƙarshen Yuli. Kwamitin Olympic na International Olympic ya sanar a ranar 24 ga Maris cewa za a sake tsara taron zuwa bayan 2020, amma ba da daɗewa ba bayan bazara na 2021.
Wannan motsi ya sa yawancin 'yan caca suka koma caca ta kan layi, tare da yawancin rukunin caca na kan layi suna ba da rahoton ƙaruwa mai ban mamaki a cikin yawan sabbin rajista. Har ila yau, masana'antar nishaɗi ta sami rauni, tare da ƙungiyoyi daban-daban sun dakatar ko soke waƙoƙin.
Yawancin manyan gidajen cin abinci, kamar su Broadway, sun dakatar da duk wasan kwaikwayon.
Wasu masu zane-zane sun sami hanyar ci gaba da samarwa da kuma raba aikin su ta yanar gizo, suna ɗaukarsa a matsayin madadin nunawa ta hanyar kai tsaye, kamar yin wasan kwaikwayo ta yanar gizo ko ƙirƙirar bikin kan yanar gizo don masu zane-zane su nuna, rarraba da nuna ayyukansu.
A kan layi, wasan kwaikwayo na yanar gizo game da cutar coronavirus ya yadu sosai, tare da mutane da yawa suna son yin ba'a da kuma jujjuya yanayi yayin rashin tabbas.
Tun bayan barkewar cutar COVID-19, an lura da karuwar tsattsauran ra'ayi da nuna bambanci ga 'yan kasar Sin da mutanen da suka fito daga gabashin Asiya da kuma mutanen da ke cikin kasashen da ke fama da cutar a Turai, Amurka da sauran kasashen.
An lura da abubuwan tsoro, shakku da rikicewa a kasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya Pacific.
Rahoton na watan Fabrairu (lokacin da aka tabbatar da mafi yawan masu kamuwa da cutar daga China) ya nuna cewa akwai nuna bambancin launin fata ga jama'ar kasar Sin a duk duniya cewa sun cancanci kamuwa da cutar ko kuma su sami abin da ake ganin lada ne daga abin da suka aikata.
Wasu kasashen Afirka ma sun ga yadda ake nuna kyamar 'yan kasar Sin.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna wariya bisa asalin yankin su.
Akwai tallafi ga mutanen China a kan layi da wajen layi da kuma ga waɗanda ke cikin yankin da aka hana shiga wanda ke fama da cutar.
Tare da ci gaba da barkewar cutar zuwa wasu ƙasashe, mutanen Italiya, wanda shine farkon ƙasar Turai da ta fara fuskantar mummunan kamuwa da cutar COVID-19, sun shiga cikin halin rashin yarda da ƙiyayya da baƙi.
A Japan, alamar #BanChinese zuwa Japan tana da babban matsayi a Twitter.
Mutanen kasar Sin, da sauran mutanen Asiya a Burtaniya da Amurka, sun ba da rahoton karuwar cin zarafin wariyar launin fata da cin zarafin mata.
An soki shugaban Amurka Donald Trump saboda kiran cutar coronavirus "Cinese virus", wata kalma da ake ganin ta nuna wariyar launin fata da kuma adawa da Sinawa.
Masu zanga-zanga a Ukraine sun kai hari kan motar bas da ke dauke da 'yan kasar Ukraine da' yan kasashen waje da ke gudu daga Wuhan zuwa Novi Sanzhary.
Dalibai daga yankin yammacin Indiya da ke kan iyakar China da kuma daliban da ke karatu a manyan biranen Indiya an bayar da rahoton cewa sun sha wahala daga zalunci dangane da barkewar cutar.
Shugaban jam'iyyar Bharatiya Janata na jihar Bengal Dilip Ghosh ya ce mutanen China sun lalata yanayi kuma "shi ya sa Allah ya rama musu".
Wannan ambaton daga baya ya sha alwashin jakadancin kasar Sin da ke Kolkata, yana mai kiranta da "karya". A cikin kasar Sin, tsoratar da baƙi da nuna wariya ga wadanda ba Sinawa ba sun kamu da cutar, inda ake kiran baƙi "ƙwararrun baƙi" kuma ana kiransu "ƙwararrun ƙwayoyin cuta".
Yawancin jaridu masu biyan kuɗi sun kawar da wannan ƙa'idar don wasu ko duk abubuwan da suka shafi cutar coronavirus.
Yawancin wallafe-wallafen kimiyya sun ba da damar yin amfani da binciken kimiyya game da cutar.
Wasu masana kimiyya sun raba sakamakon su da sauri a kan sabobin preprint kamar bioRxiv.
Cutar da ke tasowa - Cutar da ke tasowa, sau da yawa a matsayin fashewa ko kuma sabon kwayar cuta
Kwayoyin cuta da cututtuka - Bayani na Kwayoyin cuta da cututtuka
Jerin annoba da annoba - jerin mutuwar cututtuka
Cinikin namun daji da cututtukan dabbobin - haɗarin kiwon lafiya da ke tattare da cinikin namun daji da ba a saba gani ba
Gwajin gwaji na sabon nau'in cutar numfashi ta 2019 (COVID-19) da kuma cutar SARS-CoV-2 mai alaƙa sun haɗa da hanyoyin da ke gano kasancewar kwayar cutar da kuma waɗanda ke gano kwayoyin da aka samar don amsawa ga kamuwa da cuta.
An tabbatar da kasancewar kwayar cutar a cikin samfurin ta hanyar maganin polymerase chain reaction (RT-PCR) wanda ke gano RNA na kwayar cutar corona.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da kamuwa da cuta ko aiki na kwanan nan.
Ana iya amfani da ilimin ƙwayar cuta don tantancewa da kuma nazarin al'umma.
Gwajin kwayar cutar ya nuna yawan mutanen da ke da cutar, ciki har da wadanda ba su da alamun cutar da kuma wadanda ba su da alamun cutar da za a bayar da rahoto.
Za a iya tantance daidaiton yawan mutuwar da kuma matakin rigakafin mutane ta hanyar sakamakon gwajin.
Saboda iyakancewar gwaji a watan Maris na 2020, babu wata ƙasa da ke da ingantaccen bayanai game da yawan kamuwa da cutar a cikin al'ummarta.
Ya zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambancin da ke tattare da yawan gwajin da aka yi a duk faɗin ƙasar.
Wannan bambancin kuma yana iya yin tasiri sosai a kan yawan mutuwar da aka ruwaito, wanda zai iya zama ƙari a wasu ƙasashe.
Ta hanyar amfani da tsarin polymerase chain reaction na rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rikodin rik
Ana samun sakamako a cikin awanni zuwa kwana biyu.
Gwajin RT-PCR da aka yi tare da ciwon huhu yana da tabbaci ne kawai a farkon makon cutar.
Daga baya, kwayar cutar na iya sake ɓacewa a cikin hanji yayin da take kaiwa ga huhu.
Ga waɗanda suka kamu da cutar da aka gwada a mako na biyu, ana iya ɗaukar samfurin maye gurbin daga cikin hanyoyin numfashi mai zurfi ta hanyar yin amfani da takunkumin katako ko kayan aiki don yin hanci.
An kafa daya daga cikin gwaje-gwajen PCR na farko a Charité a Berlin a watan Janairun 2020 ta amfani da hanyar watsa layin polymerase-transfer-reaction real-time-transcription (rRT-PCR), kuma an kafa tushe na asali 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta kuma kafa gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya kafa aji na magani bisa kayan aikin SARS-CoV-2 PCR (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
"Hanyar tana neman kwayar ""E"" da aka rarraba ta dukkan kwayar cutar coronavirus da kuma kwayar RdRp ta musamman ga SARS-CoV-2. A China, BGI Group ita ce ta farko da ta sami izinin amfani da na'urar gano cutar ta SARS-CoV-2 ta hanyar polymerase chain reaction (PCR) daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta Kasa (China's National Medical Products Administration). A Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) tana rarraba takardar tantancewa ta hanyar yin amfani da layin cutar ta SARS-CoV-2 na 2019 (2019-nCoV) zuwa asibitocin kiwon lafiya na kasa don yin gwaji na musamman".
Gwajin kwayar halitta guda uku a cikin tsohuwar ƙarni na gwaji ya haifar da sakamakon da ba a tabbatar da shi ba saboda kurakurai da rikice-rikice na gwaji a CDC a Atlanta, sakamakon hakan ya kai ga aƙalla samfura 100 a rana an gudanar da shi cikin nasara a cikin watan Fabrairu na 2020.
Ba a tantance gwajin da aka yi da kayan aiki biyu ba har zuwa 28 ga Fabrairu, 2020, kuma ba a ba da izinin fara gwaji ga dakunan gwaje-gwaje na jihohi da na asali ba.
An amince da gwajin ne ta Hukumar Abinci da Magunguna a karkashin Laboratory na Kasuwanci wanda ke da izinin amfani da shi na wucin gadi. Laboratory na Kasuwanci ya fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a ba da gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
An kafa bincike na bincike a duk faɗin ƙasar, ana ba da sabis na gwajin COVID-19 daga 9 ga Maris, 2020.
Babu iyakar iyakar da aka sanar, tarin samfura da sarrafawa dole ne su bi ka'idodin CDC.
A Rasha, an haɓaka kuma an samar da gwajin COVID-19 ta Cibiyar Nazarin Labarai da Fasaha ta Biotechnology ta VECTOR.
A ranar 12 ga Maris, 2020, Clinic Mayo ta ba da rahoton ƙirƙirar gwajin don bincika kamuwa da cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don yin gwajin da za a iya aiwatarwa cikin awanni 3.5 a cikin babban sikelin, don haka yana ba da damar injin ɗaya ya yi kusan gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna (FDA) ta ba da izinin gaggawa (EUA) ga Abbott Laboratories don yin gwaji akan tsarin Abbott na m2000. A baya, Hukumar Abinci da Magunguna ta ba da izini iri ɗaya ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta sami EUA daga FDA ta hanyar gwajin da ya ɗauki kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar nucleic acid amplification maimakon fasahar PCR.
Saboda ba ya buƙatar sake zagayowar zafin jiki mai juyawa, wannan hanyar na iya ba da sakamako mai kyau a cikin minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka, kuma Abbott na sa ran kara samarwa domin samar da gwaje-gwaje 50,000 a rana, gwaje-gwajen da ke amfani da kwayoyin halitta guda daya da ke da alaka musamman da kwayar cutar N mai saurin kamuwa da kwayar cutar korona da ke bullowa a Taiwan, tare da fatan cewa za ta iya samar da sakamako cikin mintuna 15 zuwa 20 kamar yadda ake yi a gwajin saurin kamuwa da cutar.
"Binciken wallafe-wallafen Maris 2020 ya kammala da cewa X-ray na kirji ba shi da ƙima a farkon matakin ganewar asali, inda CT [shan wani wuri na jikin mutum] zai iya kasancewa ko da kafin bayyanar cututtuka. ""
Abubuwan da ke faruwa a CT sun haɗa da ƙarancin gilashin polyhedron tare da rarrabuwa a baya, rashin daidaituwa, da kayan aiki.
Yawancin ƙwayoyin cuta a ƙarƙashin ƙwayoyin cuta, ƙwayoyin cuta, da haɗin kai suna ci gaba yayin da cutar ke ci gaba.
Nazarin kwatancen polymerase chain reaction (PCR) da CT a Wuhan, wanda shine tushen cutar ta yanzu, ya nuna cewa CT ya fi PCR ƙarfi, tare da yawancin fasalulluka na hoton sa na huhu tare da ciwon huhu da sauran hanyoyin cutar, kodayake ba a bayyana su ba.
"A watan Maris na 2020, Kwalejin Kimiyya ta Amurka ta ba da shawarar cewa""CT bai kamata a yi amfani da shi ba don yin hoto ko a matsayin gwajin layin farko don gano cutar COVID-19"."A watan Maris na 2020, CDC ta ba da shawarar PCR don fara sa ido. "
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shine samar da kwayoyin cuta, wadanda suka hada da IgM da IgG.
Ana iya amfani da waɗannan don gano mutum-mutumin kamuwa da cuta, farawa daga kwanaki 7 ko bayan bayyanar cututtuka, don tantance rigakafi, da kuma a cikin yawan jama'a. Ana iya yin gwajin a cibiyar gwaji (CLT) ko ta hanyar gwajin da aka mayar da hankali (PoCT).
Tsarin sarrafa kansa mai zurfi a cikin ɗakunan gwaje-gwaje da yawa na asibiti zai iya aiwatar da waɗannan bincike, amma amfani da wannan tsarin zai dogara da ƙimar samarwa ga kowane tsarin.
Ana amfani da CLT sau da yawa don samfurin guda ɗaya wanda ya maye gurbin jini, kodayake ana iya amfani da samfuran gaba don lura da martani na rigakafi.
Don PoCT, ana samun samfurin jini guda ɗaya ta hanyar cututtukan fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakai na cirewa kafin a yi amfani da shi. A ranar 26 ga Maris, 2020, FDA ta sanya sunayen ƙungiyoyi 29 waɗanda suka sanar da hukumar yadda ake buƙata kuma yanzu suna iya rarraba gwajin su na asali.
A ranar 7 ga Afrilu, 2020, kawai gwajin da aka ba da izini ta FDA a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun da Epitope Diagnostics Laboratory sun sami amincewar Turai don takardun gwajin su waɗanda ke iya kare IgG da IgA kwayoyin cuta daga ƙwayoyin cuta a cikin samfurin jini.
Wannan gwajin yana iya yin ɗaruruwan samfura a cikin awanni kaɗan kuma saboda haka ya fi saurin da'awar PCR na kwayar RNA.
Yawancin lokaci ana iya gano kwayoyin cutar cikin kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu wani kwayoyin da aka saya da ya isa amfani.
"Hong Kong ta shirya wani shiri inda marasa lafiya masu zargi za su iya zama a gida ""Shugabannin gaggawa za su ba da samfurin ga marasa lafiya""; suna yin kwaskwarima, suna aikawa da kwaskwarima, kuma bayan wani lokaci za su sami sakamakon gwajin. British NHS ta sanar da cewa suna gwaji tare da wannan shirin don yin gwajin da ake zargi da cutar a gida, wanda zai rage haɗarin masu cutar su watsa wa wasu idan sun kasance a asibiti ko kuma idan akwai motar gaggawa da ke kashe cutar, idan ya cancanta.
A Jamus, likitocin inshorar lafiya na kasa sun ce a ranar 2 ga watan Mayu yana da damar yin gwaji kusan 12,000 a rana a cikin wuraren motar motar gaggawa kuma an gwada 10,700 a makon da ya gabata.
Kudin da inshorar lafiya ke biya ne idan likita ya ba da umarnin yin gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwajin 160,000 a mako.
Ya zuwa ranar 19 ga Maris, an ba da gwajin a wasu manyan biranen.
A ranar 26 ga Maris, 2020, ba a san adadin gwajin da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a cikin mako guda na 12/2020 an gwada jimillar samfura 483,295, kuma ya haɗa da mako na 12/2020 da kuma samfura 33,491 (6,9%) waɗanda suka gwada tabbatacce ga SARS-CoV-2. A cikin Isra'ila, masu bincike a Cibiyar Fasaha ta Isra'ila (Technion) da asibitin Rambam sun haɓaka kuma sun gwada hanyar yin gwaji daga marasa lafiya 64 a lokaci guda ta hanyar tattara samfura da yin ƙarin gwaji, amma a cikin wannan yanayin, an sami samfurin da aka tattara yana da inganci kawai.
Ginin da ya kasance a karkashin kulawar Wang Jian, wanda ya kafa BGI, kuma ya ɗauki kwanaki 5, samfurin samfurin Hubei ya kai kashi 47%, kuma farashin da ya shafi warware matsalar keɓewa ya ninka idan ba a yi amfani da damar gwajin ba.
An bi Wuhan Lab da sauri ta hanyar Huang-Yan Labs a Shenzhen, Zhejiang, Beijing da Shanghai a cikin birane 12 a duk faɗin China.
A ranar 4 ga Maris, 2020, jimlar gwajin ya kai sau 50,000 a rana. Buɗe tushen, an saki ƙirar da Origami Assays ya yi, wanda ya gwada samfuran marasa lafiya 1,122 don COVID-19 ta amfani da gwaje-gwaje 93 kawai.
A watan Maris, rashin isasshen adadin masu tuba ya zama abin ƙyama ga gwajin manyan samfura a Tarayyar Turai da Burtaniya da Amurka.
Wannan ya sa wasu marubuta suka nemi a shirya bikin a kan samfurin da aka dumama a 98 °C (208 °F) na minti 5 don fitar da kwayar RNA don ƙarin gwaji.A ranar 31 ga Mayu, an sanar da cewa Saudiyya tana gwada yawan jama'arta don coronavirus a cikin kwakwalwa fiye da kowace ƙasa kuma tana kan hanyar faɗaɗa matakin gwaji don isa ga yawancin jama'a.
"Wannan ta hanyar haɗuwa da ƙarfin haɓaka da sayen babban dakin gwaje-gwaje daga yawan jama'a daga Group 42 da BGI (bisa ga dakin gwaje-gwajen su na "Hu-Yang" a China)".
An gina shi cikin kwanaki 14, dakin gwaje-gwaje yana da damar yin dubun dubatan gwajin RT-PCR a rana kuma shine na farko a duniya da ke aiki a wajen kasar Sin.
An kirkiro wasu nau'ikan gwaje-gwaje daban-daban da ke mai da hankali kan bangarorin daban-daban na kwayar cutar a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta karbi takardar shaidar Jamus don kayan aikin da aka aika zuwa ƙasashe masu ƙarancin kuɗi ba tare da albarkatun ci gaban kansu ba.
An buga sigar Jamus a ranar 17 ga Janairu, 2020. Takardar da Cibiyoyin Kula da Cututtuka na Amurka suka kafa ba ta kasance ba har zuwa 28 ga Janairu. Ana jinkirta gwajin da ake da shi a Amurka, kuma Amurka tana da matsala game da amincin kayan aikin gwaji a farkon farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su da isasshen kayan aiki don saduwa da buƙatu da shawarwari don gwajin da ƙwararrun likitocin kiwon lafiya ke yi.
Akasin haka, masana sun ce gwajin da Koriya ta Kudu ta yi ya rage yaduwar sabon nau'in kwayar cutar.
An gina ƙarfin gwaji, mafi yawa a cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu, tsawon shekaru da gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji, wanda shine hanya mafi kyau don rage yaduwar cutar ta COVID-19 da wuri. Babban buƙatar gwaji saboda yaduwar kwayar cutar ya haifar da yin daruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu a Amurka da kuma samar da tsari don allunan wanka da kayan aikin gwajin sun zama mai wahala.
A watan Maris na 2020, kasar Sin ta ba da rahoton matsalolin da suka shafi daidaito a cikin kayan aikin gwajin su.
"A Amurka, gwajin da CDC ta samar yana da ""inganci""; sannan gwamnati ta cire takunkumin ofishin jakadancin da ke hana gwajin masu zaman kansu. Spain ta sayi gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta gano cewa sakamakon ba daidai ba ne".
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya haifar da gazawar tattara samfuran ko amfani da kayan aikin daidai.
Ma'aikatar Spain ta ce za ta cire na'urorin da ke ba da sakamako mara kyau kuma za ta maye gurbin su da wasu na'urorin gwaji daban-daban da Shenzhen Bioeasy ta bayar. Kashi 80 cikin dari na na'urorin gwajin da aka saya a Jamhuriyar Czech daga China sun ba da sakamako mara kyau.
"Firai Minista Matovič ya ba da shawarar a jefa shi cikin Kogin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta sayo daga China suna da ""yawan kuskuren"" kuma ""ba a yi amfani da su ba"" . "Majalisar Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China, amma a farkon watan Afrilu 2020 ta sanar da cewa ba za a iya amfani da waɗannan kayan ba. "
Gwajin bin diddigin waɗanda suka gwada tabbatacce da kuma bin diddigin waɗanda ke da alaƙa da SARS-CoV-2 sun sami sakamako mai kyau.
Masu bincike da ke aiki a Vò, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan mutane 3400 da ke keɓewa na tsawon kwanaki goma.
Kimanin rabin mutanen da suka gwada ba su da alamun cutar, kuma duk waɗanda aka gano sun kasance a keɓe.
Tare da iyakancewar tafiye-tafiye zuwa kurkuku, ana iya kawar da sabon kamuwa da cuta gaba ɗaya.
Tare da sa ido sosai kan alaƙar, ƙuntatawa na tafiye-tafiye na cikin gida, gwaji da keɓewa, annobar cutar coronavirus ta duniya ta 2020 a Singapore ta tafi a hankali fiye da sauran ƙasashe masu tasowa amma ba tare da takunkumi masu ƙarfi ba kamar tilasta rufe gidajen abinci da wuraren sayar da kayayyaki.
An soke abubuwa da yawa kuma Singapore ta fara ba da shawarar mutane su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23 ga Maris.
Sauran ƙasashe da yawa sun kuma gudanar da annobar ta hanyar haɗuwa da ƙarfi, ƙuntatawa na cikin gida, gwaji da keɓewa, amma tare da ƙuntatawa a gida, kamar Iceland da Koriya ta Kudu.
Nazarin da aka yi bisa lambobi ya gano cewa ƙasashe da suka yi gwaji da yawa dangane da yawan mutuwa suna da ƙananan ƙimar mutuwa, mai yiwuwa saboda waɗannan ƙasashe sun fi samun kariya daga cutar.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa ƙasashe waɗanda ba su da damar yin gwaji da kuma dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙarancin ƙwarewa game da COVID-19 su aika da samfuran COVID-19 na farko guda biyar da na farko da suka gabata da kuma samfuran marasa kyau guda goma zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 na WHO don tabbatar da gwaji.
Daga cikin dakunan gwaje-gwaje 16 da aka yi niyya, bakwai suna Asiya, biyar a Turai, biyu a Afirka, daya a Arewacin Amurka, daya kuma a Australia.
"A cikin teburin da ke ƙasa, layin ""positive as percentage of testing"" ya rinjayi manufofin gwajin ƙasa".
Kasar da ke gwadawa kawai mutanen da suka shiga asibiti za su sami kashi mafi girma na tabbatacce fiye da ƙasar da ke gwada dukkan 'yan ƙasa, ko suna da alamun cutar ko a'a, kuma duk abin da ya bambanta da haka.
Wanke hannu, wanda kuma aka sani da tsabtace hannu, shine aikin wanke hannuwan mutum da nufin cire datti, mai, tururi, ko wasu abubuwan da ba mu buƙata.
Wanke hannu da sabulu a wasu lokuta masu mahimmanci a rana yana hana yaduwar cututtuka da yawa, misali, cututtukan huhu da cututtukan da ke yaduwa ta baki.
Mutane na iya kamuwa da cututtukan numfashi kamar su mura ko kuma mura, misali idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakinsu (misali, hanci da hanci).
Abubuwa biyar masu mahimmanci na yau da kullun da za a yi amfani da su wajen wanke hannu da sabulu sun haɗa da kafin da bayan wanka, bayan wanke jariri, ko motsawa jariri, kafin yin wanka, kafin cin abinci, da kuma kafin ko bayan shirya abinci, ko dafa kifi da tsuntsaye.
Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu: Za mu iya wanke hannu da tawul idan babu ruwa da sabulu.
Kafin mu ci abinci, sa'ad da muke ci abinci, da kuma bayan mun ci.
Kafin da kuma bayan kula da marasa lafiya.
Bayan canza jariri, ko wanke jariri da ya yi amfani da wanka.
Bayan ka shafa hancinka, ka yi tari ko kuma ka yi taushi.
Bayan ka taɓa dabba, naman dabba ko kuma ɓarayin dabba.
Tashin hankali na ilimin kimiyya ya mai da hankali ne kan aiwatar da aikin hannu wanda ya danganci tsarin koyarwar malami.
Wanke hannu kafin shan magani ko kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar likita na wanke hannu shine don tsabtace hannaye waɗanda ke haifar da ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da haɗari ko cuta.
Yana da mahimmanci ga waɗanda ke sarrafa abinci ko aiki a cikin likitanci, amma kuma yana da mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa ga lafiyar mutum, ciki har da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana kamuwa da cututtukan cututtukan zuciya; rage kamuwa da cututtukan numfashi.
Kuma rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Wani bincike na 2013 ya nuna cewa yin wanka da hannu na iya inganta ci gaban yara a hankali a cikin yara 'yan kasa da shekaru biyar.
A cikin ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da cututtukan zuciya ta hanyar gabatar da canje-canje na dabi'u kamar wanke hannu da sabulu, da sauransu.
Wannan aiki mai sauki zai iya rage yawan mutuwar wadannan cututtuka da kusan 50%.
Shigar da hankula da ke inganta wanke hannu na iya rage cutar sankara da kusan kashi daya bisa uku, kuma wannan ya yi daidai da samar da ruwa mai tsafta a yankunan masu karamin kudin shiga.
48% na raguwar kamuwa da cutar za a iya danganta shi da wanke hannu tare da sabulu. Wanke hannu tare da sabulu shine hanya mafi inganci da araha don hana kamuwa da cutar sankara da kuma kamuwa da cutar numfashi (ARI), wanda ya zama dole a yi a wurare, makarantu da al'ummomi a duk duniya.
Ciwon huhu, babban ARI, shine babban dalilin mutuwa a cikin yara 'yan ƙasa da shekara biyar, yana kashe kusan yara miliyan 1.8 a shekara.
Cutar kansa da ciwon huhu suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da bayan wanka ya zama al'ada mai ceton rai fiye da duk wani allurar rigakafi ko kuma aikin likita ta hanyar rage mutuwar ciwon daji da kusan rabi da kuma mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ana amfani da wanke hannu tare da sauran ayyukan tsabtace jiki a matsayin wani ɓangare na aikace-aikacen ruwa, tsabtace jiki da tsabtace jiki.
Wanke hannu yana iya karewa daga cututtukan fata na hannu da aka watsa ta hanyar hulɗa kai tsaye.
Wani karamin illa na wanke hannu shine cewa wanke hannu sau da yawa na iya haifar da lalacewar fata ta hanyar bushewar fata.
Wani binciken Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da kumburi na fata wanda aka fi sani da ciwon hanci ko kumburi na hannu wanda yafi faruwa tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin yawan wanke hannu a matsayin wata alama ta cutar tunani.
Manyan lokutan biyar a rana da za ku buƙaci wanke hannuwanku da sabulu don rage kamuwa da cuta ta hanyar tuntuɓar hanci da baki: bayan amfani da gidan wanka (ƙananan ƙafa da manyan ƙafafu), bayan wanke jarirai (canza ruwan 'ya'yanku), kafin ku ba da abinci ga jariri, bayan cin abinci, da kuma kafin ko bayan shirya abinci ko dafa abinci ko riƙe kifi ko tsuntsaye.
Sauran lokutan da ya kamata a yi amfani da dabarun wanke hannu daidai don hana watsa cututtuka sun haɗa da kafin da bayan kula da rauni ko sanda; bayan kun yi taushi, kuka ko wanke hancinku; bayan taɓa ɓarnar dabbobi ko taɓa dabbobi; da kuma bayan taɓa shara.
A cikin ƙasashe da yawa, yawan wanke hannu da sabulu har yanzu yana da ƙarancin.
Wani binciken da aka gudanar a kan wanke hannu a cikin kasashe 54 a shekarar 2015 ya gano cewa, a matsakaita, kashi 38.7% na mazauna gida suna wanke hannu da sabulu. Nazarin na 2014 ya nuna cewa Saudi Arabiya ce ke da mafi girma, kashi 97%, Amurka 77% kuma China ce ke da mafi ƙarancin kashi 23%.
Shirin Kula da Kiwon Lafiya na Dole da Ma'aikatar Ilimi ta Philippines ke gudanarwa misali ne na ayyukan da suka dace don inganta lafiyar yara da iliminsu.
Cutar kwari sau biyu a shekara, tare da wanke hannu yau da kullun da sabulun hakori na yau da kullun tare da fluorite, shine babban jigon shirin na ƙasa.
An kuma yi amfani da shi cikin nasara a Indonesia.
Cire ruwan 'ya'yan itace daga fata shine wankewa ta hanyar ƙara sabulu ko soap a cikin ruwa.
Babban aikin sabulu da maganin kashe cuta shine rage shingen maganin da kuma kara narkewa.
Ruwa da kansa ba shine ingantaccen mai tsabtace fata ba, saboda kitse da sunadarai, abubuwan da ke cikin ƙasa, ba su narke cikin ruwa ba.
Duk da haka, ƙarfin ruwa mai ƙarfi zai iya taimakawa wajen wanke tafkin.
Domin sabulu mai tsauri wanda za'a iya sake amfani dashi yana dauke da kwayoyin cuta, da kuma sabulu bayan an yi amfani dashi sau daya.
Wani karamin bincike da ya duba kwayar cutar daga sabulu mai narkewa ya kammala da cewa kwayar cutar ba ta iya kwayar cutar ba saboda ta riga ta wanke tare da sabulu.
"CDC ta ci gaba da cewa, ""Ruwan sabulu a cikin kwano mai maɓallin maɓalli ya fi kyau"."
An samu karbuwa sosai daga sabulu masu hana ƙwayoyin cuta zuwa fannin kiwon lafiyar jama'a.
Ya zuwa yanzu babu wata hujja da ta nuna cewa amfani da kowane irin maganin kashe ƙwayoyin cuta ko kwayoyin cuta da aka ba da shawarar zaɓaɓɓu ne ga jikin da ke da juriya ga maganin rigakafi a yanayi.
Duk da haka, sabulun antibacterial yana dauke da wakili na antibacterial na yau da kullun kamar trichlosan, wanda yake da nauyi mai yawa a cikin matsin lamba na jiki.
Don haka, idan ba a zaɓi wasu ƙwayoyin cuta da za su iya tsayayya wa maganin ba, sabulun da ke kashe ƙwayoyin cuta ba zai yi tasiri ba kamar yadda ake tallatawa.
Baya ga kayan aikin huhu, rigakafin cututtukan fata da kuma kayan aikin kare fata, wannan kayan lambu na karya yana dauke da sinadarin sinadarin acetate, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin acid, sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinad
Ruwan zafi mai narkewa don wanke hannu ba ya isa ya kashe kwayoyin cuta.
Kwayoyin suna girma sosai a zafin jiki (°C 37).
Koyaya, ruwan zafi mai zafi yana da tasiri fiye da ruwan sanyi da sabulu a cikin tsabtace mai na ƙasa wanda ke riƙe ƙasa da ƙwayoyin cuta.
Nazarin kimiyya, wanda ya sabawa yarda da aka sani, ya nuna cewa amfani da ruwan zafi ba shi da tasiri wajen rage ƙwayoyin cuta a hannu.
Alkoholic wanke hannu ko kuma maganin kashe cuta a hannu shine mai tsabtace hannu wanda baya amfani da ruwa.
A ƙarshen 1990s da farkon karni na 21, kayan aikin tsabtace hannu ba tare da ruwa ba, watau giya (wanda aka fi sani da ruwan wanke hannu, wanke hannu, disinfectant, wanke hannu) ya fara samun karbuwa.
Yawancin su suna dogara ne akan isopropylene ko ethanol, suna haɗuwa tare da kayan aiki kamar su carburizer (wani abu mai polyester na acrylic acid) zuwa gel, ko kuma wasu abubuwa kamar glycerin, zuwa cikin ruwa ko kumfa don sauƙaƙe amfani da rage tasirin busassun giya.
Ƙara sinadarin hydrogen-peroxide yana ƙara aikin kashe ƙwayoyin cuta. Ruwa mai wanke hannu wanda ya ƙunshi akalla kashi 60 zuwa 95% na alkali ya isa ya kashe ƙwayoyin cuta
Ruwan wanka na ruwan sha yana kashe ƙwayoyin cuta na yau da kullun, ƙwayoyin cuta masu saurin maganin magani (MRSA da VRE), ƙwayoyin cuta da ƙwayoyin cuta (ciki har da cutar kanjamau, cutar zazzabin cizon sauro, RSV, cutar mura, allurar zazzabin cizon sauro, da cutar hepatitis) da kuma magunguna.
Ruwan wanka na barasa yana kashe kwayoyin cuta da ke dauke da kashi 70% na barasa, yana kashe kashi 99.97%, yana rage kashi 3.5 daidai da rage (decibel 35) na kwayoyin cuta a hannu (sakanin 30 bayan amfani) da kuma kashi 99.99% zuwa 99.999% (rage 4 zuwa 5 alamu) na kwayoyin cuta a hannu minti 1 bayan amfani. Ruwan wanka na giya yana da tasiri sosai akan kwayoyin cuta kuma yana da tasiri sosai akan wasu ƙwayoyin cuta.
Ruwan wanka na giya ba shi da tasiri sosai a kan cutar Norovirus (ko Norwalk), wanda shine mafi yawan sanadin kamuwa da cutar ta farfadowa. Ya kamata a yi amfani da tsabtace hannu ko kuma wanke hannu da giya.
An yi wanka a kan yatsun hannu, wuyansa, da tsakanin dukkan yatsunsu na kimanin dakika 30 har sai ruwan ya bushe.
Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar wanke hannu da ruwa mai tsabta, wanke hannu, da kuma tsabtace hannu, musamman idan hannayen suna kallon duhu.
Haɓaka amfani da waɗannan wakilai ya dogara ne akan sauƙin amfani da saurin kashewa a kan cutar ta yau da kullun. Amma bai kamata su maye gurbin wanke hannu daidai ba sai dai idan babu sabulu da ruwa.
Yin amfani da wanke-wanke na yau da kullun na iya sa fata ta bushe idan ba a ƙara kayan shafawa da / ko danshi na fata a cikin kayan shafawa ba.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da / ko wasu abubuwan da ke saurin bushewa a cikin formula.
A cikin gwaji na likita, wanke hannu tare da kayan shafawa na fata ya haifar da ƙananan kumburi da bushewar fata fiye da sabulu ko sabulu na microbicides.
Rashin kumburi na fata ta hanyar tuntuɓar wani abu mai ƙwayoyin cuta, alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan da cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Rashin sake yin amfani da shi na iya haifar da kumburi na fata daga tasirin tasirin. Wave reaction ya zama mai jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Baya ga ingancinsa, wakili mara ruwa ba zai iya wanke hannayen da ke dauke da kwayoyin cuta ba, amma zai iya kashe kwayoyin cuta a hankali.
Saboda wannan, wanke hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta masu yawa, saboda ƙwayoyin cuta suna kan hannu.
Ingancin wanke hannu ba tare da barasa ba ya dogara sosai akan sinadarai da kuma siffar, kuma a tarihi akwai ruwan giya da wanke hannu marasa tasiri.
Kwanan nan, an nuna sigar da ke amfani da ƙwayoyin cuta na benzalkonium don ci gaba da haɓaka ayyukan antibacterial bayan amfani, ba kamar giya ba, wanda aka nuna yana raguwa bayan maimaita amfani, mai yiwuwa saboda ƙaruwa da halayen fata.
Mutane da yawa a cikin ƙananan al'ummomin ba za su iya sayen sabulu ba kuma su yi amfani da shinge ko ƙasa.
Wankewa da kwanon rufi ko ƙasa na iya zama mai tasiri fiye da wankewa da ruwa ɗaya, amma ba shi da tasiri kamar wankewa da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko ƙasa ta kamu da ƙwayoyin cuta, hakan na iya ƙara yaduwar cutar maimakon rage ta.
Farin yana da maganin kashe ƙwayoyin cuta kamar sabulu, domin idan ya haɗu da ruwa, yana samar da sulfuric acid.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da takalma ko yashi a matsayin madadin lokacin da sabulu bai samu ba.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar yin wanka da kyau don hana kamuwa da cutar, wanda ya ƙunshi matakai masu zuwa:
Ka wanke hannunka da ruwan zafi ko ruwan sanyi.
An ba da shawarar yin amfani da ruwa mai gudana saboda tankunan ruwa na iya zama marasa haske yayin da zafin jiki a cikin ruwa bai yi banbanci ba.
A kan hannayenku, ku yi amfani da sabulu mai yawa, ku haɗa da wuyan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙugu.
Sabulu na iya kawar da cuta daga fata, kuma bincike ya nuna cewa mutane da yawa sun fi son wanke hannayensu da kyau lokacin da suke wanka da sabulu maimakon ruwa.
Yi taƙama na akalla dakika 20.
Wankewa yana haifar da tsawa wanda ke kawar da ƙwayoyin cuta daga fata, kuma wankewa na dogon lokaci zai taimaka wajen kawar da ƙwayoyin cuta.
Ka yi wanka sosai a ƙarƙashin ruwa mai gudu.
Wankewa a cikin wani wanka (ko ruwa ya gudana) na iya sake gurɓata hannayenka.
Ka ɗauki wanki mai tsabta ka wanke hannayenka ko ka bar su su bushe a iska.
Hannun da ke da fitsari da kuma hannu mai fitsari suna da saukin kamuwa da cutar. Wuraren da aka fi kamuwa da cutar sune hannu, hannu, tsakanin yatsun hannu da kuma ƙarƙashin wuyan hannu.
Maganin ƙwayoyin cuta da magungunan ƙwayoyin cuta na iya zama mafaka ga ƙwayoyin cuta na jiki.
Ana ba da shawarar yin wanka mai ƙanshi don kiyaye hannaye daga bushewa. Gashin fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za'a iya yin zaɓuɓɓuka masu ƙarancin kuɗi don sauƙaƙe wanke hannu a wuraren da babu ruwan injin da/ko sabulu, misali, ɗora ruwa daga tankin ruwa ko famfo mai dacewa da kuma/ko amfani da famfo idan ya cancanta a ƙasashe masu tasowa. A cikin yanayin da ke da iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar "tippy-taps" da sauran zaɓuɓɓukan farashi mai sauƙi.
Tashin ruwa na ruwa shine fasaha mai sauki ta amfani da tankin ruwa wanda aka yi amfani da shi ta hanyar igiya, kuma kuna amfani da ƙafafunku don zuba ruwa a hannunku da sabulu.
Yin bushewar hannu mai inganci wani muhimmin bangare ne na aikin wanke hannu, amma akwai wasu muhawara game da mafi ingancin bushewa a cikin gidan wanka na jama'a.
Ƙarin bincike ya nuna cewa takardar wanka tana da tsabta fiye da na'urar bushe hannu da ke cikin ɗakunan wanka da yawa.
A shekara ta 2008, wani bincike da aka gudanar a Jami'ar Westminster, London, tare da haɗin gwiwar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'antar masana'
Bayan wanka da bushewa da bushewa, an sami karuwar kwayoyin cuta a kan tawul, a matsakaita na 194% da kuma a kan dabino na 254%.
Yin bushewa tare da na'urar bushewa yana haifar da matsakaicin ƙaruwar adadin ƙwayoyin cuta a kan allon hannu da kashi 42% da kuma a kan wuyan hannu da kashi 15%.
Bayan wanka da bushe hannayenka da tawul, an rage adadin kwayoyin cuta a kan tawul da kashi 76% kuma a kan yatsun hannu da kashi 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don tantance yiwuwar yaduwar kamuwa da cutar a cikin sauran masu amfani da gidan wanka da kuma yanayin gidan wanka sakamakon kowace hanyar bushewa.
Injin busar da iska ke fitarwa daga injin a cikin saurin 180 m/s (650 km/h 400 mph) yana da ikon fitar da kwayoyin cuta daga hannu da injin busar, kuma yana iya haifar da makanta ga sauran masu amfani da gidan wanka da kuma yanayin da ke kewaye da gidan wanka mai nisan mita 2.
Yin amfani da na'urar bushewa na iya yada iska mai zurfi (ƙananan jiki) har zuwa mita 0.25 daga na'urar bushewa.
Tsabtace takarda bai nuna ba micro-masu amfani da kayan shafawa. A cikin 2005, wani binciken da TÜV Produkt und Umwel ya gudanar ya yi la'akari da wasu hanyoyin bushewa na hannu daban-daban.
An lura da sauye-sauyen ƙwayoyin cuta bayan bushewar hannu kamar haka:
Kamfanoni daban-daban na bushewa sun kasance, kuma an kwatanta bushewar hannu da bushewa tare da takarda.
Yin amfani da wanka na hannu don wanke hannu shine zaɓi a lokacin da muke tafiya ba tare da isasshen sabulu da ruwa ba.
Ruwan wanke hannu mai giya ya kamata ya kasance yana da aƙalla kashi 60% na giya.
Wanke hannu a asibiti ya zama dole bayan likitan Hungary Ignaz Semmelweis, wanda ya gano ingancinsa (a 1846) a cikin rigakafin kamuwa da cuta a cikin asibiti.
Akwai na'urorin lantarki da ke ba da sigina don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta su yi hakan.
Wani bincike ya gano cewa yawan kamuwa da cutar ya ragu tare da amfani da su.
Wanke hannu na likita yana da aƙalla dakika 15, tare da sabulu da ruwa ko gishiri a cikin adadin da ya dace don shafawa da kuma shafa kowane ɓangare na hannu.
Ya kamata mu ƙarfafa juna ta wajen yin magana.
Ya kamata ka yi amfani da igiya don cire ƙuƙwalwar ƙuƙwalwa a ƙarƙashin wuyan hannu, idan akwai.
Yana da matukar muhimmanci a wanke hannayenka sosai kuma a bushe su da wanki mai tsabta, saboda ƙwayoyin cuta na iya zama a cikin ruwan da ke hannayenka.
Bayan wanke hannu, amfani da takarda mai tsabta don rufe ruwa (kuma buɗe kofa idan ya cancanta).
Wannan yana hana sake kamuwa da cutar daga hannu zuwa gaɓoɓin.
Manufar wanke hannu a wuraren kiwon lafiya shine kawar da ƙwayoyin cuta da kuma hana su yaduwa.
Wani sabon rahoton likitancin Burtaniya ya ba da rahoton cewa rashin wanke hannu ya kasance a matakin da ba za a iya yarda da shi ba a yawancin cibiyoyin kiwon lafiya, tare da yawancin likitoci da masu ilimin lissafi suna mantawa da wanke hannu kafin su tuntubi marasa lafiya, wanda ke haifar da yaduwar cutar.
Wani bincike ya nuna cewa wanke hannu da sauran hanyoyin da ba su da wuyar yi ya rage yawan kamuwa da cutar da ke tattare da kamuwa da jini da kashi 66 cikin dari.
Ana iya samun takardun shawarwari na kungiyar kan tsabtace hannu a shafin yanar gizon ta don neman ra'ayoyin jama'a.
Wani bincike na gaba da aka yi ta Whitby et al.
Kayan kasuwanci na iya auna da kuma tsabtace hannu idan an nuna buƙatar aiwatar da matakan gama gari.
Hukumar Lafiya ta Duniya ta ba da umarni biyar na wanke hannu:
Bayan an yi hulɗa da jini ko ruwan jiki
Kafin ka yi aikin tsabtace jiki, ka yi amfani da maganin kashe ƙwayoyin cuta da kuma na'urar tsabtace jiki.
Bayan kulawar mai haƙuri, ƙara sinadarai masu kashe ƙwayoyin cuta zuwa sabulu (wani "magani" ko "kariya") wanda zai iya haifar da aikin kashe ƙwayoyin cuta a cikin kayan wankin hannu.
Ana iya buƙatar yin irin wannan aikin kashe ƙwayoyin cuta kafin aiki ko a cikin wuraren da kwayoyin cuta ke da ƙarfin maganin rigakafi. Don haka, wanke hannayenku a lokacin aikin yana buƙatar rubin mai zafi, buɗewa da rufewa ba tare da taɓa shi ba, ta amfani da chlorhexidine ko iodine, tsabtace matattarar hannu don bushewa bayan wankewa, da kayan aikin tsabtace hannu don tsabtace ƙarƙashin hannu.
Ya kamata a cire duk kayan ado.
Wannan tsari yana buƙatar wanke hannu da kuma motsa hannu har zuwa hannu, wanda yawanci yana da minti 2-6.
Ba a bukatar jinkiri na minti 10.
Dole ne a hana ruwa daga wanke hannayenka daga komawa hannayenka lokacin wanka.
Ka wanke hannayenka da tawul mai tsabta, ka bushe bayan ka wanke hannayenka, kuma ka saka rigar tiyata.
Don rage yaduwar kwayar cutar, yana da kyau a wanke hannu ko amfani da maganin kashe cuta kafin da kuma bayan kula da mai haƙuri.
Don sarrafa kamuwa da cutar staphylococcal a asibiti, an gano cewa mafi girman fa'ida daga wanke hannu ya fito ne daga farkon kashi 20 cikin ɗari na tsabtace hannu, kuma ƙananan fa'idodin da aka samu daga tsabtace hannu na yau da kullun sun ƙaru sama da kashi 35 cikin ɗari.
Wanke hannu da sabulu na yau da kullun har yanzu yana da sau uku na kamuwa da ƙwayoyin cuta daga abinci idan aka kwatanta da wanke hannu da sabulu mai kawar da ƙwayoyin cuta. Kwatanta tsakanin wanke hannu da alkali da wanke hannu da sabulu mai kawar da ƙwayoyin cuta na tsawon dakika 30 ya nuna cewa wanke hannu da alkali na iya rage kamuwa da cuta da kashi 26% fiye da sabulu mai kawar da ƙwayoyin cuta.
Amma sabulu da ruwa sun fi wanke hannu da maganin kashe cuta tasiri wajen rage kamuwa da cutar mura ta H1N1, da kuma cutar Clostridium, wanda ke haifar da cutar daga hannu. Taro don inganta tsabtace hannu a wuraren kiwon lafiya na iya haɗawa da ilimantar da ma'aikata game da wanke hannu, haɓaka alƙawura tare da ruwan giya, da tunatarwa ta kai tsaye da kuma magana ga ma'aikata.
Akwai bukatar ƙarin bincike kan wane irin sa baki ne ya fi tasiri a wurare daban-daban na kiwon lafiya.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu an gane shi a matsayin mai sauƙin amfani, wanda shine babban kayan aiki don samun lafiya da kuma samun abinci mai gina jiki.
Amma rashin isasshen ruwa mai tsabta, sabulu, ko kuma wuraren wanke hannu a gidajen mutane, makarantu, da wuraren aiki na kawo cikas ga cimma manufofin wanke hannu a duniya.
Misali, wuraren wanke hannu a mafi yawan yankunan karkara a Afirka, kusa da wuraren zaman kansu da wuraren wanka na jama'a, ba su da yawa, duk da cewa akwai zaɓi mai tsada a cikin gina wuraren wanke hannu.
Koyaya, wannan ƙarancin wanke hannu na iya zama sanadin rashin wanke hannu fiye da rashin ruwa ko sabulu.
Tallafawa da kuma fafutukar wanke hannu da sabulu na iya tasiri kan yanke shawara, kara wayar da kan jama'a game da fa'idodin wanke hannu, da kuma haifar da sauye-sauyen halayyar jama'a na dogon lokaci.
Don wannan aikin ya zama mai inganci, ana buƙatar kulawa da kimantawa.
Wani bita na tsarin bincike kan karatu 70 ya gano cewa hanyoyin da aka bi a cikin al'umma suna da tasiri wajen inganta wanke hannu a cikin LMICs yayin da kamfen na talla na zamantakewa ba shi da tasiri.
Lokacin da aka cika mafi ƙarancin ƙa'idodi, makarantar na iya canzawa daga tauraro ɗaya zuwa mafi girman taurari uku.
Gina wuraren wanke hannu da yawa wani bangare ne na inganta wanke hannu wanda ke taimakawa wajen rage kamuwa da cuta da rage mutuwar yara.
"Gidan wanka na duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke kokarin kawo sauyi a halin da ake ciki.A sakamakon yaduwar cutar coronavirus ta 2019-20, UNICEF ta inganta yarda da alamar wanke hannu".
Wasu ƙananan karatu sun yi la'akari da tasirin tasirin wanke hannu a cikin ƙasashe masu tasowa waɗanda ke da alaƙa da DALYs.
Amma wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin tsabtace jiki da ruwa tsada.
Muhimmancin wanke hannu ga lafiyar ɗan adam, musamman ga waɗanda ke cikin yanayi mai rauni kamar uwaye masu haihuwa ko sojoji da suka ji rauni a asibiti an fara gane su a tsakiyar karni na 19 ta hanyar masu fassarar hannu biyu, likitan Hungary Ignaz Semmelweis, wanda ke aiki a Vienna, Austria, da Ingilishi Florence Nightingale, "mai kafa aikin jinya na zamani".
A lokacin, yawancin mutane sun yi imani cewa cutar ta samo asali ne daga ƙanshi mai ƙanshi, wanda ake kira miasmas.
A cikin shekarun 1980, barkewar cututtukan abinci da cututtukan da suka shafi kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su inganta inganta tsabtace hannu, wanda shine babban hanyar hana yaduwar cutar.
Bayan barkewar cutar mura ta alade a shekarar 2009 da kuma annobar COVID-19 a duniya a shekarar 2020, wasu kasashe sun fahimci cewa wanke hannu da sabulu yana da matukar muhimmanci wajen kare kansu daga kamuwa da cutar.
Misali, an sanya allon hoto mai taken "daidaitaccen hanyar wanke hannu" a gefen wuraren wanke hannu a cikin wuraren wanka na jama'a da kuma cikin wuraren wanka na gine-ginen ofis da filayen jirgin sama a Jamus.
"Wanke hannuwanka don wanke wani abu" yana nufin sanar da rashin yarda da alhakin wani abu ko kuma raba gaskiya a cikin lamarin.
Ya samo asali ne daga nassi na Littafi Mai-Tsarki a cikin littafin Matta inda Pontius Pilate ya wanke hannunsa daga yanke shawarar gicciye Yesu Kristi, amma ya zama wani karin magana da aka fi amfani da shi a cikin wasu al'ummomin Ingilishi.
Matsayin Mabed a cikin wasan kwaikwayon ya fara toshe hannunta ta hanyar ƙoƙarin tsabtace ta hanyar yin tunanin cewa tana wakiltar fahimtar laifinta game da laifin da ta aikata da kuma ƙarfafa mijinta ya aikata.
Sun gano cewa mutane bayan sun tuna ko kuma tunanin halin rashin mutunci, sun fi tunanin wanke hannu fiye da sauran mutane kuma sun fi daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba su izinin wanke hannayensu bayan irin wannan tunanin ba su da damar shiga cikin "wankewar tsabta" ko wasu ayyukan tsabtace jiki kamar masu sa kai.
Alamar wanke hannu ta hanyar amfani da ruwa ba tare da amfani da sabulu ba wani ɓangare ne na takamaiman yanayin wanke hannu a wasu addinai, ciki har da Bahá'í Faith, Hinduism, tevilah da netilat yadayim a addinin Yahudanci, Lavabo a Kristanci, da Vodou a cikin Musulunci. Dukkanin addinai sun kuma tabbatar da cewa dole ne a wanke hannu musamman bayan wani aiki.
Addinin Hindu, Yahudanci da Musulunci suna buƙatar wanke hannu bayan wanka.
Addinan Hindu, Buddha, Sikh, Yahudanci, da Musulunci suna bukatar wanke hannu kafin da kuma bayan cin abinci.
Gudanar da haɗarin aiki a kan COVID-19
Gudanar da haɗarin aiki don cutar COVID-19 shine aiwatar da hanyoyin lafiya da lafiya na aiki don gudanar da haɗarin rigakafin cutar coronavirus na 2019 (COVID-19).
Kula da haɗarin aiki ya dogara da wurin aiki da aiki, bisa la'akari da tushen haɗarin haɗari, tsananin cutar a cikin al'umma, da kuma haɗarin kowane ma'aikaci wanda zai iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ma'aikata suna fuskantar ƙananan haɗarin aiki tare da ƙananan hulɗa tare da jama'a da sauran abokan aiki, waɗanda aka ba da shawarar yin amfani da matakan rigakafin kamuwa da cuta na yau da kullun, gami da wanke hannu, ƙarfafa ma'aikata su kasance a gida idan suna rashin lafiya, rashin jin daɗi na yau da kullun, da kiyaye tsabta da kuma aikin kashe cututtukan yanayin aiki.
Matsakaicin haɗarin aiki ya haɗa da waɗanda ke buƙatar yin hulɗa na yau da kullun ko kusanci tare da waɗanda ba a san su ba ko waɗanda ake zargi da COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar kamuwa da cuta na al'umma ko tafiya ta ƙasa da ƙasa.
Wannan ya hada da ma'aikata da ke hulɗa da jama'a, kamar a makarantu, wuraren aiki masu yawan jama'a, da kuma wasu manyan wuraren sayar da kayayyaki.
Gudanar da haɗari ga wannan rukunin ya haɗa da matakan rigakafin kamuwa da cuta na asali, ciki har da iska mai iska mai iska mai iska mai ƙarfi, shinge mai guba, da kayan kariya na mutum wanda za'a iya amfani dashi yayin hulɗa da waɗanda ke da COVID-19.
OSHA tana ɗaukar ma'aikatan kiwon lafiya da na jana'iza waɗanda aka sani ko ake zargin suna da COVID-19 a cikin haɗari mai haɗari ta hanyar kai tsaye wanda ke ƙara haɗarin haɗari idan ma'aikata suka aiwatar da tsarin samar da rufi ko tattara ko sarrafa samfuran daga mutanen da aka sani ko ake zargin suna da COVID-19.
Gudanar da haɗari ga waɗannan ma'aikata sun haɗa da sarrafa injiniya kamar su ɗakunan iska masu matsin lamba da kayan kariya na mutum wanda ya dace da aiki.
Cutar COVID-19 na iya shafar wasu wuraren aiki.
Ma'aikata na iya kasancewa daga aiki saboda rashin lafiya, kula da wasu, ko kuma tsoron yiwuwar haɗari.
Lambar kasuwanci na iya canzawa duka a cikin yanayin abin da ake buƙatar kaya da kuma hanyar samun waɗannan kayayyaki (kamar cinikin da ba shi da iyaka a cikin lokutan mafi girma ko ta hanyar sufuri ko sabis na tuki).
A ƙarshe, an dakatar da jigilar kayayyaki daga yankunan da cutar ta COVID-19 ta shafa sosai. Za a iya amfani da shirin amsawa da shirye-shiryen cutar don ba da shawarar ayyukan rigakafi.
Shirin ya shafi matakan haɗarin da ke tattare da aiki da ayyuka, gami da tushen haɗari, haɗarin da ke tattare da gida da kuma al'umma, da kuma haɗarin kowane ma'aikaci, kamar tsufa ko yanayin rashin lafiya.
Sun kuma bayyana matakan da ake buƙata don magance waɗannan haɗarin da kuma shirin tsaro don yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen kamuwa da cuta da amsawa na iya zama batun shawarwarin ƙasa ko na ƙasa.
Manufofin amsawa ga barkewar cutar sun haɗa da rage watsawa tsakanin ma'aikata, kare mutanen da ke cikin haɗarin haɗarin rashin lafiya, kiyaye ayyukan kasuwanci, da rage tasirin tasirin tasirin ga sauran ƙungiyoyi a cikin layin samar da su.
Yanayin rashin lafiya a cikin al'umma ya kasance saboda kasuwancin da ke cikin yankin da abin ya shafa sun amsa.
Gudanar da haɗari shine tsarin da aka yi amfani da shi sosai a cikin aminci da lafiya na aiki don ingantaccen gudanar da haɗarin haɗari.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa shine sarrafa injiniya, sannan kuma gudanarwa, da kuma na ƙarshe na kariya ta mutum.
Gudanar da aikin injiniya ya haɗa da cire ma'aikata daga haɗarin haɗarin aiki ba tare da la'akari da halayyar ma'aikata ba kuma yana iya zama mafi kyawun mafita mai tasiri don aiwatarwa.
Gudanar da gudanarwa shine canjin manufofi ko hanyoyin aiki waɗanda ke buƙatar aiki daga ma'aikata, ma'aikata ko ma'aikata.
Kayan kariya na mutum (PPE) ana ganin ba su da tasiri fiye da na injiniya da na gwamnati, amma suna iya taimakawa wajen kaucewa wasu ƙalubale.
Duk nau'ikan PPE dole ne a zaɓi bisa haɗarin ma'aikata, waɗanda aka sanye su daidai gwargwado (misali masu numfashi), an sanya su kuma an bincika su daidai, ana kiyaye su kuma an maye gurbin su yadda ya kamata, kuma an cire su daidai, an tsabtace su kuma an adana su ko an zubar da su don hana yaduwar cuta.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗari suna da ƙarancin hulɗa da jama'a da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta da aka ba da shawarar don wuraren aiki sun haɗa da wanke hannu da yawa da kuma rashin nutsuwa, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, cututtukan numfashi ciki har da tari da tari, samar da takardar wanka da kayan wanka, shirya don wayar tarho ko canza aljihu idan ya zama dole, ba ƙarfafa ma'aikata su yi amfani da kayan aiki da kayan aikin wasu ba, da kuma kiyaye kayan aiki da kuma kashe ƙwayoyin cuta na yanayin aiki.
Bayyana mutum mai cutar da keɓewa muhimmin mataki ne na kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wuraren aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) suna buƙatar ma'aikata da ke da alamun cututtukan numfashi na yau da kullun su huta a gida har sai sun sami zazzabi, zazzabi, da sauran alamun cutar aƙalla awanni 24, ba tare da shan maganin rage zazzabi ko wasu magungunan canza alamun ba, kuma ƙa'idodin izinin rashin lafiya suna da sauyawa wanda ke ba ma'aikata damar zama a gida don kula da dangin da ke rashin lafiya, kuma ma'aikatan suna buƙatar sanin waɗannan ƙa'idodin.
Dangane da OSHA, ayyukan da ke fuskantar haɗarin matsakaici sun haɗa da waɗanda ke buƙatar yin hulɗa na yau da kullun ko kusanci a cikin ƙafa shida (1.8 m) na baƙi ko waɗanda ake zargi da cutar COVID-19 amma suna iya kamuwa da cutar SARS-CoV-2 saboda kamuwa da cuta na al'umma yana gudana a kusa da wurin kasuwanci ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa wurin da ke da yaduwar cutar COVID-19.
Waɗannan sun haɗa da ma'aikata masu hulɗa da jama'a, kamar a makarantu, wuraren aiki, wasu manyan mutane masu ƙarfi, da kuma ƙayyadaddun wuraren sayar da kayayyaki. Gudanar da injiniya ga wannan rukunin da manyan ƙungiyoyin haɗari sun haɗa da shigar da ingantaccen iska, ƙara yawan iska, shigar da kariya kamar filastik, toshe ƙofofi, da shigar da katangar buɗe ido don sabis na abokan ciniki. Gudanar da gwamnati ga waɗannan ƙungiyoyi da ƙungiyoyi masu haɗari mafi girma, ƙarfafa ma'aikata su zauna a gida. maimakon yin rigakafi, sanya manyan alamun sadarwa tare da ma'aikata, ƙirƙirar manyan wuraren shakatawa, dakatar da ba da izini ga masu amfani da baƙi waɗanda ke ba da izinin cutar COVID-19, samar da sabbin hanyoyin sadarwa da keɓaɓɓu, samar da sabbin hanyoyin sadarwa da keɓaɓɓu, da kuma samar da sabbin hanyoyin sadarwa da keɓaɓɓu da kuma hanyoyin sadarwar ma'aikata.
Ma'aikata a cikin wannan rukunin haɗarin suna buƙatar yin amfani da kayan numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin, kulawa mai kyau don kare ma'aikata da sauran fasinjoji sun haɗa da ware marasa lafiya daga wasu ta hanyar mita 6, sanya wani mai kula da lafiyar don kula da marasa lafiya da kuma ba da gudummawa ga marasa lafiya, ko kuma tambayar marasa lafiya su buɗe bakinsu da hanci yayin yin tari ko tari.
Ya kamata ma'aikatan jirgin sama su sanya safofin hannu na likita da za a iya zubar da su bayan an yi amfani da su lokacin kula da fasinjoji marasa lafiya ko kuma taɓawa da ruwa, kuma za a iya ƙara kayan kariya na mutum idan kuna da zazzabi, rashin ƙarfi ko kuma rashin numfashi.
Ya kamata a zubar da kayan hannu da sauran abubuwan da za a zubar da su a cikin akwatin mai mai, kuma ya kamata a tsabtace da kuma kashe kwayoyin cuta. Don jigilar kasuwanci, gami da jiragen ruwa da sauran jiragen ruwa, kula da haɗari sun haɗa da jinkirta tafiya lokacin rashin lafiya, keɓe kai, da sanar da cibiyar kiwon lafiya a cikin jirgin gaggawa idan wani yana da zazzabi ko wasu alamun bayyanar yayin jirgin.
A ka'ida, lura da lafiya ya kamata ya faru a cikin ɗakunan mutane. Don makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko kashe ƙwayoyin cuta idan mutum ya kamu da cutar a cikin makarantar, ba tare da la'akari da yaduwar al'umma ba.
Lokacin da aka gabatar da mafi ƙarancin al'umma zuwa matsakaici, ana iya aiwatar da dabarun zamantakewar jama'a kamar watsi da tafiye-tafiye zuwa filin wasa, taro, da sauran manyan tarurruka kamar ilimin jiki ko azuzuwan ƙungiyar mawaƙa ko cin abinci a kantin kofi, ƙara tazarar tsakanin teburin isowa da fitarwa, iyakance adadin baƙi marasa mahimmanci, da amfani da keɓaɓɓun wuraren kiwon lafiya don yara masu alamun cutar AIDS.
Lokacin da akwai ƙarin sufuri a cikin al'ummomin da ke ƙasa, ban da dabarun jagoranci na zamantakewa, za a iya yin la'akari da ƙarin horo na makaranta.
Jami'an tilasta bin doka waɗanda dole ne su kasance tare da mutanen da aka tabbatar ko ake zargi da cutar COVID-19 an shawarce su da su bi umarnin da aka ba da su ga masu fasahar likita na gaggawa, gami da kayan kariya na sirri.
Idan aka katse sadarwa a lokacin wannan lokacin damuwa, ma'aikata ya kamata su tsabtace da kuma kashe kwayoyin cuta ga kayan aikin su da igiyoyin su kafin sake amfani da su ta hanyar yin amfani da kayan shafawa ko kayan wanka, kuma su bi ka'idodin tsari na adanawa da zubar da kayan aikin likita da aka yi amfani da su, da adanawa da kuma kwashe tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da na jana'iza a matsayin masu haɗari, nau'ikan haɗarin haɗari.
Ayyukan haɗari sun haɗa da samar da sabis na kiwon lafiya, tallafin dakin gwaje-gwaje, da ma'aikatan jigilar likitoci waɗanda aka gano suna da marasa lafiya da ake zargi da COVID-19.
Waɗannan sun zama haɗari masu haɗari idan ma'aikata suka aiwatar da hanyoyin samar da taimako ko tattara ko riƙe samfuran daga sanannun ko waɗanda ake zargi da cutar COVID-19.
Hanyar samar da ingantaccen rarrabuwa mai ƙarfi ko ruwa zuwa gas ya haɗa da sutura, hanyar yin kwaskwarima, binciken huhu, wasu hanyoyin da binciken haƙori, ko kuma tattara samfurin cutar.
Ayyukan jana'izar suna da haɗari sosai, gami da ma'aikatan da ke cikin shirya gawawwakin mutane waɗanda suka san ko kuma suka yi tsammanin akwai COVID-19 a lokacin da suka mutu.Duk waɗannan wuraren suna fuskantar haɗari sosai idan sun yi kwayar halitta.
Ana iya yin amfani da matsin lamba mai iska mai iska mai iska a wasu wuraren kiwon lafiya da kuma makabarta.
Samfuran ya kamata a ajiye su a hankali a matakin tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya masu zuwa zuwa yankuna daban-daban dangane da ko suna da cutar COVID-19. Bugu da ƙari, PPE daban-daban OSHA ta ba da shawarar yin amfani da kayan numfashi ga waɗanda ke aiki a nesa da ƙafa 6 na sanannun ko waɗanda ake zargi da cutar SARS-CoV-2, da kuma duk waɗanda ke aiwatar da hanyoyin samar da iska.
A cikin Amurka, ana amfani da kayan aikin numfashi na fuska na N95 na NIOSH da aka yarda ko mafi kyau a cikin mahallin ingantaccen tsarin kare numfashi wanda ya haɗa da gwaji mai dacewa, horo, da kuma aikin likita.
Sauran nau'ikan na'urorin numfashi na iya samar da ƙarin kariya da haɓaka lafiyar ma'aikata. WHO ba ta ba da shawarar yin sutura ba, saboda COVID-19 cuta ce ta numfashi maimakon ta hanyar ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska ga ma'aikatan kula da shiga kawai.
Ga waɗanda ke tattara samfurin numfashi, masu kula ko masu jigilar marasa lafiya na COVID-19 ba tare da yin amfani da hanyoyin rarraba gas ko ruwa ba, WHO ta ba da shawarar yin amfani da abin rufe fuska, abin rufe fuska ko abin rufe fuska, makamai da sutura.
An aiwatar da hanyar samar da ingantaccen rarrabuwa na gas ko ruwa zuwa gas. An maye gurbin abin rufe fuska na N95 ko FFP2.
Saboda wadatar PPE ba ta isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, kayan aikin jiki kamar su windows masu haske, ba da damar waɗanda ke cikin kulawa ta kai tsaye su shiga cikin ɗakunan da ke dauke da marasa lafiya na COVID-19, suna amfani da PPE da ake buƙata don takamaiman aiki, ci gaba da amfani da na'urar numfashi iri ɗaya ba tare da ɓata lokaci ba, kula da marasa lafiya da yawa tare da irin wannan cutar, bincika da daidaita layin samar da PPE, da ƙarfafa amfani da shinge ga mutanen da ba su da alamun cutar.
Daga: Katherine Maher, Shugabar Wikimedia Foundation
Ga dukkan ma'aikatan Wikimedia Foundation:
TAMBAYA: [COVID-19] Rashin nauyi da kuma shiri don nan gaba
Ranar da lokacin da aka aika: 14 ga watan Maris 2020 a 00:24 UTC
An rubuta shi a matsayin CC0: Babu haƙƙin mallaka
A wannan watan, mun fahimci cewa muna cikin yanayi mai ban sha'awa.
Cutar COVID-19 ita ce ta nuna alaƙar da ke tsakanin mutane da duniyarmu da kuma nauyin da muke da shi ga junanmu.
Ba mu da samfurin da zai iya magance wannan kalubalen, amma mun san cewa amsar da ta fi dacewa ta dogara ne da irin fahimtar duniya, haɗin kai da kuma gina al'umma, wanda shine ainihin cibiyar ƙungiyar.
Hoton da kuma kulawar da muka gani a cikin dukkan abokan aikinmu ta hanyar imel, kiran waya da tattaunawa shine kyakkyawan ƙarfin mutane masu ban mamaki waɗanda muke da sa'ar yin aiki tare.
Ba abin da ya fi ni farin ciki, kamar yadda nake farin ciki da ku, domin kun zama abokan aikina.
A makon da ya gabata, mutane sun zo sun gaya mini cewa suna godiya da aikinmu.
Sun ji daga gare ni abin da ake nufi da duniya ta koma Wikipedia yanzu da kuma abin da ke da alama mai ƙarfi ga wannan muhimmin albarkatun da za su kasance a kan layi kuma su kasance ga kowa.
Aikinku ne ya sa hakan ya yiwu, ko kun kiyaye shafin ko abokan aikinmu sun biya ko kuma al'ummarmu tana cikin koshin lafiya.
Duniya na bukatar bayanin da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba, amma yadda muke yi zai yi tasiri a duniya.
Saboda muhimmancin wannan manufa da kuma matsayinku, za mu yi wasu gyare-gyare ga yadda muke aiki tare, daga mako mai zuwa.
Aikinmu da kuma tsarinmu
Kamar yadda Robyn ta ambata a baya, Team C sun taru a daren jiya don tattauna hanyoyinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawar, mun yi tunani game da abin da muke ganin ya dace da abin da muke fuskanta da kuma yadda za mu iya inganta ƙungiya a wannan lokacin.
Fiye da haka, muna son kawar da tashin hankali da kuma tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar sake kira, ba laifi.
Ga ma'aikata, ma'aikata da ma'aikatan kwangila:
Za mu yi aiki na awa 4 a rana ko kuma awa 20 a mako har sai an ba da sanarwar.
Ba ma sanar da ranar hutu - idan za ka iya yin aiki bayan lokaci, wannan aikin zai bukaci ka.
Koyaya, duniya ba ta iya hango ko wane lokaci ba, kuma ko kuna buƙatar kula da ƙaunataccenku, sayen kayan shafawa, ko ziyarar likita, lafiyarku ita ce fifiko.
Ba mu lura da lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata a yi shiru, amma muna magana.
Babu ranar ciwo ko PTO da ake buƙata - kawai sanar da manajan ku kuma taimaka wa ƙungiyar ku gyara aikace-aikace da jadawalin don tabbatar da cewa an rufe mahimman sassan aikin.
(Idan an gano cewa kana da COVID-19, sanar da Bryan a cikin T&amp;C Ops don T&amp;C ta iya ba da tallafi da kuma tabbatar da cewa yanayinka yana samun kulawa ta daidai daga masu gudanarwa.)
Za a biya ma'aikata cikakken kuɗin sa'o'in aikinsu.
Mun riga mun faɗi haka, kuma muna sake yin alƙawarin mu cika alƙawarinmu ga ma'aikatanmu da abokan aikinmu kowane lokaci.
Kowa zai sami albashi bisa ga aikinsa na yau da kullun a cikin yanayi na yau da kullun.
Wannan ya haɗa da idan ka yi rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kun yi aiki, muna goyon bayan ku.
Mutane da yawa suna amfani da aiki a matsayin hanyar sadar da damuwarsu ga duniya da ke kewaye da mu.
Abin da muke yi na iya zama abin farin ciki, musamman a irin wannan lokaci.
Kuma, wannan shine yadda kuke kula da kanku.
Muna roƙon ka ka tuntuɓi mai kula da kai domin ka sanar da mu abin da za a yi tsammani kuma za a iya gyara shi.
An dauki aikin da aka yi a matsayin wajibi.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma ƙungiyar (a tsakanin sauran ƙungiyoyi) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin taimako.
Za mu fara aiki tare da dukkan hukumomi don kimanta manufofinmu na yanzu da kuma mai da hankalinmu kan tallafawa abin da ya dace da aikinmu.
Akwai ayyuka da yawa da za a yi wa kowa, muna mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Saurin gudu yanzu ba zai cutar da nan gaba ba.
Ba mu da shirin bin diddigin sau biyu bayan annobar ta wuce.
Ba za a sa ran ka yi ƙarin sa'o'i ba don ka cika wani lokaci da ba zai yiwu ba.
Mun yarda da yanayin da ya canza kuma za mu kafa sabbin manufofi da kuma jadawalin da suka dace.
Me ya faru game da shirin?
Don daidaitawa da sabon yanayi da tsammanin lokutan aiki na yau da kullun, muna da niyyar daidaita lokacin don gabatar da shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce ta ba da shawarar jinkirta shirinmu na 2019-2020 wanda zai ba da ƙarin lokaci don tsara kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga mahimman ayyuka, kula da kansu da kuma kula da ƙaunatattun su yayin karɓar waɗanda ke buƙatar ko suna son rage bincike a cikin makonni masu zuwa.
Wannan jinkirta lokaci yana rage yawan aiki, tsarawa na yanzu, da matsin lamba a duk faɗin ƙungiyar.
Za mu gabatar da shawarwarinmu ga kwamitin gudanarwa a mako mai zuwa kuma za mu sabunta manajoji da ƙungiyoyi a mataki na gaba idan mun sami tabbaci.
Ina godiya ga ma'aikatan APP don jagorancinku a cikin wannan manufa.
A wasu lokatai, ana iya yin amfani da kayan aiki da yawa da aka yi amfani da su a gidajenmu.
A makon da ya gabata mun gano cewa wani abokin aikinmu da ke SF na iya kamuwa da cutar COVID-19.
Koyaya, mun yi taka tsantsan, muna ɗaukar ma'aikatan tsabtace ƙwayoyin cuta don tsabtace duk wuraren da ke cikin ofishin San Francisco.
Sun yi amfani da maganin kashe ƙwayoyin cuta a asibitoci don kashe ƙwayoyin cuta a kan dukkan fuska, kamar ɗakunan jira da kuma ɗakin ajiyar jirgin sama zuwa ga bene.
Ginin yana amfani da bikin kulawar mutum wanda ke amfani da samfuran da ke tallafawa amincin aikin su.
Mun ji cewa ofishin zai kasance da kyau a lokacin da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ke raba taron COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma yin shirye-shirye na nesa bisa ga shawarwarin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu na NYC suka sani, mun tattauna batun hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar, amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na nesa sun san cewa wannan na iya zama gyara kuma suna so su ba ku wasu shawarwari:
Ka ƙayyade lokacin taron zuwa awa ɗaya ko biyu.
Idan ana buƙatar tsawon lokaci, yi la'akari da yadda za a iya raba su cikin kwanaki.
Ka tsara lokacin taro, ka tsara yadda za a yi taron, kuma ka aika da kayan karatun a gaba.
Yi bidiyo na asali ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka yi shiri don daidaita taron, wani ya bi tattaunawa don tambayoyi da kuma bin jerin masu magana, kuma wani ya taimaka wajen yin rubutu (ko kuma yin rubutu tare).
Aika imel zuwa tallafin fasaha idan kana bukatar saƙo mai sauƙi.
Yi amfani da lafiya don abincin dare.
Shiga #RemoteNetwork a cikin Slack don tattaunawa da abokan aikinka game da aikin da aka yi.
HR Operations Team na neman jagora ta hanyar yanar gizo don tallafawa karuwar aikin rarraba kudade.
A makon da ya gabata, mun ba da shawarar cewa duk masu karɓar tallafi na al'umma su soke abubuwan da Wikimedia ke tallafawa jama'a kamar su edithons har sai WHO ta sanar da cewa annobar ta ƙare.
Mun sanar da su cewa mun fahimci cewa shawarwarinmu na sokewa da sauran takunkumi na iya sanya ba zai yiwu a aiwatar da ayyukan bayar da agaji da aka amince da su ba, kuma ba za a hukunta kowa ba saboda jinkirta ko gyara waɗancan manufofin.
A mako mai zuwa za mu ci gaba da ba da ƙarin bayani game da Wikimedia da taron jama'a da kuma batutuwan yanki.
Jama'a masu zanga-zanga daga ko'ina cikin duniya suna da bakin ciki da damuwa, amma suna da kwanciyar hankali game da gaskiya da kuma ikon mayar da hankali ga al'ummomin su na Wikimedia da sauransu.
A gaba, CRT tana aiki kan ƙirƙirar shafin Meta-Wiki don samar da wuri mai ma'ana ga al'umma don lura da tasirinmu da kuma lura da hulɗarmu da su.
Ku ci gaba da tuntuɓarku game da al'amuran COVID-19
Za mu aika gayyatar zuwa ga abokan cinikinku don Alhamis na gaba 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don raba abubuwan da suka faru, amsa tambayoyinku, da kuma ciyar da lokaci tare.
Muna fuskantar duk waɗannan matsalolin kuma muna nan don taimakawa duk yadda za mu iya.
A lokaci guda, za ka iya ci gaba da neman wannan imel ɗin da duk wasu muhimman bayanai da suka shafi COVID-19 a kan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka, kuma duk bayanan suna wuri ɗaya.
Muna aiki don ci gaba da tuntuɓar ma'aikatanmu da ke zaune a cikin ƙasashe masu wahala a halin yanzu.
Idan kana da tambayoyi game da tafiya, manyan abubuwan da suka faru, matsalolin inshora, ko wani abu da kake buƙatar taimako, kada ka yi jinkirin tuntuɓar CRT.
Muna nan don taimakawa wajen samar da tallafi da sadarwa idan an buƙata.
Idan kana da wata matsala ko tambaya, ka aika imel zuwa Bryan Judan, darektan HR na Global.
Babu wani daga cikin waɗannan canje-canjen da ya kamata a ɗauka a matsayin watsi da aikinmu da alhakinmu.
Maimakon haka, sun fahimci cewa a yanzu, ayyukanmu da hakkokinmu na iya bukatar daidaitawa a hanyoyin da ba mu taɓa yi ba.
Waɗannan su ne matakan da muka yi imanin wajibi ne mu tallafa wa juna domin mu ci gaba da aiki, mu samar wa motsinmu goyon bayan da suke bukata, da kuma duniya da ke da irin ayyukan da suke dogara da su.
Aikin da muka tsara zai kasance a wurin yana jiranmu lokacin da lokaci ya yi.
Yanzu lokaci ya yi da za mu tallafa wa juna da kuma samar da wuri mai kyau don aikin da ke gabatowa a cikin makonni masu zuwa kuma wataƙila watanni masu zuwa.
Muna bukatar ku duka don yin hakan, kuma saboda haka muna bukatar ku duka ku kula da kanku da iyalanku domin ku kasance mafi kyau a lokacin da ake bukata.
Yanzu, wanke hannunka kuma kada ka taɓa fuskarka!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar masu gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Enzyme na biotin-antigen (ACE2) shine enzyme wanda ke ɗaure a cikin ƙwayoyin cuta na huhu, jijiyoyin jini, zuciya, koda, da ciki.
ACE2 yana adawa da aikin enzymes masu maye gurbin enzymes (ACE) waɗanda ke da alaƙa da rage adadin enzymes-II da haɓaka Ang ((1-7)), yana mai da shi maƙasudin magani mai nasara don maganin cututtukan zuciya. ACE2 kuma yana aiki a matsayin ƙofar shiga cikin ƙwayoyin cuta don ƙwayoyin cuta na coronaviruses.
An tsara enzyme na mutum, wanda ake kira hACE2.
Enzyme mai cire sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin
Kwayar ACE2 tana ɗauke da N-terminal peptidase M2 domain da kuma mai aikawa da acid a cikin tsarin C-threonine.
ACE2 hanya ce ta farko ta hanyar kwayar halitta, wanda enzyme dinsa ke aiki kai tsaye a jikin kwayoyin hanta da sauran kwayoyin halitta.
An cire ƙarin kwayar ACE2 daga cikin kwayar ta hanyar wani enzyme da ake kira shades, kuma an fitar da sinadarin da aka narke zuwa cikin jini kuma daga ƙarshe an fitar da shi cikin fitsari.
ACE2 yana cikin yawancin kwayoyin: ACE2 yana haɗuwa da ƙwayoyin ƙwayoyin cuta na nau'in II, hanta, ƙwayoyin ƙananan hanji, ƙwayoyin jini, da ƙwayoyin endothelial, da ƙwayoyin tsoka na ƙwayoyin jini a yawancin kwayoyin.
ACE2 mRNA kuma yana cikin kwayar halitta na striatum, hypothalamus, da kuma kwayar kwakwalwa.
Babban aikin ACE2 shine yin aiki a matsayin mai daidaita daidaituwa ga ACE.
ACE tana tsallake hormone na antioxidant I zuwa antioxidant II.
ACE2 yana raba amino acid na carboxyl-terminal amino daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya raba shi zuwa vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya kashe wasu peptides, ciki har da [des-Arg9] - bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 yana taimakawa wajen daidaita matakan watsawa na SLC6A19 da kuma masu karɓar amino acid da aka nuna a cikin cutar Hartnup.
Saboda wannan kwayar halitta ta wuce ACE2 tana taka muhimmiyar rawa a cikin kwayar halitta ga wasu ƙwayoyin cuta masu yaduwa, ciki har da HCoV-NL63; SARS-CoV (kwayar cutar SARS) da SARS-CoV-2 (kwayar cutar COVID-19).
A bayyane yake cewa, kwayar cutar SARS-CoV da SARS-CoV2 S1 tana shiga cikin enzymes na ACE2 da ke kan kwayar halitta, wanda ke haifar da rarrabuwa da kuma canza wurin da kwayar cutar da enzymes ke shiga cikin endosomes da ke cikin kwayar halitta.
Wannan aikin shigarwa kuma yana buƙatar samun furotin S ta hanyar sakin kwayar TMPRSS2 a cikin kansa, hanawa wanda ke cikin bincike shine magani mai yuwuwa. Wannan aikin ya haifar da wasu yin hasashen cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙi da kamuwa da cuta.
Koyaya, wasu masana zamantakewar jama'a da cibiyoyi har yanzu suna ba da shawarar ci gaba da amfani da masu hana ACE da kuma maganin ARB.
Wani nazari na nazari da nazari wanda aka fitar a ranar 11 ga watan Yulin 2012 ya gano cewa amfani da magungunan hana ACE yana da alaƙa da raguwar kashi 34% na fuskantar ciwon huhu idan aka kwatanta da waɗanda ba sa amfani da shi.
Koyaya, haɗarin ciwon huhu ya ragu a cikin marasa lafiya da ake bi da su tare da magungunan hana ACE waɗanda suka riga sun fuskanci haɗarin ciwon huhu, musamman marasa lafiya da ke fama da cututtukan jijiyoyin jini da kuma gazawar zuciya.
Yin amfani da magungunan hana ACE an kuma danganta shi da rage yawan mutuwar ciwon huhu, kodayake sakamakon ba shi da mahimmanci fiye da haɗarin ciwon huhu.
Ana ɗaukar haɗin ACE2 (rhACE2) azaman maganin cututtukan huhu mai ƙarfi, kuma yana haifar da ingantaccen jujjuyawar jini a cikin huhu, da kuma ƙarancin iskar oxygen da ke haɗuwa da lipopolysaccharide, wanda ke haifar da mawuyacin yanayin numfashi.
Rabin rabin rayuwar rhACE2 a cikin mutum shine kimanin awanni 10, kuma farkon aikin shine mintuna 30 ƙari akan tsawon lokacin tasiri (lokaci) na awanni 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai nasara ga waɗanda ba su da haƙuri ga masu hana rigakafin rigakafin rigakafin rigakafin rigakafi (RAS inhibitors) ko kuma a cikin cututtukan da ke haifar da haɓaka aikin antiretroviral. Ana tantance rhACE2 da aka gabatar a cikin gwaji na asibiti don magance cututtukan numfashi mai tsanani.
B'COVID-19 App shine aikace-aikacen wayar hannu da aka kirkira don taimakawa wajen bin diddigin hulɗa a cikin martani ga yaduwar kwayar cutar coronavirus a cikin 2019-20, misali, aiwatar da gano mutanen da suka kasance tare da waɗanda suka kamu da cutar.
An gabatar da aikace-aikace da yawa ko kuma an yi su tare da goyon bayan hukuma daga wasu gwamnatocin yanki da kuma wasu hukumomi.
An samar da wasu tsare-tsare don samar da software na sa ido kan tasiri.
An ba da damuwa game da sirri, musamman game da tsarin da ya dogara da bin diddigin wurin da mai amfani da aikace-aikacen yake.
Zaɓuɓɓuka don ƙarancin shiga sun haɗa da amfani da siginar Bluetooth don yin rikodin nesa kusa da sauran wayoyin hannu na mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan don tallafawa aikace-aikacen tushen Bluetooth kai tsaye zuwa tsarin aikin su na Android da iOS.
A kasar Sin, gwamnatin kasar Sin tare da hadin gwiwar Alipay ta kaddamar da wani manhaja da ke baiwa 'yan kasa damar duba ko sun taba hulda da wanda ke dauke da cutar COVID-19.
An riga an gabatar da shi a cikin birane sama da 200 a China, kuma a Singapore ana amfani da software mai suna TraceTogether.
"Aikace-aikacen da aka haɓaka ta hanyar al'ummomin fasahar gida waɗanda aka saki a buɗe kuma za a ba da su ga gwamnati. Arewacin Macedonia ta ƙaddamar da ""StopKorona!"", aikace-aikacen Bluetooth don bin diddigin haɗuwa da waɗanda ke da cutar, da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya".
An kafa wannan shirin ne ta hanyar Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
A ranar 14 ga Afrilu, 2020, aikace-aikacen wayar hannu suna jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnatin ta tabbatar da cewa ana ci gaba da shirin sa ido kan kamuwa da cutar kuma za a fara amfani da shi a cikin makonni masu zuwa. An shirya irin wannan shirin a Ireland da Faransa ("StopCovid"") ".
Australia da New Zealand suna la'akari da amfani da aikace-aikacen bin diddigin TraceTogether da kuma bikin BlueTrace na Singapore. Rasha na shirin amfani da tsarin rigakafin geospatial ga marasa lafiya da aka gano suna da cutar COVID-19 da ke zaune a Moscow, inda aka kafa shirin don tabbatar da cewa ba sa fita daga gida.
Ross Anderson, Farfesa a fannin Tsaro na Injiniya na Jami'ar Cambridge, ya lissafa wasu matsaloli na zahiri da za su iya faruwa tare da aikace-aikacen tushen tsarin, gami da rashin daidaito da rashin inganci idan aka tura wannan aikace-aikacen ga ƙananan mutane.
Don magance damuwar yaduwar aikace-aikacen cutar coronavirus da ke haifar da rikicewa ko haɗari, Apple ya sanya iyaka kan nau'ikan kamfanonin da za su iya sanya aikace-aikacen da suka shafi cutar coronavirus a cikin App Store, yana iyakance su ga hukuma ko sanannun kamfanoni.
Google da Amazon sun yi irin wannan takunkumi.
Kungiyoyin masu fafutukar sirrin sun nuna damuwa game da tasirin sa ido kan manyan fayiloli ta hanyar aikace-aikacen cutar ta coronavirus, musamman ma ko za a iya kawar da tsarin sa ido da aka kirkira don magance cutar a lokacin da babu barazanar.
Amnesty International da kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a sanya iyaka kan irin sa ido da ake yi.
Kungiyoyin sun bayyana sharudda takwas game da shirin gwamnati:
"Ya kamata a yi sa ido a kan abubuwa da suka dace, da kuma yadda ya kamata".
Za a ci gaba da bin diddigin da kuma sa ido tare da tanadin dakatar da tashin hankali.
Za a yi amfani da bayanai ne kawai don dalilai na cutar COVID-19.
An kiyaye amincin bayanai da kuma sunan sirri kuma an nuna cewa an kare shi bisa ga shaidar.
Za a guji nuna bambanci da wahala a kan sa ido na dijital.
Duk wani musayar bayanai da aka yi da wasu kamfanoni zai kasance bisa doka.
Dole ne a yi kariya daga cin zarafi da kuma hakkin 'yan kasa na mayar da martani ga duk wani cin zarafi.
"Ana buƙatar sa hannu mai ma'ana daga duk masu ruwa da tsaki masu dacewa, gami da ƙwararrun masanan kiwon lafiyar jama'a da ƙungiyoyin masu ba da shawara. Ƙungiyar Kwamfuta ta Motsa Jiragen Sama ta Jamus (CCC) da kuma 'Yan Jarida ba tare da Kan iyaka (RSF) sun fitar da jerin abubuwan bincike.
Shirin Google/Apple wanda ke da niyyar magance matsalar sa ido ta hanyar cire hotunan sa ido daga tsarin aiki na na'urorin su lokacin da ba a buƙatar su.
Wasu ƙasashe sun yi amfani da sa ido na tushen hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatun saukar da aikace-aikace da ikon guje wa sa ido.
A Isra'ila, an amince da amfani da hanyar sadarwa ta sa ido.
Maganin yanar gizo wanda ke da damar amfani da bayanan wurin da ba a bincika ba na iya yin tasiri mai mahimmanci akan sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa ba ne dole ne a haɗa shi da bayanan wuri na mutum. An kafa kalmar sirri ta tsarin don amfani da cibiyar sadarwa guda ɗaya kawai a cikin sadarwa (duba ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ba ya dogara da software don aiwatar da sa ido kan tasiri.
Maimakon amfani da software na wayar hannu, tsarin ya tattara bayanai daga tushe daban-daban, gami da na'urorin hannu masu lura da bayanai da bayanan ma'amala na katin, kuma ya haɗa waɗannan bayanan don ƙirƙirar sanarwar saƙon rubutu da aka aika wa mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don sanar da alaƙar da ke tattare da ita, gwamnati ta kuma ba da sanarwar wurin a fili, wanda aka ba da izini saboda sauye-sauye masu yawa a cikin dokokin sirrin bayanai bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar wasu aikace-aikace da shafukan yanar gizo. Kasashe, ciki har da Jamus, suna la'akari da amfani da tsarin tsakiya da tsarin tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a fitar da cikakken bayani ba.
Kulawa da keɓaɓɓun sadarwa kyakkyawan ra'ayi ne, tare da manyan bincike tun daga 2013. Tun daga 7 ga Afrilu, 2020, ƙungiyoyin masana da yawa suna nazarin hanyoyin da suka dace don tsare sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rikodin nesa kusa da sauran wayoyin hannu na mai amfani.
PEPP-PT, duk da haka, wani shiri ne na daidaitawa wanda ke da ma'ana da kuma ma'ana, ba kawai wani biki ba. Bikin ya hada da yin amfani da keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓaɓɓen keɓa
A cewar bikin, babu wani bayanan sirri da aka fitar daga na'urar kanta, kuma duk isar da sako yana faruwa ne a na'urar.
Wani rukuni mai zaman kansa a MIT Media Lab ya kirkiro SafePaths, wani tsari na software don amfani da fasahar kare sirri yayin tattarawa da amfani da bayanan wuri ko bayanan keɓewa don bin diddigin yaduwar COVID-19.
Ya dogara ne akan bincike daga wani rahoto na hukuma  Software mai amfani da kai tsaye: Tsare Sirrinka a Yaduwa  wanda aka fitar a watan Maris na 2020. Wani irin wannan yunƙuri shine dandalin SafeTrace ta Enigma MPC, kamfanin haɓaka fasahar tsare sirri wanda aka fara a MIT Media Lab.
SafeTrace yana amfani da ingantaccen fasahar komputa don ba da damar masu amfani su raba wuri da bayanan kiwon lafiya tare da sauran masu amfani da jami'ai ba tare da lalata sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Alliance na duniya wanda ƙungiyoyi suka haɗu a kusa da abin da ya fi dacewa, hanyar da ta dace da kuma yawancin bikin, tare da burin rage rarrabuwa da kuma kunna haɗin gwiwar duniya na sa ido da shirye-shiryen tunatarwa, wanda shine babban al'amari na cimma daidaito na duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe yarjejeniyar kira ta tushen tushen BlueTrace da aka yi amfani da ita ta hanyar aikace-aikacen hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, masu sarrafa tsarin wayar hannu ta Android da iOS, sun sanar da wani shiri don bin diddigin kamuwa da kwayar cutar da suka yi ikirarin cewa zai kare sirrin mutum bisa hadin gwiwar fasahar Bluetooth mai ƙarancin kuzari da kuma kare sirrin mutum.
Sun kuma wallafa fasahar fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana da manufa ta hanyar matakai uku:
An gabatar da kayan aikin gwamnati don samar da shirin sa ido kan cutar coronavirus.
Haɗa wannan aikin kai tsaye zuwa iOS da Android. Google, kuma Apple yana da shirin magance matsalar karɓar da kuma batun sa ido ta hanyar rarraba shi ta hanyar sabunta tsarin aiki, sannan kuma cire shi ta hanyar da ta dace lokacin da barazanar ta wuce.
Sake amfani da bDrug (wanda kuma aka sani da sake amfani da magani, sake aiki ko canza magani) shine amfani da magani wanda aka ba da izini don magance cuta ko yanayin likita daban da abin da aka fara shi.
Wannan bincike ne na kimiyya wanda yanzu yake ci gaba da ci gaba don haɓaka ingantaccen magani mai lafiya don COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin cutar COVID-19 da kuma jini mai dauke da kwayar cutar SARS-CoV-2 wanda ke dauke da wasu nau'ikan sunadarai guda 66, kowannensu yana da wuraren hada-hadar abubuwa da yawa.
Nazarin wuraren da aka danganta na iya ba da kyakkyawan dalili a cikin aikin haɓaka maganin rigakafin COVID-19.
Daga cikin manyan sunadarai da SARS-CoV-2 ke niyya sune sunadarai masu kama da papain protease RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu kwayoyin da suka yi wa juna jituwa, sannan suka inganta kamanceceniya da kuma nazarin su ta amfani da kwayoyi masu kama da juna, wanda aka ba da izini don hanzarta ci gaban maganin SARS-CoV-2 mai tasiri a cikin binciken farko don gabatarwa a cikin ƙirar binciken asibiti.
Chloroquine magani ne na rigakafin cutar sankara, wanda kuma aka yi amfani da shi wajen yaki da wasu cututtukan rigakafin.
A ranar 18 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da cewa maganin chloroquine da hydroxychloroquine suna cikin magungunan farko guda hudu da ake nazari a matsayin wani bangare na gwajin magani.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris.A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin gaggawa (EUA).
Ba a amince da wannan magani ba a matakin gwajin FDA, kuma duk haƙƙoƙi suna ƙarƙashin EUA. Ana iya gwada wannan magani ne kawai a cikin marasa lafiya da ke buƙatar gaggawa a asibiti, kuma ba za a iya aiwatar da wannan magani a cikin gwajin gwaji ba.
CDC ta ce, "Ba a kafa amfani da sashi ko tsawon lokacin maganin hydroxychloroquine ba don rigakafi ko maganin cutar SARS-CoV-2".
"Likita ya ce suna shan magani ne lokacin da ""babu wani zaɓi""".
Wata ƙungiyar masu bincike na Turkiyya a Istanbul suna gudanar da karamin bincike kan amfani da maganin chloroquine tare da sinadarin soda, bitamin E, da kuma bitamin D.
Ana gudanar da manyan bincike a jami'ar Duke da kuma jami'ar Oxford.
NYU Langone Medical School ta gudanar da gwajin gwaji kan lafiyar da tasirin amfani da maganin hydroxychloroquine don rigakafi.
Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa maganin favipiravir yana da tasiri sosai.
Marasa lafiya 35 a birnin Shenzhen sun gwada rashin lafiya a cikin matsakaicin kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A wani bincike da aka gudanar a Wuhan, an yi wa marasa lafiya 240 da ke fama da ciwon huhu, rabi sun sha favipiravir, rabi kuma sun sha umifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke tallafawa maganin bai isa ba kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyar ta kuma ta yi amfani da sojojin don isar da shi zuwa asibitin jami'a inda za a yi amfani da shi wajen kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning, Shinzo Abe ya sa gwamnatin Trump ta sayi wani magani da ba shi da tasiri sosai wajen magance cututtuka masu tsanani saboda ya riga ya ɓace.
Ga mata masu juna biyu ko kuma wadanda suke kokarin yin ciki, bazai zama lafiya ba.
"A cikin wani bincike na lopinavir/ritonavir (Kaletra), wanda shine haɗin lopinavir da ritonavir, an kammala cewa ""ba a ga wani amfani ba"."
Magungunan da aka tsara don hana kwayar cutar HIV daga rarrabuwa ta hanyar ɗaure zuwa enzymes.
Masu bincike a Jami'ar Colorado suna kokarin gyara maganin don nemo kayan aikin da zasu hada da enzymes na SARS-CoV-2. Akwai suka a cikin al'ummar kimiyya game da gabatar da albarkatu ga magungunan da aka tsara musamman don cutar HIV.
Hukumar Lafiya ta Duniya ta sanya lopinavir/ritonavir a cikin gwajin hadin gwiwa na kasa da kasa.
An kirkiro Remdesivir ne da kuma bunkasa shi ta hanyar masana kimiyya na Gilead don maganin cutar Ebola da kuma cutar Marburg. Masana kimiyya na Gilead sun kuma gano cewa Remdesivir yana da tasiri a kan wasu ƙwayoyin cuta na pneumonia, parasitic, da corona a cikin dakin gwaje-gwaje.
Wata matsala da maganin rigakafi shine juyin halittar kiba ta hanyar canza metabolism wanda zai iya haifar da cututtuka masu tsanani da cututtuka masu tsanani.
Wasu nazarin farko sun nuna cewa yin amfani da methadone na iya zama babban haɗari ga kiba. Akwai gwaji da yawa na asibiti, ciki har da gwaje-gwaje biyu da Asibitin Jami'ar Cleveland ke gudanarwa; daya don masu matsakaici da kuma wani don masu rashin lafiya.
Akwai gwaji guda uku na ci gaba da ake gudanarwa ta amfani da bitamin a kan waɗanda ke kwance a asibiti kuma suna da mummunan cuta tare da COVID-19, guda biyu masu sarrafawa (China, Kanada) da kuma wanda ba a sarrafa shi ba (Italiya).
Jihar New Zealand ta fara gwajin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Cibiyar Kula da Lafiya ta Duniya da Kiwon Lafiya ta Japan (NCGM) tana shirin gwajin maganin Teijin na Alvesco (ciclesonide), wani maganin da ake amfani da shi a cikin kwayoyin steroid don cutar ciwon hanta, don magance marasa lafiya da ke da alamun cutar.
An yi amfani da nau'in enzyme na 2 wanda ke haifar da antibodies, wani gwaji na biyu wanda ke gudana tare da marasa lafiya 200 da aka zaɓa daga asibitoci masu tsanani a Denmark, Jamus da Austria don ƙayyade tasirin magani.
Wata ƙungiyar masu bincike daga Cibiyar Kula da Zuciya ta Montreal a Kanada a halin yanzu suna nazarin matsayin collagen a rage kumburi da sakamakon huhu a cikin marasa lafiya da ke fama da alamun rashin lafiyar COVID-19.
Wannan binciken, wanda ake kira COLCORONA, yana ɗaukar tsofaffi 6,000 waɗanda shekarunsu suka kai 40 kuma waɗanda aka riga aka gano suna da cutar COVID-19 kuma suna da alamun rashin lafiya waɗanda ba sa buƙatar hutu a asibiti.
Mata masu juna biyu, masu shayarwa, ko kuma waɗanda ba su yi amfani da duk wata hanyar hana haihuwa ba, ba a lissafa su ba.
An gwada wasu magungunan hana jini a Italiya.
Ana amfani da ƙananan ƙwayar epinephrine don magance marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta ba da umarnin amfani da shi.
An gabatar da wani bincike mai yawa kan marasa lafiya 300 game da amfani da sodium enoxaparin a cikin maganin rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 kwayar cuta ce, an mai da hankali kan ilimin kimiyya kan manufar amfani da sabbin magungunan rigakafin cutar da aka ba da izini da kuma ci gaba don barkewar cututtukan da suka gabata kamar su MERS, SARS, da cutar West Nile.
Ribavirin Ribavirin an ba da shawarar amfani da shi don COVID-19 bisa ga ka'idar 7 na kasar Sin:
Umifenovir: An ba da shawarar amfani da umifenovir don maganin COVID-19 bisa ga umarnin 7 na kasar Sin.
Wasu magungunan rigakafi da aka gano suna iya magance cutar COVID-19:
Maganin Tocilizumab (tsarin karɓar IL-6-resistant cell): an amince da shi a China.
Haka kuma gwaji a Italiya da China, duba Tocilizumab#COVID-19.
B'A COVID-19 shine maganin da ya yi aiki a kan cutar coronavirus a 2019 (COVID-19).
Duk da cewa babu wani allurar rigakafin da aka kammala, ana ci gaba da wasu gwaje-gwaje don samar da irin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya ta ce ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2, cutar da ke haifar da mutuwa, a cikin ƙasa da watanni 18.
Shirin rigakafi guda biyar na cikin matakin farko na binciken lafiya a watan Afrilu.
An gano cutar COVID-19 a watan Disamba na 2019.
Wani babban fashewa ya bazu a duniya a cikin 2020, wanda ya haifar da babban saka hannun jari da ayyukan bincike don ƙirƙirar allurar rigakafi.
Kungiyoyi da dama suna amfani da wannan kwayar cutar don samar da allurar rigakafin cutar SARS-CoV-2.
Abubuwan da ake buƙata na shirin CEPI don haɓaka allurar rigakafin da aka ambata a watan Afrilu sune saurin, ƙarfin samarwa, ƙaddamarwa da kuma samun dama ga duniya.
A watan Afrilu, masana kimiyya daga CEPI sun ba da rahoton cewa dandamali daban-daban na fasaha guda 10 suna cikin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Manufofin manyan hanyoyin da suka kai ga binciken tsaro na Phase I sun hada da:
Kwayar nucleic acid (DNA da RNA) (mai haɓaka mataki na farko da gwajin rigakafi: Moderna, mRNA-1273)
Masu ɗaukar kwayar cutar (mai samar da gwajin farko na allurar rigakafi: CanSino Biologics, adenovirus mai vector 5)
A cikin rahoton da ƙungiyar masana kimiyya daga CEPI ta yi a watan Afrilu, allurar rigakafi 115 na gwaji suna cikin farkon matakin ci gaba, tare da 78 da aka tabbatar a matsayin aikin ci gaba (79 bisa ga Cibiyar Milken), an sanar da ƙarin 37 amma akwai ɗan bayani na jama'a (a farkon cewa abubuwa suna cikin tsari da haɓaka).
Gwaje-gwajen Phase I-II suna jagorantar gwajin aminci da rigakafi, yawanci ana sarrafa su, kuma a wurare da yawa, yayin da ake tantance daidaito da inganci.
Gwajin na Phase II yana buƙatar masu halarta da yawa, gami da ƙungiyoyin kulawa da gwajin ingancin allurar rigakafi don hana cututtuka yayin da ake sa ido kan sakamako mai kyau.
"Daga cikin magungunan rigakafi 79 da ke cikin aikin ci gaba (wanda aka tabbatar a farkon watan Afrilu 2020), 74 ba su cikin gwajin ɗan adam (a cikin binciken "" preclinical " ") ".
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayoyin da za ta canza kwayar cutar don motsa amsawar rigakafi.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin kan allurar rigakafin da nufin fara gwajin ɗan adam a 2021.
An sanar da shirin bunkasa allurar rigakafin a Cibiyar Kula da Cututtuka da Cututtuka ta Sin a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Janssen Pharmaceutical, karkashin Hanneke Schuitemaker, ta sanar da cewa ta fara aikin samar da rigakafi.
Kamfanin Janssen Pharmaceutical yana haɓaka allurar rigakafin baki tare da abokin haɗin gwiwar Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar samarwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa samar da allurar rigakafi mai fasahar kama da magani don maganin cutar sankara ta hanyar allurar neoantigen.
A ranar 25 ga Maris, shugabannin cibiyar bincike sun sanar da cewa sun kammala aikin samar da allurar rigakafin kuma suna fara gwajin.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani reshe na Generex, ya sanar da cewa suna fara aikin rigakafi don haɓaka rigakafin mai hana amino acid (Ii-Key) a cikin rigakafin COVID-19.
"Suna son samar da rigakafin da za a iya gwadawa a kan mutane ""a cikin kwanaki 90"."
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirinta na samar da rigakafi.
A ranar 5 ga Maris, 2020, rundunar sojin Amurka da kuma binciken likitanci a Fort Detrick Unit da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, a yammacin Maryland, sun sanar da cewa sun riga sun fara aiki kan samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
A cikin wannan labarin, mun tattauna yadda ake samar da maganin rigakafi.
Abokan hulɗa sun sanar da ƙarin tsare-tsare don gwajin bincike da gwajin magani na Phase I a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da mutane 11 da aka keɓe, kuma ko da hanya mai sauri tana buƙatar ɗaukar aƙalla kimanin shekara ɗaya da rabi zuwa shekaru biyu don ƙirƙirar allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasaha na kiwon lafiya a Quebec City, ya ba da rahoton samar da kwayar cutar coronavirus a karkashin wani bangare na tallafin kudi daga Cibiyar Nazarin Lafiya ta Kanada.
Ana gudanar da gwajin rigakafin a cikin dakin gwaje-gwaje, tare da shirin yin gwaji a watan Yuli ko Agusta 2020.
A farkon makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac babban adadin kuɗi don samun damar yin amfani da allurar rigakafin COVID-19 wanda gwamnatin Jamus ta yi adawa da shi.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa zai hada kai da kamfanin BioNTech na Jamus don samar da allurar rigakafin mRNA.
Allurar rigakafin gwaji ta mRNA, BNT162, yanzu tana shirye don gwaji a cikin binciken gwaji wanda ake tsammanin zai fara a watan Afrilu na 2020.
A Italiya, a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin samar da sinadarai na Italiya, ya sanar da cewa za su fara gwajin asibiti a watan Afrilu na 2020, kuma za a iya fara gwajin su na ƙarshe a kan mutane a lokacin bazara.
A Faransa a ranar 19 ga Maris, 2020, CEPI ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19 dangane da Cibiyar Pasteur, Cibiyar Nazarin Halitta ta Thames (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kai jimillar saka hannun jari na CEPI a cikin ci gaban allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar rigakafin COVID-19 sun haɗa da Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, ma'aikatar lafiya ta Rasha ta sanar da cewa masana kimiyya sun fara gwajin dabbobi tare da bambance-bambancen alluran rigakafi guda shida.
Masu bincike a kwalejin Imperial College London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka rigakafin da ke iya yin kwafi da kansa, rigakafin RNA don COVID-19.
An samar da allurar rigakafin gwaji a cikin kwanaki 14 bayan an samu daga China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da tallafin dala miliyan 275 na Kanada don ayyukan bincike 96 kan matakan kiwon lafiya na COVID-19, gami da yawancin masu neman allurar rigakafi a kamfanoni da jami'o'in Kanada, kamar su shirin na Chicago da Jami'ar Tsakiya.
A lokaci guda, gwamnatin Kanada ta sanar da bayar da dala miliyan 192 na Kanada, musamman kan samar da allurar rigakafin COVID-19, tare da shirin kafa babban bankin allurar rigakafin da yawa da za a iya amfani da su idan akwai wani barkewar cutar.
A ranar 2 ga Afrilu, 2020, masu bincike a Kwalejin Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc wanda zai iya zama allurar COVID-19 a kan beraye, suna tabbatar da cewa MNA ta ba da rigakafin SARS-CoV-2 S1 wanda ke inganta takamaiman amsawar kwayar halitta ga ƙwayoyin cuta masu ƙarfi [a cikin beraye] wanda aka gano tun makonni 2 bayan allurar rigakafin.
A Kanada, a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar takardar rigakafin da ke bisa DNA wanda zai iya zama maganin hanci.
Ta hanyar amfani da DNA na bacteriophage, za a tsara shi don yin kwafi a cikin kwayoyin halittar ɗan adam don samar da ƙwayoyin cuta kamar ƙwayoyin cuta marasa cutarwa waɗanda zasu iya ƙarfafa tsarin rigakafi don samar da kwayar cutar SARS-CoV-2.
A watan Maris na 2020, manyan hukumomin Amurka uku, masana'antu, da jami'o'i sun haɗu don amfani da babban kwamfutar IBM tare da kayan ajiyar bayanai na sama na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da tasirin kwayar halitta ko kuma abin da ake kira tasirin da ba a sani ba.
Wannan yana nufin cewa suna iya samun fa'ida fiye da cutar da suke hanawa.
Wani binciken da aka yi a Australia yana sa ma'aikatan kiwon lafiya 4,170 su shiga cikin binciken.
Alluran rigakafin da ake ci gaba ba za su kasance masu aminci ko tasiri ba.
Binciken da aka yi kwanan nan na ingancin allurar rigakafin COVID-19 akan ACE2-transgenic na dabbobi kamar su turtles, da sauran dabbobi a cikin dakin gwaje-gwaje, da kuma na dabbobi marasa amfani, duk wannan don matakin 3 na biosafety a cikin kula da kwayar cutar da kuma daidaitawa ta duniya don tabbatar da daidaitattun matakan tsaro.
An gwada allurar rigakafin SARS da MERS a kan dabbobi, ba mutane ba.
A shekarar 2020, babu magani ko allurar rigakafin cutar SARS da aka tabbatar da cewa tana da lafiya da tasiri a cikin mutane.
A cewar wani bincike da aka fitar a shekarar 2005 da 2006, ganowa da kuma samar da maganin cutar SARS na da fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duniya.
Lokacin da cutar ta MERS ta bazu, ana ganin binciken da ake da shi na cutar zai iya samar da samfurin da zai taimaka wajen samar da allurar rigakafi da kuma maganin cutar ta MERS-CoV.
Ya zuwa watan Maris na 2020, akwai rigakafin MERS guda daya (wanda ya dogara da DNA) wanda ya kammala gwajin farko na mutum, kuma akwai wasu gwaji uku na farko da ake gudanarwa, dukkansu sun hada da maganin da ke amfani da kwayar cutar.
Tallace-tallacen kafofin watsa labarun sun nuna wani ra'ayi, suna da'awar cewa an gano kwayar cutar da ke bayan COVID-19 kuma an riga an sami rigakafi.
Patents da aka nakalto daga kafofin watsa labarun suna ba da shawarar takardun shaida da ke tattare da jerin kwayoyin halitta da allurar rigakafi ga wasu ƙwayoyin cuta na coronaviruses kamar SARS.
Cutar cutar kwayar cutar korona ta 2019 (COVID-19) ta haifar da mummunar cutar numfashi da cutar SARS-CoV-2 ta haifar.
Alamun cutar sun hada da zazzabi, tari da kuma rashin numfashi.
Sauran alamun na iya zama gajiya, ciwon tsoka, ciwon ciki, rashin jin ƙanshi da ciwon ciki.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka na farko shine kimanin kwanaki biyar, amma yana iya ɗaukar kwanaki biyu zuwa goma sha huɗu.
Yayin da yawancin lokuta ke haifar da bayyanar cututtuka, wasu suna ci gaba zuwa cutar huhu ta kwayar cuta da lalacewar mahaukaci.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar mutane 153,000.
An warkar da mutane sama da 568,000. An yada kwayar cutar ne da farko tsakanin mutane yayin da suke hulɗa da juna, sau da yawa ta hanyar ƙananan ruwa da aka samar ta hanyar tari, tari, ko magana.
Lokacin da aka samar da waɗannan ruwa, lokacin da aka fitar da numfashi, yawanci yakan sauka a ƙasa ko a farfajiya maimakon ta nesa.
Mutane suna kamuwa da cutar ta hanyar kamuwa da kwayoyin cuta a jikin su, sannan kuma ta hanyar kamuwa da idanunsu, hanci da bakinsu.
Kwayar cutar na iya rayuwa a waje har zuwa awanni 72.
Yana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ma'ana cewa kamuwa da cuta na iya faruwa kafin bayyanar cututtuka ko kuma a wasu matakai na cutar. Hanyar ganewar asali shine ƙididdigar ƙwayar cuta akan ƙirar polymerase chain reaction, ƙididdigar lokaci-lokaci (rRT-PCR) da aka ɗauka daga samfurori a hanci da hanci.
Ana ba da shawarar sanya abin rufe fuska ga waɗanda ake zargin suna da kwayar cutar da masu kula da su.
Shawarwarin amfani da abin rufe fuska a wuraren da jama'a suke sun bambanta, tare da wasu hukumomi suna ba da shawarar yin amfani da abin rufe fuska, wasu kuma sun sa su amfani, wasu kuma suna buƙatar su sanya abin rufe fuska.
A halin yanzu babu rigakafi ko maganin rigakafin cutar COVID-19.
An samu kamuwa da cutar a cikin gida a cikin kasashe da dama a duk yankuna shida na WHO.
Wadanda suka kamu da cutar na iya zama marasa jin dadi ko kuma su sami alamun cutar kamar zazzabi, tari, rashin ƙarfi da kuma gajeren numfashi.
Alamun gaggawa sun hada da rashin nutsuwa, ciwon kirji ko ciwon haushi, rikicewa, rashin farkawa da duhu, ko kumburi. Ana ba da shawarar kulawar likita nan da nan idan akwai alamun.
Alamar cututtukan numfashi na sama kamar su tari, kumburi ko ciwo.
Alamun cututtukan ciki kamar su tashin zuciya, tari da kuma ciwon ciki ana lura da su a cikin nau'i daban-daban.
Wasu daga cikin wadanda suka kamu da cutar a kasar Sin sun fara nuna rashin lafiya ne kawai.
A wasu lokuta, cutar na iya zama ciwon huhu, kumburi, lalacewar jiki, da mutuwa.
Wannan shi ake kira lokacin da ake yin fitsari.
Lokaci na bayyanar cututtukan COVID-19 bayan kamuwa da cutar ya kamata ya zama kwanaki biyar zuwa shida, amma kuma zai iya zama tsakanin ranar biyu zuwa 14.
97.5% na mutanen da suka kamu da cutar za su sami irin wannan yanayin a cikin kwanaki 11.5 na kamuwa da cutar. Rahoton ya nuna cewa ba duk waɗanda suka kamu da cutar ba ne ke kamuwa da cutar.
Har yanzu ba a san matsayin wadannan kungiyoyin masu kwayar cutar ba a watsa kwayar cutar. Koyaya, hujjojin farko sun nuna cewa suna iya taimakawa wajen yaduwar cutar.
"Abin da ba a sani ba a halin yanzu shine yawan masu kamuwa da cutar da ba su da alamun cutar, kuma ana nazarin su, Cibiyoyin Kula da Cututtuka da Cututtuka (KCDC) sun ba da rahoton cewa kashi 20% na duk masu kamuwa da cutar ba su da alamun cutar yayin asibiti.
Hukumar Lafiya ta kasa ta kasar Sin ta fara lissafin wadanda ba su da alamun cutar a cikin rahoton ta na yau da kullun a ranar 1 ga Afrilu, daga cikin mutane 166 da suka kamu da cutar a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwaji.
Dukkanin hanci da jini suna iya ɗaukar kwayar cutar.
Magana mai ƙarfi tana fitar da ruwa fiye da magana ta al'ada.
Wani bincike a Singapore ya gano cewa yin ihu ba tare da yin magana ba na iya sa ruwa ya yi tafiya har zuwa mita 4.5 (15 feet).
Kodayake ba a yadu da kwayar cutar ta iska ba, masana kimiyyar kimiyyar kasa sun ba da shawarar cewa isar da iskar gas na iya yiwuwa, kuma an sanya masu tattara iska a cikin manyan ɗakunan waje na mutane don ƙirƙirar samfuran RNA masu kyau.
Wasu hanyoyin jinya kamar su numfashi da kuma aikin CPR na iya sa hanyar numfashi ta waje ta tsaya, wanda hakan ke haifar da yaduwar cutar ta iska.
Duk da yake akwai damuwa cewa ana iya yada shi ta hanyar cutar, ana ganin wannan hadarin yana da ƙarancin gaske.Virus yana da saurin yaduwa lokacin da mutane ke da alamun cutar, yayin da za a iya yaduwa kafin bayyanar cututtuka, haɗarin yana da ƙarancin.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta yi nuni da cewa, yayin da ba a bayyana yadda sauƙin cutar ke yaduwa ba, a gaba ɗaya mutum ɗaya na iya yaduwa daga mutane biyu zuwa uku.
Musamman, an gano cewa kwayar cutar tana iya ganowa na tsawon kwana ɗaya a kan takarda har zuwa kwana uku a kan filastik (polypropylene) da baƙin ƙarfe (AISI 304) da kuma tsawon awa huɗu a kan 99% na tirela.
Koyaya, ya bambanta dangane da ƙanshi da zafin jiki.
Sabulu da sabulu na wanki ma suna da tasiri idan aka yi amfani da su yadda ya kamata. Samfuran sabulu suna lalata tsarin rigakafin mai na kwayar cutar, suna kashe ta, kuma suna tsabtace fata da sauran wurare.
Sauran magungunan kamar su benzalkonium chloride da chlorhexidine gluconate (magungunan kashe ƙwayoyin cuta) ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an ɗauki samfurin hanci a matsakaici kwana biyu bayan fara asibiti.
Biyar daga cikin marasa lafiya shida, samfurin farko ya nuna ƙaruwa mai yawa na kwayar cutar, kuma mara lafiya na shida ya nuna ƙaruwa mai yawa na kwayar cutar a rana ta biyu.
Wannan cutar SARS-CoV-2 tana da kama da cutar coronavirus mai saurin kamuwa da cuta, wanda aka fara warewa daga marasa lafiya uku da ke fama da cutar huhu, wanda aka danganta da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 sun bayyana a cikin kwayar cutar da ke da alaƙa da kwayar cutar corona.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida wanda ke haifar da fashewar garkuwar jikinta. SARS-CoV-2 yana da alaƙa da kwayar cutar SARS-CoV.
Hanyoyin huhu sune mafi yawan kwayoyin da cutar ta COVID-19 ta shafa, saboda kwayar cutar tana shiga cikin kwayoyin ciki ta hanyar kwayar cuta ta hanyar maganin maganin cuta mai sauya kwayar cuta ta 2 (ACE2), wanda ke yaduwa ta hanyar ƙananan ƙwayoyin cuta na huhu na biyu.
"Wannan kwayar cutar tana amfani da wani takamaiman superficial glycoprotein da ake kira ""spike"" (peplomer) wanda ke haɗuwa da ACE2 kuma yana shigar da kwayar cutar".
An gano cewa cutar ta zuciya ta kamu da kashi 12 cikin 100 na wadanda suka kamu da cutar da kuma wadanda ke kwance a asibiti a birnin Wuhan na kasar Sin, kuma yawancinsu na da matukar tsanani.
Yawan cututtukan cututtukan zuciya suna da yawa saboda amsar kumburi da kuma matsalolin tsarin rigakafi a lokacin ci gaban cutar, amma raunin jijiyoyin zuciya na iya danganta da masu karɓar ACE2 a cikin zuciya.
Ana nuna masu karɓar ACE2 sosai a cikin zuciya kuma suna cikin aikin zuciya.
An gano yawan hawan jini na hanta (31%) da kuma na jini (25%) a cikin marasa lafiya na ICU da ke dauke da COVID-19 kuma ana iya danganta su da rauni.Clinical analysis a kan mutanen da suka mutu daga COVID-19 ya gano lalacewar alveolar (DAD) da kumburi da ke dauke da lymphocytes a cikin huhu.
Kodayake SARS-COV-2 yana buƙatar enzyme ACE2 wanda ke kan ƙwayoyin jijiyoyin jini, marasa lafiya da ke da mummunan cutar COVID-19 suna da alamun bayyanar cutar.
Musamman, GM-CSF ya fitar da kwayoyin T wanda ya nuna cewa yana da alaƙa da kumburi saboda yana da alaƙa da sakin IL-6 daga monocytes da kuma mummunan kumburi a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton cewa ana yin maganin cututtukan lymphocyte.
Hukumar Lafiya ta Duniya ta sanar da hanyoyi da dama na gano kwayar cutar.
Hanyar gwaji ta yau da kullun ita ce ainihin lokacin da aka yi amfani da layin polymerase chain reaction (rT-PCR).
Ana yin wannan gwajin ne a kan samfurin numfashi da aka karɓa ta hanyar sauti. Duk da haka, ana iya amfani da samfurin hanci ko samfurin ƙura.
A yawancin lokaci ana iya ganin sakamakon a cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya yin gwajin jini, amma waɗannan gwaje-gwajen suna buƙatar samfuran jini guda biyu da aka raba tsawon makonni biyu, kuma sakamakon yana da ƙarancin farashi nan take.
Masana kimiyya na kasar Sin sun iya rarraba kwayar cutar corona da kuma rarraba kwayoyinta, don haka dakunan gwaje-gwaje a duk duniya zasu iya kirkirar gwajin polymerase da kansa don gano kamuwa da cutar.
Ya zuwa 4 ga Afrilu, 2020, gwajin kwayar halitta (wanda zai iya gano kamuwa da kwayar cutar da kuma ko mutum ya riga ya kamu da cutar) yana cikin ci gaba amma ba a yi amfani da shi sosai ba tukuna.
Kwarewar Sinawa tare da gwajin ya nuna daidaito na kashi 60 zuwa 70 cikin dari.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin magani na farko a ranar 21 ga Maris, 2020, don amfani a ƙarshen wannan watan.Jagorar bincike da asibitin Wuhan University ya bayar ya ba da shawarar hanyoyin da za a bi don gano cutar ta hanyar maganin kai tsaye da kuma hadarin cutar.
Rashin daidaituwa a kan gilashin Multilayer tare da rarraba kayan aiki, kayan aiki, da baya ba daidai ba ne a farkon kamuwa da cuta.
Ƙarfafawar subpleural (ƙarawar lobular septal tare da cika alveolar a matsayin aether) da kuma haɗuwa na iya faruwa yayin da cutar ke ci gaba.
Akwai karancin bayanai game da microscopy da kuma yanayin cutar COVID-19.
Babban abubuwan da aka gano yayin yin allurar rigakafi sune:
Abin da za mu iya gani shi ne: ruwa a cikin huhu, bugun zuciya, bugun jini, da kuma ciwon hanta.
Ana iya lura da nau'ikan cutar huhu guda huɗu:
Cutar ciwon huhu: ciwon huhu, kumburi, ƙwayoyin huhu suna girma ba bisa ƙa'ida ba, kumburi na ciki tare da shigar da ruwa mai guba da kuma samar da ƙwayoyin cuta.
Cutar ciwon huhu mai tsanani: fashewar manyan bututun huhu tare da narkewar ruwa daga bututun huhu.
DAD shine dalilin da ke haifar da rikicewar numfashi (ARDS) da kuma rashin isashshen iskar oxygen a cikin jini.
Jiyya na ciwon huhu: Shirye-shiryen exudates a cikin alveolar da ciwon huhu na ciwon huhu
Jinin: Rashin jinin jini (DIC) halayen ƙashin ƙugu
Hanyoyin kariya don rage damar kamuwa da cutar sun hada da zama a gida, guje wa wuraren da mutane suke, wanke hannuwanka da sabulu da ruwa akai-akai na akalla dakika 20, kiyaye tsabtace numfashi, da kuma gujewa taɓawa idanu, hanci, ko baki lokacin da ba a wanke hannaye ba.
CDC ta ba da shawarar yin wanka da hanci tare da tawul lokacin da kake yin tari ko tari, kuma ta ba da shawarar yin amfani da ɓangaren ciki na hannu idan babu tawul.
Ana ba da shawarar tsabtace hannu daidai bayan tari ko tari.
CDC ta ba da shawarar yin amfani da abin rufe fuska a cikin jama'a a matsayin wani ɓangare na ƙididdigar watsa kwayar cutar daga mutanen da ba su da alamun cutar.Hanyar keɓewa na zamantakewar jama'a na nufin rage yawan kamuwa da cutar ta hanyar rufe makarantu da wuraren aiki, ƙuntatawa tafiye-tafiye, da soke manyan tarurrukan jama'a, da sauransu.
Shawarwarin tsare ido sun kuma hada da cewa mutane su kiyaye nesa da juna na aƙalla ƙafa 6 (1.8 m).
Babu wani magani da aka sani da zai iya taimakawa wajen hana COVID-19. Saboda ba a sa ran gano allurar rigakafi har zuwa 2021, babban bangare na kula da COVID-19 shine ƙoƙarin rage girman cutar, wanda aka sani da "haɗin gwiwa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na akalla sakan 20, musamman bayan wanka ko idan hannayensu sun yi fari kafin cin abinci da kuma bayan hanci, hanci, ko fitsari.
Ƙungiyar ta kuma ba da shawarar yin amfani da ruwan wanki mai ruwan giya wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya, amma idan ba za a iya amfani da sabulu da ruwa ba. Don yankunan da ba a sayar da ruwan wanki ba, Hukumar Lafiya ta Duniya ta ba da tsari guda biyu don samarwa a gida.
Dukkanin waɗannan abubuwan da ke haifar da aiki da ƙananan ƙwayoyin cuta suna da ƙaruwa daga ethanol ko isopropanol.
An yi amfani da sinadarin hydrogen peroxide don kashe kwayoyin cuta a cikin alkama, ba shine mai kashe kwayoyin cuta a hannu ba.
An kara glycerol a matsayin mai kiyayewa.
Ana kula da mutane ta hanyar kulawa mai taimako, wanda zai iya haɗawa da maganin ruwa, samar da iskar oxygen, da kuma taimakawa wajen kaiwa ga sauran kwayoyin da ke fama da cutar.
CDC ta ba da shawarar cewa duk wanda ke zargin cewa yana da kwayar cutar ya sa abin rufe fuska na yau da kullun.
Ana amfani da maganin extracorporeal oxygenation (ECMO) don magance matsalar rashin numfashi, amma amfaninsa har yanzu yana cikin bincike.
An ba da shawarar tsabtace jiki da salon rayuwa mai kyau, da kuma abinci don inganta juriya.
"Abin da ya faru a cikin wannan makon ya nuna cewa, a cikin wani sabon yanayi, an yi wa mutane da dama barazana, inda suka yi watsi da cutar, kuma sun yi watsi da cutar, inda suka ce, "Babu wani abu da ya faru a nan da ya faru a nan da ya faru a nan da nan".
Kwararrun likitocin gaggawa da masu kula da cutar huhu a Amurka suna ƙoƙarin haɗa takaddun magani daga hukumomi daban-daban zuwa tushen bayanai wanda zai iya ɗaukar bayanan IBCC kyauta.
Ya zuwa watan Afrilu na 2020, babu wani takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu likitoci suna ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen don amfani da farko.
Dole ne a yi taka tsantsan don rage haɗarin watsa kwayar cutar, musamman a wuraren kiwon lafiya yayin aiwatar da hanyoyin da za a iya samar da iskar gas kamar su injin matse iska ko na'urar bushe hannu.
Kwararrun likitocin na da matukar damuwa game da mutanen da ke dauke da cutar COVID-19. Cibiyoyin Kula da Cututtuka (CDC) sun ba da shawarar ware marasa lafiya a cikin ɗakunan keɓewa don hana cututtukan iska (AIIR), ban da yin amfani da daidaitattun matakan tsaro, kiyayewa a cikin hulɗa da kuma kiyayewar cutar ta iska. Cibiyoyin Kula da Cututtuka da Cututtuka sun kuma ba da shawarar yin amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan aikin da aka ba da shawarar sune: rigar rigakafin mutum, kayan numfashi ko abin rufe fuska, kayan kariya na ido da kuma takunkumin likita. Idan akwai kayan numfashi, ya kamata a yi amfani da su a matsayin fifiko (maimakon abin rufe fuska).
An amince da abin rufe fuska na N95 don ƙayyadaddun masana'antu, amma Hukumar Abinci da Magunguna (FDA) ta ba da izinin abin rufe fuska don amfani a ƙarƙashin izinin gaggawa (EUA).
An tsara su ne don karewa daga ƙwayoyin cuta na iska kamar ƙura, amma ba a tabbatar da inganci a kan takamaiman ƙwayoyin cuta ba don amfani da su a waje.
Lokacin da babu abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska, aƙalla yin amfani da abin rufe fuska da aka yi da hannu.
Yawancin cututtukan COVID-19 ba su da tsanani wanda ke buƙatar sanya kayan aikin numfashi, amma akwai wasu ƙananan adadin da ake buƙata.
Ana nazarin nau'ikan taimakon numfashi ga mutanen da ke da matsalar numfashi da ke da alaƙa da COVID-19 a cikin asibiti, tare da wasu shaidu da ke nuna cewa ana iya guje wa shigar da iska ta hanyar yin amfani da bututun hanci mai zurfi ko bi-level positive airway pressure therapy.
Ko waɗannan sun kawo fa'idodi iri ɗaya ga mutanen da ke da cututtuka masu tsanani ba a sani ba.
Wasu likitoci sun fi son kasancewa tare da tsarin iska mai iska mai iska a duk lokacin da zai yiwu, saboda wannan fasaha tana iyakance yaduwar ƙwayoyin cuta na iska idan aka kwatanta da na cannula, wanda ke da babban gudana.
Yawancin ƙasashe masu tasowa ba su da isassun asibitoci, wanda ke iyakance ikon tsarin kiwon lafiya don magance ƙaruwar adadin manyan cututtukan COVID-19 da ke buƙatar isasshen asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5% sun shiga asibiti, kashi 2.3% sun bukaci taimakon likita na numfashi, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da ke asibiti da suka kamu da cutar COVID-19 an shigar da su ICU.
Injin injin na inji ya zama mai inganci yayin da alamun cutar ta ARDS ke ƙaruwa a cikin COVID-19 kuma shigar da iskar oxygen yana da wahala.
Ana buƙatar fanfo mai ƙarfin sarrafawa, matsin lamba da PEEP mai ƙarfi don samar da iskar oxygen mai yawa yayin rage haɗarin raunin huhu da cututtukan huhu.
Babban PEEP mai yiwuwa ba a kan tsofaffin injin iska ba.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020, kuma wasu magungunan rigakafin cutar na cikin gwajin asibiti.
Remdesivir, maganin rigakafin cutar da ke da tasiri mai yawa, ya bayyana cewa zai samar da mafi yawan nasara.
Kodayake sabon magani na iya ɗaukar har zuwa 2021 don haɓaka, wasu daga cikin magungunan da aka gwada an riga an ba da izini don sauran amfani ko kuma ana yin gwaji mai ƙarfi.
Ana iya gwada maganin rigakafin cutar a kan waɗanda ke da mummunar cuta.
Hukumar Lafiya ta Duniya ta ba da shawarar masu ba da gudummawa su shiga gwaji kan inganci da amincin magani. FDA ta ba da izinin ba da izini na ɗan lokaci ta hanyar maganin jini ta hanyar amfani da jini na jini, wanda ke yin gwajin gwaji a wasu lokuta inda marasa lafiya ke fuskantar mummunan rauni da mutuwa.
Ba a yi nazarin asibiti da ake buƙata don nuna cewa yana da aminci da tasiri ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta kafa wani manhajar wayar tarho don magance yaduwar cutar.
Ana tambayar masu amfani da su shigar da sunayensu da lambar shaidarsu.
"Aikace-aikacen na iya gano ""aiki na kusa"" ta amfani da bayanan sa ido, kuma don haka yana iya sanin haɗarin kamuwa da cuta".
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan an gano wata barazana, ba wai kawai ana ba da shawarar masu yin gwajin ba, amma ana ba da sanarwar ga jami'an kiwon lafiya na gida. An yi amfani da babban bayanan bayanai kan bayanan wayar hannu, fasahar gano fuska, sa ido kan wayar hannu da kuma saƙonnin rubutu don bin diddigin mutanen da ke da cutar da kuma waɗanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da izinin jami'an tsaro su bi bayanan wayar hannu na mutanen da ake zargin suna dauke da cutar.
An dauki matakai don karfafa keɓewa da kuma kare duk wanda ya kasance tare da masu kamuwa da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wurin waya tare da hukumar gwamnatin Tarayyar Jamus, masanin kimiyyar Robert Koch, don bincike da hana yaduwar kwayar cutar.
Rasha ta tura fasahar gano fuska don gano masu laifin LSD.
Jami'in kiwon lafiya na yankin Giulio Gallera ya ce an sanar da shi ta hanyar kamfanin waya cewa kashi 40% na al'ummar Italiya suna tafiya yadda ya kamata.
Gwamnatin Jamus ta kafa wani hackathon na tsawon sa'o'i 48 a karshen mako, tare da halartar mutane sama da 42,000.
Shugaban Estonia Kersti Kaljulaid ya yi kira ga duniya da ta nemi hanyoyin magance cutar ta coronavirus.
Mutum na iya fuskantar matsin lamba daga hukumomi, takunkumin tafiye-tafiye, tasirin magani, ko tsoron kamuwa da cuta.
"BBC ta nakalto abokin aikinta Rory O'Connor tana cewa, ""ƙaruwar keɓewa daga jama'a, kadaici, damuwar lafiya, damuwa da koma bayan tattalin arziki, duk wani hadari ne mai tsanani da ke barazana ga lafiyar kwakwalwa da lafiyar jama'a"."
Wannan cuta na iya faruwa a cikin ƙananan matakan da ba tare da alamun bayyanar ba ko kuma kusan kusan wasu cututtukan cututtukan numfashi na sama kamar su mura.
Yawancin lokaci, marasa lafiya sukan dawo cikin makonni biyu, yayin da masu rashin lafiya mai tsanani ko kuma masu tsanani za su iya daukar makonni uku zuwa shida kafin su dawo.
Mata masu juna biyu na iya zama cikin haɗarin kamuwa da cutar COVID-19 bisa ga bayanai daga wasu ƙwayoyin cuta masu kama da SARS da MERS, amma bayanai na COVID-19 sun kasance marasa ƙarfi.
A cikin waɗanda suka fi fuskantar cutar, COVID-19 na iya zama cutar rashin lafiya mai tsanani na numfashi (ARDS) wanda ke haifar da lalacewar ƙwayar cuta ko lalacewar mahaukaci.
Abubuwan da ke tattare da COVID-19 sun haɗa da cututtukan ƙwayoyin cuta na jini, ƙwayoyin cuta marasa kyau, da lalacewar zuciya, koda, da hanta.
An bayyana rashin daidaiton jini, musamman ma ƙara yawan prothrombin a cikin kashi 6 cikin dari na waɗanda aka kwantar da su a asibiti da cutar COVID-19, yayin da aka ga rashin daidaiton aikin koda a kashi 4 cikin dari na rukunin.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna nuna ƙaruwar enzymes na hanta.
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da mutane biyar da ke kwance a asibiti.
Duk da haka, marasa lafiya da aka tura ICU suna da matsakaicin kwanaki bakwai tsakanin hutu a asibiti da mutuwa.
A cikin binciken farko, matsakaicin lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance kwanaki 14, daga kwanaki shida zuwa 41.
A cikin binciken Hukumar Lafiya ta Kasa (NHC) ta kasar Sin, maza suna da kashi 2.8 cikin dari na mace-mace kuma kashi 1.7 cikin dari.
Binciken kwayar cutar ta kwayar cutar ta hanta bayan mutuwa ya nuna lalacewar alveolar tare da fibromyxoid exudates a cikin hanta biyu.
An lura da sauye-sauyen kwayar cutar a cikin ƙwayoyin huhu.
An gano cewa cutar ta hanyar cututtukan zuciya da kuma na jini, da kuma cututtukan zuciya, da kuma cututtukan zuciya, da kuma cututtukan zuciya, da kuma cututtukan zuciya, da kuma cututtukan zuciya.
Kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta China ta ruwaito, cutar zuciya ta kasance ta hanyar karuwar matakan thrombin ko kuma bugun zuciya.
A cewar bayanan Maris daga Amurka, kashi 89% na waɗanda suka shiga asibiti suna da yanayin rashin lafiya kamar yadda suka kasance a asibiti. Samun damar samar da kayan aikin likita da zamantakewar al'umma na yanki na iya shafar yawan mutuwa.
Kimanin yawan mutuwar daga yanayin rashin lafiya ya bambanta saboda yankuna sun bambanta, amma kuma saboda hanyoyin da ake amfani da su wajen kimantawa suna da rikitarwa.
Rashin ƙididdigar ƙananan ƙwayoyin cuta na iya haifar da kuskuren ƙididdigar mutuwar.
Amma gaskiyar cewa mutuwar ta kasance sakamakon abubuwan da suka faru a baya na iya nufin cewa yawan mutuwar yanzu ya wuce gona da iri.
Masu shan sigari suna iya samun alamun cutar COVID-19 har sau 1.4 kuma kusan sau 2.4 suna iya buƙatar kulawa ta musamman ko mutuwa idan aka kwatanta da waɗanda ba sa shan sigari.
Hukumomin asibitocin Hong Kong sun gano raguwar lafiyar huhu a cikin wasu mutanen da suka warke daga kashi 20 zuwa 30%, kuma binciken da aka yi na huhu ya nuna lalacewar hanji.
Zai iya haifar da bayyanar cututtuka bayan kulawa mai tsanani bayan warkewa.
Ya zuwa watan Maris na 2020, ba a san ko cutar ta baya tana ba da cikakken rigakafi na tsawon lokaci ga waɗanda suka warke daga cutar ba.
Tsarin rigakafi ya bayyana a matsayin mai dogara da halaye na sauran ƙwayoyin cuta na corona, amma a wasu lokuta, warkarwa daga COVID-19 shine ta hanyar gwada tabbataccen kwayar cutar ta corona a wani lokaci.
An yi imanin cewa waɗannan lokuta suna nuna ci gaba na kamuwa da kwayar cutar na dogon lokaci maimakon sake kamuwa da ita.
An yi imanin cewa kwayar cutar ta samo asali ne daga tsire-tsire kuma ta samo asali ne daga dabbobi ta hanyar yaduwar cuta.
Tushen ainihin ba a san shi ba tukuna, amma a watan Disamba na 2019 akwai fashewar yaduwar kwayar cutar, wanda ke haifar da kamuwa da mutum daga mutum zuwa mutum.
Nazarin farko na 41 na kamuwa da cutar COVID-19, wanda aka buga a cikin Janairu 2020 a cikin mujallar The Lancet, ya nuna ranar farko ta fara bayyanar cututtuka shine 1 ga Disamba, 2019.
Ofishin Hukumar Lafiya ta Duniya ya ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da wasu matakan ne don tabbatar da yawan mutuwar.
Wadannan lambobin sun bambanta ta yanki da lokaci, kuma suna da tasiri ta hanyar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar, da yanayin alƙaluma kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A ƙarshen 2019, Hukumar Lafiya ta Duniya ta sanya lambar cutar ta gaggawa ta ICD-10 ta U07.1 don mutuwar cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar cutar ta COVID-19 ta asibiti ko annobar cutar ba tare da kamuwa da SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje ba.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mutuwar cutar a duniya ya kai 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun hada da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutanen da suka kamu da cutar (IFR), wanda ke nuna yawan mutanen da suka kamu (wanda aka gano da wanda ba a gano ba) da suka mutu daga cutar.
Waɗannan ba su da lokaci kuma suna biye da takamaiman yawan jama'a daga kamuwa da cuta ta hanyar warwarewa.
Duk da cewa ba dukkan mutane da suka kamu da cutar ne ke samar da rigakafin cutar ba, kasancewar rigakafin zai iya ba da bayani game da adadin mutanen da suka kamu da cutar.
A tsakiyar barkewar cutar a Italiya, Castiglione d'Adda, wani karamin gari mai yawan mutane 4600, 80 (1.7%) sun riga sun mutu.
A Gangelt, cutar ta bazu ta hanyar bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin
Bugu da ƙari, ba a rufe tsarin kiwon lafiya na Jamus ba.
A Netherlands, kimanin kashi 3 cikin 100 na masu ba da jini suna iya samun rigakafin cutar a lokacin da ake tantance su.
69 (0.004% na yawan jama'a) an ce sun mutu ne saboda COVID-19.
Tasirin cutar da yawan mutuwar ta sun bambanta tsakanin maza da mata.
An yi bincike a kasar Sin da Italiya, inda aka gano cewa yawan mace-mace da ke mutuwa a kasar Sin ya fi na maza.
Hadarin ya fi yawa ga maza a shekara 50, inda bambancin tsakanin maza da mata ya kai 90 kawai.
A kasar Sin, mace-mace sun kai kashi 2.8 cikin dari a cikin maza da kuma kashi 1.7 cikin dari a cikin mata.
Ba a san ainihin dalilin da ya sa ake da irin wannan bambancin ba, amma ƙwayoyin halitta da halayyar hali na iya zama dalilai.
Bambancin tsarin rigakafin jima'i, raguwar yawan shan sigari a cikin mata, da maza masu sauyin yanayi iri ɗaya kamar cutar hawan jini a ƙuruciya fiye da mata duk na iya ba da gudummawa ga yawan mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne, kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Ya zuwa watan Afrilu 2020, gwamnatin Amurka ba ta bi bayanan da suka shafi jima'i na kamuwa da cutar COVID-19 ba.
Bincike ya nuna cewa cututtukan da ke haifar da ƙwayoyin cuta kamar su Ebola, Hiv, zazzabin cizon sauro da SARS suna shafar maza da mata daban.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan kiwon lafiya mata ne, kuma suna da babban damar kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar a hukumance shine COVID-19.
Shugaban Hukumar Lafiya ta Duniya Tedros Adhanom Ghebreyesus ya bayyana cewa CO na wakiltar corona, VI don kwayar cutar, D don cutar, da 19 don lokacin da aka fara gano barkewar cutar, 31 ga Disamba, 2019.
An zaɓi wannan sunan don kaucewa yin nuni ga takamaiman wuri na ƙasa (misali, China), nau'in dabba ko rukunin mutane, bisa ga shawarwarin duniya don sanya sunaye, wanda ke nufin hana yaduwar cutar. An sanya sunan kwayar cutar da ke haifar da COVID-19 a matsayin cutar coronavirus mai saurin kamuwa da cuta ta 2 (SARS-CoV-2).
Bugu da kari, Hukumar Lafiya ta Duniya ta yi amfani da kwayar cutar COVID-19 da kuma kwayar cutar da ke haifar da cutar COVID-19 a cikin hulɗa da jama'a.
"A cikin kowacce, cutar da kwayar cutar ana kiranta "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an fi kiran cutar da cutar "coronavirus" da "coronavirus Wuhan".
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar 2019-nCoV da cutar numfashi mai saurin kamuwa da cuta 2019-nCoV a matsayin sunaye na wucin gadi ga ƙwayoyin cuta da cuta, daidai da shawarar da aka bayar game da amfani da su a cikin sunan cutar da sunan kwayar cuta na 2015.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakantaccen damar da ake samu a cikin tsarin samar da kayayyaki, wasu kamfanonin dijital suna samar da kayan kiwon lafiya kamar su na'urar hanci da na'urar daukar iska.
A wani misali, lokacin da asibiti na Italiya ke buƙatar mai shigar da iska cikin gaggawa kuma mai ba da sabis ba zai iya ba da isasshen lokaci ba, sabon kamfanin gida ya ƙirƙiri kayan aikin injiniya na baya kuma ya samar da allurar da ake buƙata 100 a cikin dare.
Nan da nan bayan barkewar cutar COVID-19, an yada labaran karya da bayanai marasa inganci game da asalin cutar, rigakafinta, maganin ta da kuma yanayin ta, kuma duk bayanan sun bazu ko'ina cikin Intanet.
Mutane sun bayyana cewa suna da ikon yada kwayar cutar zuwa wasu dabbobi.
Binciken bai sami tabbacin kamuwa da kwayar cutar a cikin aladu, aladu da kifi ba.
Babu wani magani ko rigakafi da aka amince da shi don magance cutar.
Binciken ƙasa da ƙasa kan allurar rigakafin cutar COVID-19 yana ƙarƙashin jagorancin gwamnatoci, ƙungiyoyi, malamai da masu bincike.
A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da wani gwaji na haɗin gwiwa don kimanta tasirin maganin maganin rigakafin cutar guda huɗu da ke akwai da kuma gano mafi ingancin kayan aikin.
Babu allurar rigakafi, amma hukumomi suna aiki tukuru kan samar da rigakafi.
Ana buƙatar sake yin amfani da binciken SARS-CoV na baya saboda SARS-CoV da SARS-CoV-2 suna iya shiga cikin ƙwayoyin ɗan adam ta hanyar mai karɓar ACE2.
Akwai gwaji uku na rigakafin.
Da farko, masu bincike sun yi niyyar samar da cikakkiyar rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko ta kashe ko ta kashe, da nufin saita tsarin garkuwar jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi ta subunit, tana da nufin samar da allurar rigakafi da ke tayar da garkuwar jiki zuwa wasu sassan kwayar cutar.
A cikin SARS-CoV-2+, irin wannan binciken ya mai da hankali ne kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin enzyme ACE2.
Na uku shi ne rigakafin nucleic acid (DNA ko RNA, sabuwar fasaha da ake amfani da ita wajen samar da rigakafi).
A ranar 16 ga watan Maris na shekarar 2020, an fara gwajin farko na allurar rigakafi tare da masu sa kai hudu a Seattle.
An nuna cewa ƙarfafa dogaro da maganin rigakafi na iya zama ƙalubale ga ci gaban allurar rigakafin SARS-COV-2, amma yana da rikici.
Akwai gwaji sama da 300 na gwaji na kai tsaye da ke gudana a watan Afrilu na 2020.
An yi nazarin gwaje-gwaje bakwai kan magungunan da aka riga aka amince da su don cutar kansa, ciki har da gwaje-gwaje huɗu kan hydrogen peroxide ko chlorine.
Antiviral da aka sake amfani da shi ya fi dacewa da binciken kasar Sin, tare da gwajin kashi na uku na uku na Remdesivir a kasashe da dama, kamar yadda rahotanni suka nuna a karshen watan Afrilu.
An sake nazarin yanayin ci gaban asibiti don allurar rigakafin COVID-19, kuma an gabatar da takaddun shaida a watan Afrilu na 2020. Ana nazarin magungunan antiviral da yawa don maganin COVID-19 Remdesivir, Chloroquine da Hydroxychloroquine, Lopinavir/Ritonavir da Lopinavir/Ritonavir tare da Interferon beta.
Akwai shaidar wucin gadi game da ingancin Remdesivir a watan Maris na 2020.
An lura da ci gaba mai kyau a cikin marasa lafiya da ke karbar maganin remdesivir.
Ana gudanar da gwajin asibiti na Phase III a Amurka, China da Italiya. An yi nazarin chloroquine, wanda aka yi amfani da shi don magance cutar sankara, a China a watan Fabrairun 2020 tare da sakamakon farko.
Amma akwai kira ga sake duba binciken.
Hukumomin lafiya na Koriya da China sun ba da shawarar yin amfani da maganin chloroquine.
Koyaya, Cibiyar Kwayoyin cuta ta Wuhan ta ba da shawarar yin amfani da gram ɗaya kawai, kuma idan muka yi amfani da gram biyu, yana da haɗari sosai kuma yana iya zama mai mutuwa.
A ranar 28 ga Maris, 2020, hukumar FDA ta ba da sanarwar buɗewa don ba da izinin amfani da magungunan hydroxychloroquine da chloroquine na gaggawa bisa ga shawarar likitoci a cikin kula da marasa lafiya da ke dauke da cutar COVID-19. Shawarar ta 7 ta China ta kuma ba da izinin amfani da magungunan interferon, ribavirin ko umifenovir don cutar COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban matakin ribavirin don hana SARS-CoV-2 a cikin gwajin asibiti.
An ba da shawarar ƙarin nazarin Nitazoxanide bayan an gano cewa yana da ƙananan rigakafin cutar SARS-CoV-2. Sauran nazarin ya nuna cewa akwai sakin furotin ta hanyar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Nazarin chloroquine da hydroxychloroquine don amfani tare ko ba tare da azithromycin ba yana da mahimmanci, saboda akwai ƙin yarda daga ƙungiyar likitoci cewa ya kamata a yi amfani da waɗannan jiyya ba tare da yin nazarin su ba. Oseltamivir baya dakatar da SARS-CoV-2 kuma baya taka rawa wajen magance COVID-19.
Wannan ƙaruwar cytokine na iya zama sakamakon ƙarshen matakin COVID-19.
Akwai tabbacin cewa hydroxychloroquine na iya hana haɓakar ƙwayoyin cytokine.Tocilizumab ya kuma shiga cikin maganin, a cewar Hukumar Lafiya ta Kasa ta China, bayan kammala karamin binciken.
Yana cikin kashi na biyu na gwajin da ba a yi ba a matakin kasa a Italiya bayan ya nuna tabbatacce ga waɗanda ke da mummunan cuta.
Tare da gwajin jini na serum hydrochloride don gano Cytokine Storms, ana nufin yaƙi da irin wannan juyin halitta wanda ake ɗauka a matsayin sanadin mutuwa a cikin mutane masu fama da wasu sakamako.
FDA ta amince da maganin maye gurbin interleukin-6 bisa binciken binciken baya-bayan nan don maganin cutar cytokine mai saurin motsa jiki wanda ke haifar da cutar ta hanyar kwayoyin CAR T a shekarar 2017.
Ya zuwa yanzu, babu wata hujja da za a iya sarrafawa ta hanyar yin amfani da tocilizumab a matsayin magani mai tasiri ga CRS.
Ana ba da maganin rigakafi da aka yi wa allurar rigakafi da tsarin rigakafin waɗanda suka warke daga COVID-19 ga mutanen da suke buƙatarsa a matsayin hanyar rigakafi ba tare da allurar rigakafi ba.
An gwada wannan dabarar don SARS tare da sakamako mara tabbas.
Kwayar cuta ita ce hanyar da maganin antibody mai aiki zai iya daidaita kariya daga SARS-CoV-2.
Duk da haka, akwai wasu hanyoyin da za a iya yi, kamar su cytotoxin, ƙwayoyin cuta masu dogara da antireceptors da/ko phagocytes.
Misali, wasu nau'ikan maganin kwayoyin halitta masu amfani da kwayoyin halitta masu amfani da kwayoyin halitta masu amfani da kwayoyin halitta masu amfani da kwayoyin halitta suna cikin ci gaba.
Samfurin da aka yi wa mutanen da suka warke da jini daga mutanen da suka warke da cutar ya ƙunshi takamaiman kwayoyin da ke yin yaki da cutar da ta fara fitowa.
Cutar kwayar cutar coronaviruses wani nau'i ne na cututtuka da ke da alaƙa da alamun cutar.
Li Wenliang, likita a asibitin Wuhan Central, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya yada fahimtar yaduwar cutar.
